var title_f23_49_24336="Disseminated granuloma annulare - papules";
var content_f23_49_24336=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=DERM%2F51459&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=DERM%2F51459&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Disseminated granuloma annulare",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 432px; height: 381px; background-image: url(data:image/jpeg;base64,/9j/4AAQSkZJRgABAQAAAQABAAD/2wBDAAYEBQYFBAYGBQYHBwYIChAKCgkJChQODwwQFxQYGBcUFhYaHSUfGhsjHBYWICwgIyYnKSopGR8tMC0oMCUoKSj/2wBDAQcHBwoIChMKChMoGhYaKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCj/wAARCAF9AbADASIAAhEBAxEB/8QAHwAAAQUBAQEBAQEAAAAAAAAAAAECAwQFBgcICQoL/8QAtRAAAgEDAwIEAwUFBAQAAAF9AQIDAAQRBRIhMUEGE1FhByJxFDKBkaEII0KxwRVS0fAkM2JyggkKFhcYGRolJicoKSo0NTY3ODk6Q0RFRkdISUpTVFVWV1hZWmNkZWZnaGlqc3R1dnd4eXqDhIWGh4iJipKTlJWWl5iZmqKjpKWmp6ipqrKztLW2t7i5usLDxMXGx8jJytLT1NXW19jZ2uHi4+Tl5ufo6erx8vP09fb3+Pn6/8QAHwEAAwEBAQEBAQEBAQAAAAAAAAECAwQFBgcICQoL/8QAtREAAgECBAQDBAcFBAQAAQJ3AAECAxEEBSExBhJBUQdhcRMiMoEIFEKRobHBCSMzUvAVYnLRChYkNOEl8RcYGRomJygpKjU2Nzg5OkNERUZHSElKU1RVVldYWVpjZGVmZ2hpanN0dXZ3eHl6goOEhYaHiImKkpOUlZaXmJmaoqOkpaanqKmqsrO0tba3uLm6wsPExcbHyMnK0tPU1dbX2Nna4uPk5ebn6Onq8vP09fb3+Pn6/9oADAMBAAIRAxEAPwD5kmd/Ok+dvvHvSb5P77/99Glm/wBdIf8AaP8AOmdO1ZGo8u/99vzNHmP/AH2/Om4zj/Clx6UhXAvJ/ff86cryf33/ADoAp2MUXEIHf++//fVPDSf33/OhRmr2l2DXcwz/AKsHk+vtUOVlcqMW3YsaPYS3TiSV3EI9/vV2VjaOqrgsB2GelN02wO1Qq4QcdK37aDpxx7VySk5s7oRUFZCWsL7QCW6etaFtDJkZZqmtoeOmKuwoVAz19KVrFC2yMABls/WrK7g3GfQ81JCrKmeMn26VYSIjnGaaQDYImYfNu/OrcMGDjLfnS27hyMA4HtV5IgWHHJ70h7FZFcORk4+tTx7znJwB6GrAhxwelSLFn5fX9KqwriJkoOTUqI56ZGKkEWAADUiphdvcd6pIVxiIWOCTUiKwBI5FOjQYOT0qaGMgH0HTNMRGFfIzn1PNWI8k4yaekZBy1SRqMccUtxCqCBjNLkk8ZpUXBJJpwIDgYp2AXkngnNL82Tyc/WpFUAE4NRIWLn0qluADcWzkjn1qzGMZPNRFfmFT+S7j5D1piY5FyQTmleIuwwfepUj4w3WpiAuPWgkqFSgPXNOWJtmW71ZVCcE09o8rjpTC5W8oBd3UD3pEJDYCkDvVjysL65p5jXBOOe9AEYxIMDNNdfl69B61JsXJOcc0rhcDjqPzoJ9Cky/NnJwKmBxjn2p8iDcNozTWjUOH69sVVhDSzA4GfTNOQErknvkVIFy3zf8A6qRyMlQMDPBpisQyOdxHOQc9agwWOAxweassmSWx6GmfKHwByTQMj2GMZz0p0b9T0I5FOl+ZCp78HPrSBcRnA59qYhFYuxxn0HNJIpXkZ5680RZHP3Sen1p7riPIGT9etCBkChicYIP+cUnJ4PXvUwGOVOTjvTNp3bivFAEQUohzkjHTNOAyBtJzjJ7U5xkYLEqenvTAxDqACAe+aBkbE85DY4FKqkYJJ9uaeAACOcn0phXlSW4HQYoEfCE/+uk/3jTBxUkoPmyf7xpMVRzjQD3p4HFH1pc0gE9KcKOKcOtICezga4mVE79fYV3ejWCQxqqLwBWR4dsdiAsPnfn6Cu20614AxgVy1JczsdlKHKtSa3hCRj361qQxgKoC4FJDEAPXFXY4ieh/KpRqCoR0HBrQtYVfknntTI4sdOfStCCHaAMcmgdhiwqFOOcVYt4spjvUghJGB1q1DHtXoD2oRT2I44hx8ucVdjTAz39aYqNgbeD61YYfIueDTSJbB4wQSvT1qVIsISMkAU5E+XLDp2qWIAKeeKexIlvhVyRyfanxqrk+tLEhbnBxmpYgASAMGmIYYQo44zUnQgLTuScVJGnNC1GMBJJGanXAU+tIkRLGpIo8kjvVpCZFtIA7nNWYIwx5GKTG05I6VIBnB6UxDnBC8VGLckAjNWoY8qN1ShQB7ZoEQpEFAzUikgfLUgUE59KkVVVcd6BEWDkDFSEA4DZp68npTlGCDRYZCGKkinoWbsc0joWLfWnJnZjHvxTEC7jJk9BQVPbrmlTduIJ4FOPbFMRC6k8dD1pWXdzklgakbJYE96SP5dxPSgBqsO4OR2pjIxO5Txn0p8hO9R2p6ccYxk9fSmIiVTt5+lNdc9T7mpCCB8xz7/yqHeCCFHPpTQhCW5BHSkVQGJb0/rUqk5we360xsKNufmpiICCXySM9cYpxVSM559KQnknBxjJqNWZnzgZ7YoAsDryuAKj+YhiSAKkIYIcHJHUGjIwBjOOnNAEI+7gAA+tDJngZ2jnn0p86kEFsehApGBVBtOAeB+FAEMg2ygL0AyKCjZwxz3xUkaAqTkc98007gM8e9MBhb5QfWkKj5SOoNRMp3gA5B7+lSKFzknGP15pAfCE3+uk/3j/OmGpJv9dJ/vGo6o5he9OHPaminDpSGKKv6XbG4uBkfKvJqiORXTeGrf5VJHL/ADVnUlZGtKPM9TqNItgFXd6YrpbVAMY4FZ2nR7VAPOa37aIYGe1cqR2EiJ2Aq5AjbemaZFGSeOuK0IIP3Y9aoaEt4yBk1phSuGqvEgUgDpV6IArkCkxijJ/nip4d2fQDvUSZJOB9KsRqWAxxzTW4h4Bx1qZU+YAjrSeU2QOvrVmJcnGASKt2JEVCOM8CnKmMkdKlQc4AxSPk9OlAiWPJWpEwF96RN2MA5pRGSwpMB2MHingMBkCnqMdcZqWNCVyetNbgyKJTtzT0hIOd2amEXABFSKhVRVARorN24p4AyARU0Xyg5H1oVQHyR1oEAJVenTmkyRjjrUxwOAM0x1+bLdqoRJFjaPWnBQwJ49qVUGePqKUKV6UCuEKEHJ6USBg3HK0qt1xk1IjbkZQM4p2FciyBn1x0ogUEnJ4zipHAOflwfQc80sYwigDv+VAri4ULkDnODStggY9aiBJQD3qaEALzjOaYEDI24c5welTSBVGR09M9aJwQd2RyM/jShOCT+NCBkBG/kfhQ/Uhee+KnKhdwGCB6VGpHOMk46+lAXISHJyp4z3ppjAJ4G4YpzHaNwz6CjGQXz6c/hVIQ3jd8xxz1qHDZ4wAenFTpjcCeSTQV3EYHI9qYhhhBQ9SCPyqPbtweDxkVN5uTgADIwQOg4qJyIwMdTxigBuWBOOeM5oGA23cR74pqAqCeeOmKVRmQdielACAkEZGc0rgFcsBjPanSkLhUxnkE+tRkYJ3n0oERqPl4x9KVsn7xPHT0qV8Kignnk00kuhIwcDH1oGV7gHBGD7UiuPLXjB9cU75tmWIx6dxTSpIyqjGR+FAHwjN/rn/3jTKfN/rpP940zvQc4opfam9+acBQIkhXe6qM8nFd1ocONvH3eK47TI990vXA5r0DR0HAPtXNWeqR10VZXOk09Q6jscVs2y421l6evPTrgGtyJMMc9AKlI2LUEeJMngHirkRCrjiqkP3AWOTVqIbdrfnTsNFqMDg1aRQo9sVBDnJzz6VdT7nuO1CQMWEb1zgYq1Cnz56KahRTtGOB7VZVyFAxxTFclQZJ4FSwgFiaYmTzjkU87jgK2CfSgkkGAcetLsBokRl2jr3zT+rDHSqAco24xVrblAQBUKFTjHapskD5cAUAIinGW4FTquIxg5FR/exxTlyCQpz7UIZOgbAwKlAOzkcjvUSNhR1zmpEJZgDn8KLCJFGB79adtJb5cU9RzjPNKq4bpwelMVxrDawz1xSN8xAHGal2h+ScgVL5QKDPJzTsK5XIKnnPTOKkbnlc5qTysSZyOmBS4CoVC9TxVCbIIwfukc+v0qzbIRlh35NMlO07scggFfrVlNwJiPB689/agTK0iFiCp4GM08AjBAAAPJpUY+WvyD+8CPT0okL7ioxjO446UC3IWXc5bHQZwaRSQ+DwQO3epH4JJ6nnFJj5fb+lMY89RkAjGfpTCfnBPPUU7cUcMxGMZI+tRtkZz07ZoEDnLZHI6/So5COg69c1KGVEYjoPWq55JyecUwuSRRFUYYzzz+NQkg4A6jr70+NyVBIOPQ1GB+8Yr+tOwrisOQR0GTSs+CV/i749qHLAHj/Cq0ZO5iwPGOtMRKylSSgIz1qHaC7Mee30o887gMYH8qdgDnOB1IzQ0AhJ8sqpGR+lRKhGcsSAflpzDL5U5JHIP6UojywIPtzRYdxu/I5FK7YA7kU8LhSc81XMgKnByCe9KwD1+YH1HT/CmNuDfN0xgCnY2/dbtTWYPkZwCKaQDJGO05ztP6kUzzlUAdyeKVgBFjkke1JGA23fgelAHwpN/rpP940wfSnTf66T/ePf3puaRzC0o9qaOKcPWhjRsaJHl93HJrvdJQKAcY2nNcnosG1YgenQ++a7nSl27c9Bwa5Zayud0FaKRu2CgEH1GK1VQkZBzmqFqpXaAO3FaKhgVOcqaEUy3D9zaetXowDtAHQVUiBEgwODWjEBvx2oAfboWJyatovzfWoUjKn5c4qzEuJFpoB3ltt4z1qxGp4z1FLu2nOKUMWOR36GmQ2KCcj1qWN8vjoag3EuRyasRLhORk0wWpOfu5647U6EBjg55pqjKACp4lwMigY5E2dR+NSISSQe1J8zHjlaepA6DmgB0eGJ709QVJ4pYduOOtSL8x/2TQIWNWLgdqnjXkkHpSRLxgdu3rUqxhc4HB5+lMVyRY8jPOSKcoABJ5wMH296fEnTJOG6UCEFSeMscCqJuNCHYTgdO1SxYKsXz905psgaNT67c/mKbg71c9SMkDtQA8/fHBAGf5UZB3ZK5wBntilYglA52kqAG9elQsSZFPJGP8/1qhEkozJz6bvf2qU46huOvPfj/wCvio0cufmUbBknnk88VEpkEmMDaSSAe1ICdAASCfmIIx2FJGwCtnA6cn0p23jaOcjB/wA/rUTK3YEgjaB3oDcWZSzquRnhgeg9f60wZ8zk5Q9akKBgitwpHFMcZjKk/OTwaYDZMElcHB96RiyDnDDH8qYGKn8O/enqDKeOfb2ouA2Vd8eR+VNCp5YbO3B5qRk2qR3Axg0wKERdvY9+9UIRXVkKjv0piSAphhggZzUjAAMQMHvUB6lT/D1ouAjHcoBPzdPwpr4C9RyMf/XpdgLcDgUjY3ktngYApgMwFVt2ORjPrUaAFtx5GKeRuYD+EUj42jaAe2DTWohyyIsmVH/16RFJY4I596RSqcY5PrUbuS21RyMkn2pASSBQOWH09arONwAzx6CpJOhPUDtUSnbIGHUUDFzuyWbAXjApvlsBlPy7ilkzt+XA9xRHIQNuQQOc4603oBFLvA4PPrUYzlc8cirD56/w9arlN7gL0z34pDPhqb/Xyf7xpuO4p03+uk/3jTaRyi1LAm+ZAehNR1asVzcLSlsVHVnW6THlQcduK7LTV+ZT2rmNEXj1GK66wUAgdmHWuVHdfoblkMqSc8fpV6MZxzwarWR2KBjOeKuxqccH6VWwJFu3Vs5PIHStGEcg9KpQkhAMZYVahO5Q3pQMvIcHHrTym5iAeRVdWJwQOnFWNuNrA0wH89ScnHNJExzn1p7oQwOeD6UW5G48ZbP5UxPYsRjcM45/zxVlAGQEdagQEEe1TqW3cKRiglCxo28gjv0q0ilWGew60hAkw3Run1p5I2g8+mKdiiWM8YU4z+tOiUZ56dKZEAO+cdqnG0n5cCkAqKvfpViMcHOOtNKBiG6mpFI3KoBy3QUIQ6MgkgcMBxT4lLNuYgAjPX8x9adFguC3GTjpSAfvCG4FVYlk8JZNmRkKfpUy4xwM56fT1pgPlqCcNjnA5zg1AdwO6POOoHY54xTehNrk7hg5YHoAD6GlkBUPlvuhV5/HihpMZDZyPbvxjj8KZIpAY/w56A+lAAv3QXBwCRx644xSOoVl64zj1pzOpAG455b8fao2BZiOQGP8qYJEsWFYlwNoOM+tJLIpYD1Xj/P51EzknGcDBPpSbQTljwv8qAsOaTaBt5JHTrg0rSlkLY2kDj/P51BI0g4yOeuOvpTpJCUB2/LzgfTigqw7zCGwQA3X2FP4bIPGTxn0qu7AAFumOvoaQyDbgk5IIHH8v1pisWdgIIJBPTPeiICMcEbh6VCkqlcL1HWmlzu3YweOaQrDy2DuY5GeB6UyXKgjIweeDSLuZ8nIUdjUQU5LZyPSmmKw5iXbH8I5pBGTksByOKkQjZlRn1PvUTsxk2iqEG4IMcEkcVBK/dePX3p7KWYH0FNkOCF9cc0rgiJ8mP7x44NKpAXb1OOKWVtvGOTziq5B83njHIqkMmc/OcHIA6VErlmPGAfWlR9wGTgZ5AFNDEkBQDnqadxWJSxLhB3PpUDq6rwMg9zUxVRyTg9agySOenY0kwGM2cc9euKeCq5IPGO9R5+cgAEn0pzYwPXvT3Aa0megxio0l+YZxtJ9KR3IyqgCoyQrjnP60hnxDMP38mf7xpv0p0x/fSf7xpvekco4e1XtMUmb24FUF61p6UMEnHeonsaU/iO20XoD1UcV11gu1VrlNDHyHnpzXW2ZBUDsBjNc6O1LU2LM8cDk8VqxAZBHOOazbEEjJGMVowEbzj8KYy0Acjnj2q3H2HaqaEPjFXrdQVyOvcU0gLCLgcdKeW2nB6imRsw47U88cEZB6GqQiQs27AOQOaljAIGTUQGMdx3FTxpg7gM4/hoEW1ZFYD16VYbAAPbp9KpxrvxxjPQ1aLYQL6dqYiVEBU4OSBxUgK4IY8YyPrTFYCPI4z2HY0RANg55JzTC5YQAglfpU8aEcnn2qFSsb/OCFPHNTxFwAhxkHGc0guSIxLY77tvX8jQx/eKWyNvBOOhpI5NzYVcv79xRJGWJJJx1HvjvTQi2qjfzkqOhP6U9dvpk7sj/AAqAymJBvyR2FKHBK7T8oG446hfWmKxei2k4ZeACf07fnTztUKCC2OAfT1FU40ILO7HjKkHsamRh1zwfX1oFYZlhnPPOM+3pT2ctuXAxnO2kOGydwBXke/tUZwD0w3cn60DJiAsgU8/1PrTd4D4f8MU0dctj+8Of5UjnkZAIx39KZKCThCy8njgjrUIO0kZypFSSkjDKCT2qAkhT5gw3YdxQikPeUk++3FNV853gr9PT/wDXTFYH2H86rXzkLkZB6CgpK42e7VjsyASSOe+P/r1G8zM6Bu3bPXjGay2cCUgZJzuOfU8VJAzvNhSSoz+HtSTNuWxqwtJuIP3h1qwZQQRjr+lVoZArNjJPepkALkjgCqRjLcnLrjO4UAhl+vSoQASAeRQzkKcdB3pGbQwllkbaMDuB0qWMDbuBO/1qAklcLyfXPWhnwMDO4CqEycuOmMEcfWm5Xdkjnpg1CpyvIA75zRuIxnn2oFYeThyOcntVaYkucZ445qdiGJYEZPU1DnaCVxjpjNCYwblRnB746VEoxLkDrzTxgpuY5zyPpmhWUKQD170xEkhDuBnoOtRzkBVCngetRSSZ47dsUjEE9eemKAGxn5yOv17U8nOVI/GmBVjLcke9NaTg4HFMCE5LMQDgd6RCC4I5/CkJPOOD9KSI5kBb7tK4HxHMf38n+8aaDzTpR++k6feP86Sg5hQOa1tJAwPdqyRWvpH8IB4JqJ7GtL4jt9G+QnJyG4FdXp+Pu9dvT3rkNPyIQR1Dc11unAEBwe1c6OxM3bf7vFX4+FGOGxWfaYB461pKwA6VSQXLVvh+uc4z9K0IcBeOtZ0T4xVyBju29m6U0Jlv5gM9x1qdGyozyKrjJx+R9qsRKR17UwJFCl8Z471Ki7ZBz+NMiChiRwOh9qe+E2kYwxxzQFixnP3e3epAGI39lwCewz61FC/Xnhhj/wCtVmFcq/fP+cUCHeWwQqDtzjAPanWwcYKpwDg59ach2qRnK4z17UkO5mCJnIb5V9f/AK9UkImZRIg4yxIP4dxViNQzgbiQSecdV7E++eKZHIkrnaoUMAMk9D65qSNmi3B1OfbqKBEsbBRnnr8p6URzFsBiMLnt+lNiAzvDjKn5vQ+4H07UKMqABjB4JPPtk/1NAXG3AYgFSPl9/wDPFNs5Q0u5wRwQfx6fjSkYTO11ZQVI6Y/CoYG4wduSSOB2plp6WNNXJlIzkdeORik3AD5TznpVWNg3zKSfrUu4jJ6UEkqThlOB+OaRpCGCjkelVYkKvnONxJ9D1qaRhnnHA4OKLg0SZ/dqc8dKRZN4PNV2dmUDBGOKa7nzABjnj8KCS08m1ADxnpVaRmbj17+lDZckZ+UdRTgQB3+lBSGqQq8nBz2qC4w4yDz6HinysoGScCse+uipOOQOn+FP1NIq+w65KRggEZHIBFRQXiqTtwCfesa7unkOGbk9fWmW7neA2cDril6G3LpqdWLpCq8jJz9TU32oRn8Otc3HKQwbdj05qSe5cMAxIqkzNwudCbr5eo5p0T5XAPHpXOW9y7Hk8e9bVpJiHdIMZ6UIynHlLK5Ab1JxTlfJOeMdKrh98mQwAFOckttUjnuRTMhS5fIUgKD+NN3ZJAJJFNX5Mj0/WmyyBCcd6YEjEqcfd7dKYflGGyOahidnLN6U4OokyTnjt6+tCAUbm4ORSHjsMjmlZ22fL9aUpmMbj8zd6YEcjlgMcCmRk8jgDrTmwFAHXPT1qEMWYNtwppATMRuBJ+WoX46EUkj88kEn0qKQ/umyQT3x2piHNIF6cn9KYMmYE5qq7HjBPSljlPAC8k96llWPjGY/vpD/ALRpo5p03+ufP94/zpufWmcg4YGK1tJ6r7/41kDj61qaV1/GonsaUtztdJfcvPTriuqsHCgAfUVx2nHDKMdf1rp9OcYXcfxrJI6r2Omtnxj9K1ISCBjuOtYlvIABu71q275ICmgRowjPSrSZK4xyKqwuB3zmrcZ4A6DPX0pootocgMv0PvU/mH7vTHpVa3kBB3AZIII9D6/hTi+1tv8AF04pjRbTardcjOPapcDyj3BPQ9qihIeEofvDoe4qeI/LscdRx70APg2NjB4OAc9jmrsRzMQN2T2Ayc/TvVCMAEDnceP/AK9WmYEq8XUZHHt3Hp/SgGWCw8wFV+90UHg5HQH88eop8SKEjYhsbtpPp6H69sVUeYuANuEAAdR6+v58/WpRK3nfNID5nDZ/i9KoVi8gzwgDfNnI657j6cZqw0iLIFGJEdfkYdfcY+ueKp8ln+UqpIHPVW7/ANeadnzOR80nDfKcHNFhErkEl4shWx8vbPpTvNOdicFhg89KjaQMr4KmQnnsGH07H/IpFZpAQMcAcHv24+lArE0zhYhu5HO09vT8s1Rlk5yhIz61McgAMefeq8sa+b8mAoPTNO41oSw3S7v3gIXnJPr9aliuMkqSCOnBrPdQQ20kA8Gkt12MRye2e9Kw3Y2gcqG4P86jlckqF6dTzVcTYHBIpw+7uJ560WJuTb9qnPHHaoojwd+M49elQPN82ABzTZJiE470BYsmQBuD0pj3BYBQPm9qxZ7iRZMA5FXLd8pu5NCL5bK5PMWKYGQaxruJ88g47n1rXaQkfN09KqzlG++abQ4Tsc+ImDEt0oDgA4Az3Jq9fBUU7CCD0INZJlUSEkfQmhI3vcsK+Mlj9KGmAJyScetQNIzPhRhexzTigA9R796qwjTsB5jDPbmt1seWBwKw9NyvQDB9ea1EO8gY4pI56r1JwCEO0Aj0NSwjCFn9M5qDeuCTnPYU4MzrnBI9DTuZEj852g5NNJjEZXkv60jMQM45x0qLDOGYjgdcUxCKx3lVzwf1pJNw4AGSfzp8RKcEZzzSEqRkdqBiHcqgH9aRwVIXdmkYbhktz1PbH4VEjKu4ufnzxjtQBMzokZGM8VXkkPlrt4B/OlkYAAsQAKid9y8EYpASZULyOarSsSSSOKVpMKV6/wBBVdlaQkM4HcDPWhAICqjJOT0NCcyDHIPrSsiAdMt2pWUKFYN36elMZ8bTf6+T/eP86Z9afL/rn/3jTM8dTTOQcK09IP7wA81mDIrS0o7ZFIPeonsaU/iOx05ThD+R9a6Cw6DNYGmkOMDg10VkRwMVijoZv2pVgFetGD93gjt0rDtnycHtWvbt/C3TtVWBGpBICcirsLkrjjNZ0ZXjJwTV2LoMH5h6ClsUiwOxBq2wJCDChlz8w/i+v9PrVZcsMgAHvTxkAHPHT6U0NGhCxwrgfLnaw/un0z74NXcDIBP+7z+lZcLYVvp83vz1qwz7Rx0I9OKYFyNsTbRnIYMrMcYx1B/x/wAalRXDb0++BkgDv3/A1SjbtJ8smeT1zWqkxjCyELsHyjjI6cqfQHOcUA3YYm0gtvCuO/Qc1GGjMhJJV04XIB78gj/OamDNGOP3ildwDdx7+v16iqKIZpJVUnAHyg/eTnt6jmqQJmhBcZ+aMgE8EKR3649vY9KVH3SApgkAAkdv/r1UiidUXLEnJ7cg+n8qn3KHOSCcn5gMbvr70A7Fhj1LISpwCQf61I5ZV2IWGeeeT9aqq+6QKHIU916EDvj/ACaHkY4QMpwc8dz/AJ7UCJvMYKM8noaiaTOSFw/8/wAKrTTk8kspPQg00Ozkjgjpu9fw7UxCCbcxLbVx2zU1vKr88/nkiql1A4QEDOeSRTbJZI2xg47AilexfKmrmkST8qsSfepBlupwT2qBB13fgM9KkJIbJ5I4oIsLIcHjPHFRANk5PHvSSMc/MenoaiuLgRoORz0oQJdhzohftTtyqvHbpism5vc/TpgU1LsgDJ496ehfIzWkYsgJyD9ao3bYA5yR6iqh1AMxVTk1PEvmoc80D5XHcybqVmfbknPTFVmjdXySADWpLalW75qPyNxxjPqTUps2TXQrQIoGDkmrUSDILgbfao8FTjC4HHHerduqsvzYJ9AKYm7Fy0XGCo49q0FYIuV7VXtowEwMDP6VKy5AGcEVSOWWrHhuCT+VPOVxnr6VCR0we1OJ+XAyfU0yRk8yRjG7n69aia4ZsAEDPpUFyVVyzjJ6gHODVZ5VEY3PmQnoBzQaqKaNXzlUcNkHv60NIRwOmOKzoZEU4J4HfripkmL529x1PWgiSsWRuUA8E+9RswDnPXv6CkWTHCZZh1z0qBnCjk85o6Eklwy78k5HoKgZz/Cfmb+VG9MHqWP4VAxyctx/OkAP97DuVUUqNGTk529ai3hgSRx+VSBlwDgBecZqrDJHkZsY+6Pwpm77u45PpnpUTOSctjHtTM5ZOgGaQHyFN/rpOn3jTBT5h+9f/eP86Z0FByi1p6YAWUevNZn41o6edskWO/FTPYunudppWG9mXg1v25yAwrA0wBXV16MOhrftlwxYfjWSOlmjZEK5J6GteGQFeT7ise3+U5xjsRWpatkDPQUxGlE4I6VowN8w9f51lqpBA7HrV6AjcAfwNDGmaCSkHkYPrVsNhsjGDwR2PrVaEbioOM/XFPAGAQeT+WP6UitCct5Uu+Nfkz9084HpU43CLcpLoDwKqhzwm3Iz07/SnxsyMjK2f4h/hVILFpTvyFDMCcKfUHsasxO4KnJ2juRnGOxHcVTU73Ypkbz93tmrEEjcl/uEc+1NgTM8ihRyNpxyMqf8KezfugCASCFUk8qMev8ALNC7VkUSEmIDaQD/AA+n0pQBIQPLVgB8x6Z9s/1ppk7kgZ3+YFt4+Ug9TxnIqQOJ1yVAbqxJ4P8AhVZWMLHy2wDxtfB/z9akhlRVxzkDABHHX19KAt2HbfL3E5HPPHT61HI2QxyRjqcdPwpkj4GW5x0B5wKI5FlB+XH06j6UXGojV2EKFIz3WrcaIvA4yeMGqqBEyU/TqaYLpd+Aw/EUx2vsW5QQ+cZA9qFKA+hpm/f25NN3HGQV/GkIsZHJByD0qKSTbnngUgIKc1C/zcHJz3FMW4/zAwIHNZt8JG+7nafetHaqPtGM96btzuyOOvNIqLs7mIqPjnqOcUyUnBAODWq8aljgVTuYzvContmhmymmULfeZOFBHrW5a/LFk5yR2qtFbBAMjn6VegG0fPn2A60JWJnNMk8vcoPcVDcQnbtzzVtWzkYAHXmkkjXq3Uc07GKk0zL+zMzbcE+9XYYFhxvx7DNLFMC+Ezjpkd6c4KEHJPtTsNzb0ZIvUtuUZ6UhbcxPUCo/laUY3HHWkk6EggY6nNBNiQSK8m0ZyOvNRSzkZCdAelMK5VigC+9QsrEYyu0du5phoQXd1I5YjbgcYrNaRxIWbPPtWjJsDZ547Cq7xhgepJoNYtDI5mkUq2FXpxya0LTdsD5O7oM9qoW8WDl1wB2q6R8m8njpxTRE2tkWTKQSMde/rVed8MMgZPoaZJIWAAK+2PSopABlt25vWkQkPkfaM8mq7MQhYnn2FO5f1zSMCcbsDHpQMWFGZdzdOwFP6cEg0xWYEANgUGRRuPJNMQeZgZIOKN2SMDqRgelRSyFh8i5z6U1fkZc/e+vSmgPkyb/XPn+8abmlmx50n+8f500fnSOQcBVyE7REecYFUhV4jESkdhUSNIHZ6RLuhiPcD5q6W0GTlTniuG0Sf5EGRxxiuysJB0yQCOKzXY3Nq3AK9+e9XYRt4HWqNu37vnmr0DhuO9GwzQjkyu3GMVPExHDdD0NVY2K439+9Wlx94dOlMRet3+6jNwehPSrkMivyo2nHzA+vr/8AWrNgf5Mdef1qyrcgOOemen5/40i0y6MZ4J9u+anG1wcjjsQehqkrkY3DBHt1qeOUB8xYw4wVJ60xlmM+WykMevX/AD3q6sjxlWJEeclC33CehHsf88VnRMJVI7/TOPrUiOc4LBl4JB/r7UwsWxMsYeN1ww4weq/Q96ckgWUNGSYwfTt7iq/ykZVR7rjp+fao/nj+UEgdOOhHtTsJF83IdSjoMMcrkfyNNC7gfLbafQ96gR1wRIWKjkEjjP4fzqTzQANm/a3GByCaC7EkjMBiRT7EelJIm1QGUgt0A70ySZlQAKOO4ao1lDqfm5HRT0pBZlgqE5ZSM8jmq5TdJ6Z9qgknfdhicdu9O34bgHce1MrlZZSRkUBunrUnmZ+7kn0JqvucoFJxT4xtz8xyfxpmbRYLtxzg46CmF2UfMPxoKbVyQT9KRWDNnqO3FBJLGmRlgCfahhlfmBAFIJBv2r1FLLIeAOv8qA1IQik/KO/rTjEjHcc5zSlyqnaeO5pyyZU5fj+dBTuJtyuCCKcsZUcnOe1RtJuxuO3HbPWpELOByAKCGmOC7FO3qaHLBAOC1JJuCccmowGUEE5Pei5JHjyzj+I981KPlh24PPGaYnloSxIY0ElzhsqtMbdxRyv933zVdLdjL5m9sZ4J7/hUjuisF7Ckacbccgj9aYJtDbj5Tw5I9AahLnOM49utE0idSdp/U1Qe5CSep9elFylG5eAC8n9elNYcjBwPpVT7RvYDlvfNTedgHjinuJqw8rzkZI9TSsM4PPHY1CsoJyG5znA5p5mKg4XFAmhN2TsJAH86OA+Qd2O3YVC8wUEkc+mKYZNqg7gO9FgJywZsE4FMkdI+rZHpVf7QuCwXAH8R5qlJeAsxjwwB54oGlctvcEghVP48UiPuG1jz7VTWYNls729ulKXYsCQAenNUSy47fKASAO3eot+HUD72agmmQH5m6daj+0A7QDhc4zQgPmCb/XP/ALxpuPSnSj99J/vGmAnHTNSco4DPFaypmPB6msuPl1HTmt+BMpg9uayqM2pK5FpsjQzFa7DTrg8YyR71yjxHzN4Hf861tMmK/Kc4B/SlvqapHb2kuehyD0HpWjEeQK5qzuNrDmtiG4yc0WA2kYkDccelWoST9zp3FZkUwYAHkVegcKP60WGX7fADD5tuCfdT6/SrUYYnk4x1+mKoxuA2c4OOxqyJDsUZHy9PxoQrl/AaMLknjOfSo5IT1jzz1BqKGUEgjjsaviQMu3GRj5T0INNMtSsQQyOsgGTv6knvVxfmJDMGzzmozEhYgYfgEHoRUiEYw4yOgPf/AOvQVe5ZiVdnr0zg42mpAxUMFPy56N1qBXIPPUcc9/alyTnZk45K4zigkmfbKgZflk7kHrUUiuE55A/iHakRlJyRtx1NPZcg4cEdqZSlYijzsI3Er6E07aAMqBj60wgRkt39uKrPckseAM0rdzTfYlkYBxlTirUKKU3fN+BqvC3m9VPvVqMqAcgrn8M0xOWhIpIHOc+hFTxcc8Cq6AF8gYB6nrmpVlVVO0E4/SixDHyZIJyKrySKgI3HcfQcU7fv55H1qOdQFOAM+mKZPqSwzdNp+uaR548/MaqqGUYJx7VSuGcORk4obLjFM0pLpdp2nI9jiqMt3ufkke9MiDcknqMdKR4xktke3rUvY1SSLEdwSuRhqmhnJ7H8Kp25AGM1ZAJwFAA/Wna5EmkXBMGxgsSO9K53cY2g9Wziqqh1HHHvTwQexb3NOxi9x+BGw28DvSNKc53ZA7VE2Sec49qjK7W+bpjIApkjpH3HJOPWoZHCLkg/UU87CuSD9Kr3LHbw+FplJamddXjhsp8w75qk85fl1BJP0FJdyxb8MxZuoHWoomDP8obJ9sk/hUpnRZWJo7qQSbYuntWkHaUYzlcY9qzWQKc8hiPug81PGdzKNwUdNqngfWrMpPqXYwFGfM+X24p0kpYk7sqvqapPIFfBbg9PSiV3yNpAB75poybuWHkPOQB/SmF8k549az55AoxuP0Bqr9qY/L0GeO+aYWuaN5IhXAYgerd/wrPILdGPIxg8U77ScdQp9TVfeCNzFie2egp2BaFxZAqgLnGORTJJmOORjPU1QEu3liDmk89S2cknsKBFx5B0zn36CmCZVZcAkkjmqEt0VHzYqs16PMXbgcj3zRYXMeFTcTP/ALx/nSZ5prvmZweu40o6HpUNHMTW3M8Y966SFcAH9a5215nQ+9dVarlB+lY1NzoorQcsfHIyKlt49rdDgVOI9yg9KsQJ8+Dx/EKlGrLcMQZFIq5DIVwOajtlAx696vLAsgOKtMglglIwc49a0objOCDgVjbGjIPbtViOTjIOMc4qhnQJOcD5frVqN89enT6GsK3n3kbWwT2NaMFx1DdOwoA1onLHnJz+Yq9C5KjOPTJ/rWXbEMpHGD69KuJKZCWZz7565/rSEae8YORk9yKkPQMCOe9Z6OV3d19utSRz5X1HoaLXKTLnmZBDDkD+HpT0JKFhjA7HvVVGBIYA5B9aczEHcOCDnpQPcsqwOexNDSKrDIH0NVzNvJIAB6nHFU7q6kjwFAI9xQ3YuMbs0GnJUhWVl+lIUQ4baAfUGqNrcF/vfLmr0BBHGM+xoWpUk4j42EY4IwTSiYnIOAM9c059q4JwcionQE9B+HFOxCZa80bduR065pqttXJbOPU1ANvTOQKezRkYK5FMLgZCWwB+I5p+xyRtBx+tQRxhZAf506SWQHgDFIr0LGFyM8+gNRuoznGKajluDkU5cZpkMVx8oB5Hv2qN0JXgDB7mpTtBJI5HrUZkUtjrmhE3fQjRVTgY+pqwFBA+Yc+nWqrlQ2M80iyE9AeO9A7tlwvGpwGz9aQTnHQKPyqpvCnOMtURk/eHIz6UCsW5JvlA3Y9SKpXV95WcEcdzSzSAA8hcVh3coLNvAbHOaDSEUy4mps7nPAz19ahuLmRj3I69eKzpG291XHfrRbzYO6RmYDge9FjRpLYsLHuOSu5jVvi2TewwSOlVftqLkLjJ/Oq9wzycMSoPYnrTMm29yR7lmbPI9BU8cm9sNxnoOmapxoEG4np6U4uvzHBUHkHuaaJk0y28gjOcKD65zVZ7lsbVXP4VB9o5J4A6YqMzsrk8KfUnpT9CSeTKqNx+cjHNRMCq53ZJ9Kqy3DEkk1WlugEK7wv161SVhNl8PxgAfWq8twq5H3m9RWVLeDg5OelULi7xy0m0e5600S2a81wgbPPXrVae/AbhskdxxWMJHuGxApkOeo4FadpoNxcMDcNtHXimk2Q5pFZr7d0YuSegq1ZWV1eSodvlIWH1rc0/RLe3UbVGfWtiGNUeNVAGDzgVSh3M3Ub2PmGQ4uH/AN4/zqYciobgYnkx/eP86lXOBg81lIRYs/8Aj4T6111mpCqeOK4+24nT612Nll4hjniuepudNHY0UXEe48gDmrMUfT9aS2T5RnuKsxxYP16VCNHYmh4O09a0LcY471UiAOD39atQnPGMEd60JLShW42/Wka32/dHFOifa4NWlIAOc49u1NAZgV0bCk596njmcH5uGqzJEJASMZ+lRNCenUiqA0bW5xjpn0rQt58tk8HGawIiwOWJPpxWlDKxiX+6OuaQWNtJQ4BJOfXOakDqowMD3FY4mwx28DHfpVmG4A5bGfXvQFjTUgKzBlwMZ5xUkbEOrZJArNe6C9cFcelOivl2/MAQfQ0ilFs0i21gO3tTJNhHP8qijnV1yPoCaJPnJ4BxRYpOxKvkqSzMMduDU8U8WMIQfesyWPcpC7gaS1jEf3iaDTRrVm2WwMnGT6ioyw6rUCyDI5pDKu7I7e1UjOxZxkckY6UyTIAAPTvVSW9SPndnPqKqvqKMCAQST3FBSiy5LdCM45+ppovcyYzgVn3AE4yF3HHaoYraTOSAB70rsv3bam2l0iNnfuz7UrXDycK4XPaqEcEaYyT+FTjIOQvT1otcybV9C4JGwQxyTSGXjhTuqrE7Hqdvtmlk5GA3FMzuWN+Sd2P8KQzqBwQD9c1ULIpOetJ5gKY59hihhcmaXcWLA/U1C021T8wPbAqvNI4PU49+1VpJQDgJ9DnimgJ5pC4PzDJrPngbknI7nFT+bnrhffFQSuMjLkHtg0WKUmtiAq23AzUDKTxtO41O8igYXH1NN87YBzj8OafKHMxscewHOM1P5gQfewcZqlLeJnGQQOcVXe6j28A+v1poTdzQeUrzkZI/Kq0kwPIOR71ny3JDE7sk85qncXyA8Nx6nqadibmpNeDcACAo7DvVSe7ByeBnvmuc1HXoIFbfKqkdiea5rUPFLOSIF3+7cCmS5JHcTXiyEh5cJycZxzVGXVU4SL5m/uiuS0q5m1eVkllO4dV6cetdz4X0+FJmXZuPTBFNRuZuoVBHezjOzylbv1zVyz0USMDcOWPvXUT26FQirtx2IqvbqVPPWtFGxk5Nj7OyigxtG2tIhWA7DvVVXO4g4yPWp41DNg8CqJJYgRznPp6Vbtxl04yc1F5ajgnHsKtW4kDrtVUyR15NMD5ZkT99Jn+8f504cD3p03+ufv8AMf503p05rlbLJI+HXp1rsdJOUHrjNcYvUZ9a6nRmKhevSsahvSZ01qTtx3zWigyB61m2xIANacJz9cVCRqPQYORxVmHkdaaFzgipYkO44IqhE6qTjPQVZi44zmq68HsKmAyoHpVICwwG35Rg0MuDubHsRSAnHWlGSNuD60xjHTuB1PIx+tEbYYgdM8fWn8AYYZXFMztHJzx1pgT5KjkHPsamjk3KBjkVUUjPUgjn6VMp4yOvT2NAWLH3+rfQVWeEkkqDxUwAPQgcUoIAwSQPWk0VGbQsE8keOpAPrVgag743AjHeq5kBclsHvg01pF5Axz2HNFiua+6NOO9G7BPJ7kUkkjYyrGsVrhUI4P4cVdiuQ44AGeaVgd1qTRTTKx569hVhm39eT7VTMo4B/SlNxhflyPemlYHJyHzI5GeTn0GajjhbPzAgZ9MVWlvjGD8zMTxwaZHeGUjlgO9Ba5rGos6qdhU5qzG6HngH0JrHHJyM596siVUX5mGaCHY0vlIyAevripBKhPHX61iy3WFPr6g1AL3H3yaNQUbm+wUnAIA9M1HKyLnP5g1zdzfuP9WSfxqA6jJgglRn86EgdNI6WR1UDb+tRGUq3GSTXPR6mcYJA96sJdGYH5jgdxTsQ42NN5053E59qqtMcnaOfzqo0yg4ViagluDgdAPeqsTsW5Z8A56iqUl2ynn5f1zVWe6BYYINVZriNeSAcjgZqkguXZLoqeMZ9QKq3Vw5yFkKgjnisy61AoNq7VJPGDzWFqPiSC2DAy+ZIPQZo3E3bU6Iylejg/j/AFqhqGtQWyYkkVce9cNf+Jby5JEbCJO2OtYkkjSNl3Zj6k07GbqHX6j4syCtsjNg9ScCsG81m7ucZlMYxjC8frWZn/69HFOxm5NjnYs2WJYnuTSZpD3ooRJa067exvIriPOUPIz1HcV6r4a1GN57eeJspJgj29a8hrc8MasbG5WKRv3Dt3/hPrVRYM94mlEj54GKqzLsdu6nkGq9jMZoEfvirIRj93NaEFczg8dCP1q1BcgAB1JH1pTp00g3BMn61WeB4zyD9DxQM14rxNm0YC+gNWYblPMUnrnjmueGOhyDUkW8Om1s8jigDwCb/XSH/aP86aOlLNxM+P7xpPrXMUOX7wrotMbCj1x09a51BlgD0rc044I9DWczakdbaSbkX19q04GJIb8DWLYtgEY961YG2t1rNbmpsRMMeo9Kevyc9qr27KTyeatjJOMAr/OrYEilSQR+VTqf7uM9qjVMDjp70H5TxwfWgCZV7jgGpVJzyc02I88gc9qco28DkUxjyuQeKQImDngjocZ/ChGyetPJXHO4H1pgVhCBLlGwD6np7Va2lU5bHHIxSYBHJGPUUvbBoC9yMnnIx9KY8uM7h9M/0qYqOTtGKidVI4U4phoVnugE5z9QakRiwJHcUv2dHYZAyKVIvLOQSR9aRfMrEbJ6cMeelTRbgRkjGKUAN1HHrTxtXABz9adhObZIzFjgAYxUbNjqBj607zF/hBB9qbkE4bB/pRuSV5Gj/iOPqKqSXSqTsAJHpVyaNCCAAwPJANZc0W1j+7+X2oNIy7l+K9kQAsnH61Ol4Jc5GPrWOInxnLD2NWoFOAuWJ/SgTaLsj5H3yPaqs0gzj5uac2cYL9P9qq7uQcBgadiFJjZZTt4BI9qq+eG4IyB3NPkcscd+vA6VWZ0bPzZ78U7BzMkEvXAAqVWABBkYgckA9aqG4Rc4BA/Dmq8+oIpPzfN7UWE5Nmi1wR91iPoagmuNmdz/AJ1g3utxxKDJIgb0Jrnr3xG7Ei3XJP8AE1Mhytuddd6pDEhZmUEd/SuZ1HxOqufJUyceuBXN3V1NdOXncnPboKrMTjH5UXM3PsW7zVLq6zufYDxhOKznzj2pTnFIelUiL3GGiik61QBmnU2l6UhC0fnSUtIBR+dHbFNpRQB6x8OddgurYWl4x82LAz6j1r0ULD5YMRG32r5s0+8lsrmOe3bEiH8CPSvYvC+uR39ok0bdeCM8qfStFLoS0dzCSPlGcjsKdMgdfmUH2qraThznPJrQyoA3d6oRRa1R+GHIFRf2cAytGSOelaYCqM5oCsWUqe44NAHy5PxNJ67j/Omg80s4zK5/2jzTM1zFksXLjtzWvZnG0/nWXbAM/ToK17MfuyD61lM2pnQ6e+cf3hxWrD0B65rBs22smD7VvWj71z3qLmzLkBIxz071qQyHbz0zWbHgAHHXpVqA46cfWrTuI14hlf8AGmgEnAHNQQyZ46fWpVPPXtTAnUHHTPtTznjBz7VHHnGSc+lSnGORyD1FAxR0yVNLknH900ivkkHpS/dJA5UmmA/HA4FNAO7IPHcelKwwmV/nxRGwYAEYagB23uCR9KTcwGMAj6U7gkYB9eKfgMc5A7YIxTAh7jgc+lSEKcYP503ZglgQRntSsxByP5UAMKjPJGKhkXdgZ4qyA2dxqN1U8leaAKchZMhFJ/CqrTz54/I1ouu0ZDcfWoXVieMEH1HNA1KxDHMWzvUgU7G88EjHqKbIm36/7JqrNcFBtGVPtxTegblkxsTkhT9D0qGV/wC8uPxqkJ5M43H8KGnwME5PuaEJoldm9fpzUMkrKCahlm+Xn86zbu9ijiO6VQwFNE3Lctxx93Pqc1mzXgXkMOKwdQ19FylvmTIxntWDc3s9xw7kL6DgUyHNI6C+12OPKREOw9P8aw7rVLq4zulIU9gapAelFIyc2wOWJJJJPqaXHUHrR1FL0FBInbmmuOKcaGGRmgCs1JnmnN1pCaq4DM80h6Up6mkz7VQBR3pKWgY7v7UGkoHB60hC9/ak+tBoPWhAKK1tA1eTSbwSJloWIEiZ6j1+tZBpQaEB7xompJdW8ckUgZGGQRXT2s4lwSefQivA/CWvNpdyIZ2P2WRvX7h9fpXrem33ygowOeRWiZLOr5zwAB161JHJhhlTnNUbS482MBu3U1cgYGQHPfFUI+XZj+9kGeNxpvfAp03+uk/3j/Om4/GuY0LdiuTnGRWxaDEoGRg96zbFeBxWrEgGPY8msJO7OiC0L0abSD3PUVqWblWUHucCqcKh0wcZ/nVy2X5vmHApFs2IXDhcfjVkdKz7bgkr26VejJYZJyKpCLERZCCMGrMUpdiOBUEXUY6dqsBBuBOM9eO9UBaiOegx61LGOTgDHXmq4JXBAqVGA6NxQMnAB6ADPr2oaPkEce1ReYRjkjHtU6vuywGOOmaaAYVHCkkn1B5o+6M9R2pTtODSqmRgHn6UXAjM4T7wNSRTB+jbvxpsseR/9eo4IDG+QSB+VGpa5bF5ySBtUFR+BpCgK7gvHtQCFOCoJHcNSGUjoKZBE3X5c4prEkYBJ9qm+VlJfjFIxXHFAEDKNwzxUcgYNksSKtMmFySKr7V3HBzRcCrKDnOOPcVVeLcCdqmtCQICeCT6VRm4GF3LTQijJEcnoPwrOnyHKoCze1a0sZ2HceKrTTC3Q+WuGHoOaoTMHVVeytTPeSbUHRV6k+lcNfXkl1ISflTsvWuh8YPI1rD5zFmeUt1zwFPT8xXK0MxnLohKOe45pR7c0g+91pGYEZPNO7HFIKXPY0CE70Z546UvrQcHGcUDE6UDr05pKOlFhEUgxzUeanlHyioTTQxjdab7U5vWkq0MQ9aUdaTNLQAtFHFGaQg+lHI+tFGfWgYUZxR3oNACg12fgvxCYZEsr1/kPEbnt7GuLpwOCP50bCZ7/ZXjRkHOVNbttdrIyhW5yM/WvJvBviLz41tbpv3yDAJ/iHrXoOnTKXQDuRVpkngc3+uk/wB4/wA6RckgD86WX/XSAf3j/Oltl3TKPesGWatooBz29K1I1DoMEBu9UrRcg9cnjP4Vo2/IU46cY+lc7OqK0Llr04xmtGIddpwPes+JSCOmOorSgUsAfzoRTLMOQBjmrURweDxWayyb1MblSDnjkEehrSXHBFWiS2hwBjPHOKsIQ/KnBqnE2Dg9O2anVgDkgqwqgLAmKnax9qsI/O4qMY61UJDEH739KlicqCo5HfmmBaBG0g/KetOUkLwenHFV94IwM49TTkIBwB+XegZP5vJ3ED096mBKgYIweaiQ4A3qKeCPwoAc745Jzj0FL5mcbc4HX0ppGScZBoUYyNp/CmBMr46kAUcnkMKjwCOAcUuNqnbnBoAceTzg0PgcjA+opjE7aZJkLnqfSgB5YH3HpUEm0ZIGDT1zt7VHKwKkZxj0osBXZ2HzA8momk9Rk/WpXc//AKqrNIozk4/Wq3EQS5yWyFHY1mzEzSYB2x5xkdSM1ZuJGPLNwBmoCAse4jscA/zo2EziPGuPtltgk5RsLnoA2M/j/Suc4/CtnxU/majG3YRBR7YJP9axs9j3oZzz3A9KTOKCRmjvnNBAZ7DFHsaBignn2oAXPFKOTSCgHNAB7YoxS9Pek6Y/xoGIwyOBVY8VbxUEowaaAiamkU89Kb2qkA3pQPag0UwFFL2pKX+VIAoopaAG+3elo7d6QGgYelLmigfSgCSGV4pUkjYq6nII7GvUvBmvrqKxpKQs6EBh/Ue1eUg1b0u6ls9QgngbDqw/EdxTQhJv9c+f7xqayH77I7CoZTmWT/eP86t6auSS2OfXpWMtio7mnbD5VI4Izx61pRDb26nJHsaz4uAvZver8TkHoDxWDOqJfiXKn64q9bllXHUdKpxHe4I4HfjpVuEAOBnJ64oHIujGMn6VIqjPWokII74/lU0eDz3qkSWIiQQBzirCtkYxke9V0bnGOaeH+Xn9KrcCyCBtCDPpg09XyR/CaqA9CpBBqbJ4xye1UBa3APnAU45x0NSKFL5VssB0qvGwbtUwBADAUMaZYyQvPGOxqRW+U9aiSRSMSDj86UlcgqRikMnGOob9aa7fMMdaZkdN2RSb1zgEHFMRKrcfKefenMwJAJxUKvhicce1I0u5s7s+tAyfPGAeR61E/PXIIo3dx0qOTnqf0oFcRiykkZqvv4IIGaWQtjJzgVHvXHK49+tMTAjIzk49hVd1IIwo9BnvU0kuRhOp9ulRM2B6noDTTAquoGSSOKo3p3qVzwOST0Aq1MS2VUEnpWTqEgETjnLDr/hTEcRrz7r7A4wg/Osw4xVzVW338xHYgfkKp9KDmluHTA9KUik3c0Z60EikE9PxpOg7UZyOP1pPwoAUk9yKDzRmk78frQAdKPajt604/hQAK1NlAK4FAPoDQT6UDK9Np8i4OV6VH3q0AGkFO70BeDmmAYowcUmMHBoFIYvFFFFAgzQfyo7e9FAxMmlpD60ZoABUsH+vT/eFRdKfB/ro/wDeH86ALEv/AB8Pn+8avWShVGByapSDM78dWNaVuRlRk4yKymy4LUto2E96vQHIHoelUTnAHfrV+0GSATxWLOmJowNu2gnB9auoq8bThs8VnxDngcelX40+QZ6ikU0WYi23DZ3D9RU6P2qsoIwR2q1CVZQfWmiCzExGDTmfHToe9QhuvTNOA3Dg8CtEBIp+bIqzGRj6VTVSMhevsamR8Dk49jTAuJsbI3VKM7SDhiO1V1wfujpzTi2QCKQiUEbSFyKcp3N1OBUZcEEHhh6VF5pU9zmmUWCwUnjI9c0kQJJO4YqIPlcjFOBwuQSD2GKQyzvDNtIIPvSSuqEKcZ6VTDHdk85o8zkA7s+1OxLLZlA4FRyzDIAYEkdM1Gw3DIOfqaiGAfvLn6UwFeUfxNnPFRZ469PWnOwHQD6nrUBbDFccelCBj3+5gMT9O9RF+SBjIHHNByxOcCoXIH19BRcCOSYjPLZ9qw9Rk4boEA3H3x0rRuZNnJ+Ymua1aUpazEEknjPqapEva5zEjmSRmPViTTD1wKXjNIT9TQconfpRS5pD70AKOv0pDk0fSlyfwoEA+lFH86Xrx2oAQikx60p7Y/OkOccD8aAAgmkwM4wadnk03PfigBpGBTGTBzipOtJnJqkxkYUdqMYzT6TtTAawzUfSpSM9Kay96LgMoP60Ue9AwpfwpKXNAhO/SijvRQMQ1JD/AK6Mf7Q/nTPpToT+/j/3h/OmBdUZvDxnDE81diGDnHfNVYhm5k69Tmr8YPHQ/TvWEzSCLYKnrzxyasW7ZK8YAqtHjHOAfSrEQIc+lZHQtDQt25xnHersD5XBrNRgGGeaswSgrtHXuKCzVDEJlj0qaJwQOMGqYJ24IPOMYqeN9rYJz7UEMs8swwc9qmQHHPNVY243KMH0qdJM4Pb1q0K5OFOO2frSSKGPXH1ppfLAZH50/IPBpgKmd2NxUCniTDf1qNW2njvSlgTg5pjJlkXPXJ9RTlk55AOO9VR8vb9KFbBOCaBFveCSV49fSoy5c8N0qHft70vm9TtH1osO5Nk8EDJpVYEct9cVXMu1MBc5pu1iuMke9MCWS425VCCR1oWXjP8AF9KqiNEf3PU0/P8AdA4oBsmZtwJPJpgY5GSBxUJ9TyR+FIZQFy3T1oEOd+xJ4FVZZggJJzxwtDyDHy1VnKrnk+uaBFa7kaTO5sH16YrmtdmDRqowAW4+gH/1/wBK27ucAcHqMdOnqa5XVpN9xgdAKoio7IpHqKT260p45zmk6kUHOHGc80e/NGc8UfhQAY546UtJzn0xQOnNAgHXGKM+vFL1PXnNN46ZoGOzmkzzS9D+NJxk560CA8mg4I68UdB1ppOR1pgHY0lKT0pCc0DDp0703FLQetMBtOIzTe3vVjaCikdCKUnYaKrrg5pg61YlHNQMMN7U0wEoHSijNMQCiiimMX606H/XRn/aH86ZT4P9dHn+8KANGJf3kp/2jVuE8AdadDaZZvn6s3b3qeO0xj5+vtXPLc2joh1uepPrVsD0zn1FNtrTLMvmcH2q4tr0G/le+KhmqIlGW7cVOmVbcPlxSvaYwRIclQTxVmG3yCGfI+lM0RLbyjeVPTuOtXEIfHAyP0qpFZquGDfhirkVucg7z+VFiWhcgZIOT0qSNtuFwcU/7KN2Q2D64qRbfgDfzj0pokimb+6ufT2p0e9WGTnNSi2GD836Upt8cB+gz0pgJk56HA74pGmIQ4PbvUsUHyE7v0prW/y43/pVICol0rsRjHqDU+48H5cY/hqoYM3UaK20Mu48dea0I7XORvxj2qnYLEJZicEj8qXLZ+9ipRbZPLnP0o+zgHBOaWwDR971/GnMSFJ4FCQbXxuyD7dKl+y7hy549qVgKiNnIOcfWpN6hQvBP1pVhGCAaDFtUcgkjrigCuzZJzwPpUTtxlhtHTrVs25XHz8kZ6VDJahiPmxx6UWEUGkGTjpnrVWZjhuBgVemhbIXfxnb0qndW+5sFuBgdKZRj3j5BcnAJ4FcxM/mSu/YnjNdJq0TBWAfAzjpWF9k6Yf9KZz1XrYqdqQ8/h6GrZs8fx/pQbTA4f8AShGRUPBzSnnHargssgHzP/Hab9k/2+/93/69AFQn0NKenSrRswSAX/Sl+xckeZ+lAFTGWoNW2swP48/hR9k4+/8ApQBU49MUnQZBq59j/wBv9KT7JgfeH/fNOzEVP50hPtVv7Hkf6z9KUWe4f6z/AMdpAUzSAe2auGzyDl/0pptM/wDLT9KYyp7UnOenern2MH+P9KPseT9/p7UwKeangbI29B1p/wBk5+/+lKLQggiT9KTV0NOw2Zfk/wAaqEVrG1ymS/b0pj2IYZ34P+7URdtypIyCMUdqvtYjH+s/So/sX/TT9K1uQU6Wrf2PkfvP0o+xYH+s/SgCpT4P9dH/ALw/nU5s/wDb/SnQ2mJo/n/iHb3pjP/Z);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    This 60 year-old patient with disseminated granuloma annulare presented with hundreds of erythematous papules and plaques on the medial arms, medial thighs, and buttocks. None of the lesions showed central clearing.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f23_49_24336=[""].join("\n");
var outline_f23_49_24336=null;
var title_f23_49_24337="Coronary artery fistula coil";
var content_f23_49_24337=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=CARD%2F56611&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=CARD%2F56611&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Coronary artery fistula",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 367px; height: 278px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Selective left coronary artery (LCA) angiogram (panel A) demonstrates the termination of a fistula (red arrow) from the diagonal branch of the left anterior descending (LAD) artery to the right ventricle (RV). A small amount of flow is noted in the distal LAD (white arrow). Panel B shows the deployment of Gianturco coil (arrow) at the terminal end of the fistula; in panel C a second Gianturco coil is placed (arrow). Selective LCA angiogram soon after coil deployment (panel D) shows a small residual shunt (arrow). However, a repeat selective LCA angiogram obtained 10 minutes later demonstrates no residual shunting through the coils (panel E); there is increased flow into the distal LAD (arrow) after elimination of coronary artery steal through the fistula. Selective LCA angiogram in the lateral view (panel F) confirms the absence of residual shunting through the coils (red arrow) and increased flow to the distal LAD (black arrow).",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f23_49_24337=[""].join("\n");
var outline_f23_49_24337=null;
var title_f23_49_24338="Primary syphilis oral";
var content_f23_49_24338=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=DERM%2F82771&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=DERM%2F82771&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 524px\">",
"   <div class=\"ttl\">",
"    Primary syphilis of the oral cavity",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 504px; height: 378px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Primary syphilis manifesting as a painless tongue ulcer with indurated raised borders and clean base.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: www.visualdx.com. Copyright Logical Images, Inc.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f23_49_24338=[""].join("\n");
var outline_f23_49_24338=null;
var title_f23_49_24339="Pediculosis corporis";
var content_f23_49_24339=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"2\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Pediculosis corporis",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?23/49/24339/contributors\">",
"     Authors",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?23/49/24339/contributors\">",
"     Adam O Goldstein, MD, MPH",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?23/49/24339/contributors\">",
"     Beth G Goldstein, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?23/49/24339/contributors\">",
"     Section Editors",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?23/49/24339/contributors\">",
"     Robert P Dellavalle, MD, PhD, MSPH",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?23/49/24339/contributors\">",
"     Ted Rosen, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?23/49/24339/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?23/49/24339/contributors\">",
"     Abena O Ofori, MD",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"UTD.htm?23/49/24339/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Mar 14, 2012.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Pediculosis corporis, pediculosis pubis, and pediculosis capitis are disorders caused by infestation by one of three varieties of lice that specifically infest humans (",
"    <a class=\"graphic graphic_figure graphicRef52420 \" href=\"UTD.htm?4/8/4226\">",
"     figure 1",
"    </a>",
"    ). The organisms causing pediculosis corporis (Pediculus humanus humanus, also known as Pediculosis humanus corporis) and pediculosis capitis (Pediculus humanus capitis) are closely related variants of the same species. While pediculosis capitis is typically restricted to the scalp, patients with pediculosis corporis present with widespread symptoms, frequently involving the truncal areas.",
"   </p>",
"   <p>",
"    The clinical findings, diagnosis, and treatment of pediculosis corporis will be discussed here. Pediculosis capitis and pediculosis pubis are reviewed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?25/15/25849?source=see_link\">",
"     \"Pediculosis capitis\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?1/30/1511?source=see_link\">",
"     \"Pediculosis pubis and pediculosis ciliaris\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     EPIDEMIOLOGY",
"    </span>",
"    &nbsp;&mdash;&nbsp;Pediculosis corporis is a significant problem in countries where poverty, crowding, and a low level of personal hygiene favor spread and multiplication of the parasite. The communal bed is a major factor in the perpetuation of infestation. In Europe and North America, pediculosis corporis is largely a problem of the homeless.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h1\">",
"     PEDICULUS HUMANUS HUMANUS",
"    </span>",
"    &nbsp;&mdash;&nbsp;The body louse (2 to 4 mm in length) is a little larger, but similar in morphology, to the head louse (",
"    <a class=\"graphic graphic_figure graphicRef52420 \" href=\"UTD.htm?4/8/4226\">",
"     figure 1",
"    </a>",
"    and",
"    <a class=\"graphic graphic_picture graphicRef80539 graphicRef86443 \" href=\"UTD.htm?10/52/11079\">",
"     picture 1A-B",
"    </a>",
"    ). It lives in clothing and lays eggs along the seams. The louse visits the host's skin to feed, and can survive for up to three days without a blood meal [",
"    <a class=\"abstract\" href=\"UTD.htm?23/49/24339/abstract/1\">",
"     1",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Pediculus humanus humanus serves as a vector for diseases such as epidemic typhus, trench fever, and relapsing fever [",
"    <a class=\"abstract\" href=\"UTD.htm?23/49/24339/abstract/2\">",
"     2",
"    </a>",
"    ]. Bartonella quintana transmission via louse infestation has also been linked to endocarditis [",
"    <a class=\"abstract\" href=\"UTD.htm?23/49/24339/abstract/1\">",
"     1",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?31/5/31830?source=see_link\">",
"     \"Endocarditis caused by Bartonella\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4\">",
"    <span class=\"h1\">",
"     CLINICAL MANIFESTATIONS AND DIAGNOSIS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Itching is the chief complaint, although some individuals do not seem to be troubled by the infestation. Signs may be limited to linear excoriations on the trunk and neck along with postinflammatory hyperpigmentation (",
"    <a class=\"graphic graphic_picture graphicRef86442 graphicRef76190 \" href=\"UTD.htm?25/35/26169\">",
"     picture 2A-B",
"    </a>",
"    ). Close inspection will sometimes reveal hemorrhagic puncta or wheals from fresh bites. Skin changes tend to be concentrated around the waist and in the axillary folds, areas where clothing seams contact the integument. The honey-like crusting and redness characteristic of secondary staphylococcal infection may also be present. Diagnosis is made by identification of the louse or its nits (louse eggs) in clothing (",
"    <a class=\"graphic graphic_picture graphicRef76146 graphicRef73592 \" href=\"UTD.htm?7/60/8138\">",
"     picture 3A-B",
"    </a>",
"    ).",
"   </p>",
"   <p>",
"    The differential diagnosis often includes scabies, which can present with widespread pruritus and excoriations. Simultaneous infestation with body lice and scabies also may occur [",
"    <a class=\"abstract\" href=\"UTD.htm?23/49/24339/abstract/1\">",
"     1",
"    </a>",
"    ]. The identification of scabetic burrows and erythematous papules in classic areas of involvement (eg, web spaces of the fingers, wrists, and male genitalia) suggest the possibility of this diagnosis (",
"    <a class=\"graphic graphic_picture graphicRef51161 graphicRef50111 \" href=\"UTD.htm?1/9/1175\">",
"     picture 4A-B",
"    </a>",
"    ). Scabies mites are much smaller than lice, and are undetectable on examination with the naked eye. A skin scraping may be used to assist in the diagnosis. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?28/2/28712?source=see_link\">",
"     \"Scabies\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Atopic or contact dermatitis, pruritus secondary to systemic disease, and neurodermatitis may present with similar symptoms, and should also be considered in the differential diagnosis.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5\">",
"    <span class=\"h1\">",
"     TREATMENT",
"    </span>",
"    &nbsp;&mdash;&nbsp;The patient should be bathed thoroughly. Infested clothing and bed linen should be heat washed (temperature should reach at least 149&ordm;F), dry cleaned, or discarded [",
"    <a class=\"abstract\" href=\"UTD.htm?23/49/24339/abstract/3,4\">",
"     3,4",
"    </a>",
"    ]. Ironing clothing with particular attention to the seams will also kill lice on fabrics.",
"   </p>",
"   <p>",
"    In most cases, the above methods are sufficient for the management of pediculosis corporis. Occasionally, a few nits will be found on body hair. For these patients, some authors recommend treatment with a topical pediculicide [",
"    <a class=\"abstract\" href=\"UTD.htm?23/49/24339/abstract/1,4\">",
"     1,4",
"    </a>",
"    ]. We suggest a single 8 to 10 hour application of",
"    <a class=\"drug drug_general\" href=\"UTD.htm?27/22/28004?source=see_link\">",
"     permethrin",
"    </a>",
"    5% cream to the entire body [",
"    <a class=\"abstract\" href=\"UTD.htm?23/49/24339/abstract/4\">",
"     4",
"    </a>",
"    ].",
"    <a class=\"drug drug_general\" href=\"UTD.htm?36/34/37412?source=see_link\">",
"     Lindane",
"    </a>",
"    lotion should not be used as a first-line therapy due to the potential for severe adverse events with this drug. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?25/15/25849?source=see_link&amp;anchor=H12#H12\">",
"     \"Pediculosis capitis\", section on 'Lindane toxicity'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    A low potency topical corticosteroid cream applied to pruritic and irritated areas twice daily for a few days after elimination of lice provides symptomatic relief (",
"    <a class=\"graphic graphic_table graphicRef62402 \" href=\"UTD.htm?38/56/39809\">",
"     table 1",
"    </a>",
"    ).",
"   </p>",
"   <p>",
"    Although oral",
"    <a class=\"drug drug_general\" href=\"UTD.htm?32/13/32976?source=see_link\">",
"     ivermectin",
"    </a>",
"    therapy was associated with a dramatic reduction in the prevalence of body louse infestation in a cohort of homeless men (28 of 33 men infested at day 0 versus 5 of 27 men at day 14), the effect was transient. Further studies are necessary to determine whether treatment with oral ivermectin should be recommended [",
"    <a class=\"abstract\" href=\"UTD.htm?23/49/24339/abstract/5\">",
"     5",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"PATIENT_INFORMATION\">",
"    <span class=\"h1\">",
"     INFORMATION FOR PATIENTS",
"    </span>",
"    &nbsp;&mdash;&nbsp;UpToDate offers two types of patient education materials, &ldquo;The Basics&rdquo; and &ldquo;Beyond the Basics.&rdquo; The Basics patient education pieces are written in plain language, at the 5",
"    <sup>",
"     th",
"    </sup>",
"    to 6",
"    <sup>",
"     th",
"    </sup>",
"    grade reading level, and they answer the four or five key questions a patient might have about a given condition. These articles are best for patients who want a general overview and who prefer short, easy-to-read materials. Beyond the Basics patient education pieces are longer, more sophisticated, and more detailed. These articles are written at the 10",
"    <sup>",
"     th",
"    </sup>",
"    to 12",
"    <sup>",
"     th",
"    </sup>",
"    grade reading level and are best for patients who want in-depth information and are comfortable with some medical jargon.",
"   </p>",
"   <p>",
"    Here are the patient education articles that are relevant to this topic. We encourage you to print or e-mail these topics to your patients. (You can also locate patient education articles on a variety of subjects by searching on &ldquo;patient info&rdquo; and the keyword(s) of interest.)",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Basics topics (see",
"      <a class=\"medical medical_basics\" href=\"UTD.htm?42/5/43089?source=see_link\">",
"       \"Patient information: Lice (The Basics)\"",
"      </a>",
"      )",
"     </li>",
"     <li>",
"      Beyond the Basics topics (see",
"      <a class=\"medical medical_patient\" href=\"UTD.htm?15/44/16065?source=see_link\">",
"       \"Patient information: Head lice (Beyond the Basics)\"",
"      </a>",
"      and",
"      <a class=\"medical medical_patient\" href=\"UTD.htm?27/12/27843?source=see_link\">",
"       \"Patient information: Pubic lice (Beyond the Basics)\"",
"      </a>",
"      )",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7\">",
"    <span class=\"h1\">",
"     SUMMARY AND RECOMMENDATIONS",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Pediculosis corporis is caused by infestation by the body louse. Unlike pediculosis capitis and pediculosis pubis, the organism lives on the clothing, rather than on the skin of infested individuals. The body louse can serve as a vector for epidemic typhus, trench fever, and relapsing fever. (See",
"      <a class=\"local\" href=\"#H3\">",
"       'Pediculus humanus humanus'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Patients with pediculosis corporis often complain of pruritus. Excoriations and postinflammatory hyperpigmentation are typical signs of infestation. The diagnosis is made through the visualization of lice or nits on clothing. (See",
"      <a class=\"local\" href=\"#H4\">",
"       'Clinical manifestations and diagnosis'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Treatment of pediculosis corporis involves discarding, laundering (in hot water), or ironing infested clothing and bedding. These methods are often sufficient for eradication of the infestation. For patients who present with a few nits on body hair, we suggest the addition of treatment with",
"      <a class=\"drug drug_general\" href=\"UTD.htm?27/22/28004?source=see_link\">",
"       permethrin",
"      </a>",
"      5% cream, rather than management of bedding and clothing alone (",
"      <a class=\"grade\" href=\"._grade_6?title=Grade 2C\">",
"       Grade 2C",
"      </a>",
"      ). (See",
"      <a class=\"local\" href=\"#H5\">",
"       'Treatment'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/49/24339/abstract/1\">",
"      Ko CJ, Elston DM. Pediculosis. J Am Acad Dermatol 2004; 50:1.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/49/24339/abstract/2\">",
"      Raoult D, Roux V. The body louse as a vector of reemerging human diseases. Clin Infect Dis 1999; 29:888.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/49/24339/abstract/3\">",
"      Mikhail M, Weinberg JM, Smith BL. What's eating you? Body lice (Pediculus humanus var corporis). Cutis 2007; 80:397.",
"     </a>",
"    </li>",
"    <li>",
"     Stone SP, Goldfarb JN, Bacelieri RE. Scabies, other mites, and pediculosis. In: Fitzpatrick's Dermatology in General Medicine, 7th ed, Wolf K, Goldsmith LA, Katz SI, et al (Eds), McGraw Hill, 2008. p.2029.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/49/24339/abstract/5\">",
"      Foucault C, Ranque S, Badiaga S, et al. Oral ivermectin in the treatment of body lice. J Infect Dis 2006; 193:474.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 4036 Version 7.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0604-197.136.42.3-3A022BFF98-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f23_49_24339=[""].join("\n");
var outline_f23_49_24339=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H7\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY &amp; RECOMMENDATIONS",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      EPIDEMIOLOGY",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      PEDICULUS HUMANUS HUMANUS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H4\">",
"      CLINICAL MANIFESTATIONS AND DIAGNOSIS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H5\">",
"      TREATMENT",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#PATIENT_INFORMATION\">",
"      INFORMATION FOR PATIENTS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H7\">",
"      SUMMARY AND RECOMMENDATIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"DERM/4036\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"DERM/4036|FIG\">",
"      <a href=\"#\" title=\"FIGURES\">",
"       FIGURES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?4/8/4226\" title=\"figure 1\">",
"      Types of lice",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"DERM/4036|PIC\">",
"      <a href=\"#\" title=\"PICTURES\">",
"       PICTURES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?37/43/38577\" title=\"picture 1A\">",
"      Pediculosis corporis louse",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?43/32/44545\" title=\"picture 1B\">",
"      Pediculosis humanus humanus",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?4/60/5063\" title=\"picture 2A\">",
"      Pediculosis corporis hyperpigmentation",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?7/9/7314\" title=\"picture 2B\">",
"      Pediculosis corporis",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?31/10/31909\" title=\"picture 3A\">",
"      Body lice in clothing",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?32/15/33014\" title=\"picture 3B\">",
"      Pediculosis corporis 2",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?4/4/4160\" title=\"picture 4A\">",
"      Interdigital scabies",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?19/52/20291\" title=\"picture 4B\">",
"      Scabies wrists",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"DERM/4036|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?38/56/39809\" title=\"table 1\">",
"      Topical corticosteroids",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?31/5/31830?source=related_link\">",
"      Endocarditis caused by Bartonella",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_patient\" href=\"UTD.htm?15/44/16065?source=related_link\">",
"      Patient information: Head lice (Beyond the Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?42/5/43089?source=related_link\">",
"      Patient information: Lice (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_patient\" href=\"UTD.htm?27/12/27843?source=related_link\">",
"      Patient information: Pubic lice (Beyond the Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?25/15/25849?source=related_link\">",
"      Pediculosis capitis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?1/30/1511?source=related_link\">",
"      Pediculosis pubis and pediculosis ciliaris",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?28/2/28712?source=related_link\">",
"      Scabies",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f23_49_24340="Haemophilus influenzae type b conjugate and hepatitis B vaccine: Pediatric drug information";
var content_f23_49_24340=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"2\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"drugTitle\">",
"   Haemophilus influenzae type b conjugate and hepatitis B vaccine: Pediatric drug information",
"  </div>",
"  <div id=\"lexiTitleImg\">",
"   <img height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"  </div>",
"  <div class=\"clear\">",
"  </div>",
"  <div id=\"drugCopy\">",
"   Copyright 1978-2013 Lexicomp, Inc. All rights reserved.",
"  </div>",
"  <div id=\"topicText\">",
"   (For additional information",
"   <a class=\"drug drug_general\" href=\"UTD.htm?16/35/16949?source=see_link\">",
"    see \"Haemophilus influenzae type b conjugate and hepatitis B vaccine: Drug information\"",
"   </a>",
"   and",
"   <a class=\"drug drug_patient\" href=\"UTD.htm?13/26/13729?source=see_link\">",
"    see \"Haemophilus influenzae type b conjugate and hepatitis B vaccine: Patient drug information\"",
"   </a>",
"   )",
"   <br/>",
"   For abbreviations and symbols that may be used in Lexicomp (",
"   <a class=\"graphic graphic_table\" href=\"UTD.htm?23/39/24183\">",
"    show table",
"   </a>",
"   )",
"   <div class=\"list ubnlist drugH1Div drugBrandNames\" id=\"F178299\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Brand Names: U.S.",
"    </span>",
"    <ul>",
"     <li>",
"      Comvax&reg;",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"list_set htclist drugH1Div drugBrandNames\" id=\"F1059166\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Therapeutic Category",
"    </span>",
"    <ul>",
"     <li>",
"      <span class=\"list-set-name\">",
"       Vaccine",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"block dos drugH1Div\" id=\"F1059159\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosing: Usual",
"    </span>",
"    <p>",
"     (For additional information",
"     <a class=\"drug drug_general\" href=\"UTD.htm?16/35/16949?source=see_link\">",
"      see \"Haemophilus influenzae type b conjugate and hepatitis B vaccine: Drug information\"",
"     </a>",
"     )",
"    </p>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Infants and Children 6 weeks through 15 months: I.M.: 0.5 mL per dose",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Recommended schedule: 3 doses repeated at 2, 4, and 12-15 months of age",
"    </p>",
"   </div>",
"   <div class=\"block foc drugH1Div\" id=\"F178286\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosage Forms: U.S.",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Excipient information presented when available (limited, particularly for generics); consult specific product labeling.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Injection, suspension [preservative free]:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;\">",
"     Comvax&reg;:",
"     <i>",
"      Haemophilus",
"     </i>",
"     b capsular polysaccharide 7.5 mcg (bound to",
"     <i>",
"      Neisseria meningitides",
"     </i>",
"     OMPC 125 mcg) and hepatitis B surface antigen 5 mcg per 0.5 mL (0.5 mL) [contains aluminum; contains natural rubber/natural latex in packaging]",
"    </p>",
"   </div>",
"   <div class=\"block geq drugH1Div\" id=\"F178273\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Generic Equivalent Available: U.S.",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     No",
"    </p>",
"   </div>",
"   <div class=\"block adm drugH1Div\" id=\"F1059170\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Administration",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Shake well and administer I.M. in either the anterolateral aspect of the thigh or deltoid muscle of the arm;",
"     <b>",
"      not for I.V. or SubQ administration",
"     </b>",
"     . Adolescents and adults should be vaccinated while seated or lying down.",
"    </p>",
"   </div>",
"   <div class=\"block sta drugH1Div\" id=\"F1059162\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Stability",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Refrigerate; do not freeze",
"    </p>",
"   </div>",
"   <div class=\"block use drugH1Div\" id=\"F1059169\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Use",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Immunization against invasive disease caused by",
"     <i>",
"      H. influenzae",
"     </i>",
"     type b and against infection caused by all known subtypes of hepatitis B virus in infants 6 weeks to 15 months of age born of HB",
"     <sub>",
"      s",
"     </sub>",
"     Ag-negative mothers",
"    </p>",
"    <p style=\"text-indent:0em;margin-top:2em;text-align:justify;\">",
"     Infants born of HB",
"     <sub>",
"      s",
"     </sub>",
"     Ag-positive mothers or mothers of unknown HB",
"     <sub>",
"      s",
"     </sub>",
"     Ag status should receive hepatitis B immune globulin and monovalent hepatitis B vaccine (recombinant) at birth and should complete the hepatitis B vaccination series",
"    </p>",
"   </div>",
"   <div class=\"block mst drugH1Div\" id=\"F178315\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Medication Safety Issues",
"    </span>",
"    <div class=\"collapsible\">",
"     <span class=\"collapsible-title\">",
"      Sound-alike/look-alike issues:",
"     </span>",
"     <div class=\"collapsible-wrap\">",
"      <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"       Comvax&reg; may be confused with Recombivax [Recombivax HB&reg;]",
"      </p>",
"     </div>",
"    </div>",
"   </div>",
"   <div class=\"block arm drugH1Div\" id=\"F178313\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Adverse Reactions",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     <b>",
"      All serious adverse reactions must be reported to the U.S. Department of Health and Human Services (DHHS) Vaccine Adverse Event Reporting System (VAERS) at 1-800-822-7967 or online at",
"      <a href=\"https://vaers.hhs.gov/esub/index\" target=\"_blank\">",
"       https://vaers.hhs.gov/esub/index",
"      </a>",
"      .",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;margin-top:2em;text-align:justify;\">",
"     Central nervous system: Crying (unusual/high pitched), fever, irritability, somnolence",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Dermatologic: Rash",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Gastrointestinal: Anorexia, diarrhea, oral candidiasis, vomiting",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Local: Injection site reactions: Erythema pain/soreness, swelling/induration",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Otic: Otitis media",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Respiratory: Cough, respiratory congestion, rhinorrhea, upper respiratory tract infection",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Postmarketing and/or case reports: Anaphylaxis, angioedema, erythema multiforme, febrile seizure, seizure, thrombocytopenia, urticaria",
"    </p>",
"   </div>",
"   <div class=\"block coi drugH1Div\" id=\"F1059172\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Contraindications",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Hypersensitivity to hepatitis vaccine,",
"     <i>",
"      Haemophilus",
"     </i>",
"     b vaccine, yeast, or any component of the formulation",
"    </p>",
"   </div>",
"   <div class=\"block pre drugH1Div\" id=\"F1059158\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Precautions",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Administer with caution to patients with thrombocytopenia or any coagulation disorder that would be compromised by I.M. injection; if the patient receives antihemophilia or other similar therapy, I.M. injection can be scheduled shortly after such therapy is administered; use with caution in patients with decreased cardiopulmonary function.Antipyretics have not been shown to prevent febrile seizures; antipyretics may be used to treat fever or discomfort following vaccination (CDC, 2011). One study reported that routine prophylactic administration of acetaminophen to prevent fever prior to vaccination decreased the immune response of some vaccines; the clinical significance of this reduction in immune response has not been established (Prymula, 2009).",
"    </p>",
"   </div>",
"   <div class=\"block war drugH1Div\" id=\"F1059157\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Warnings",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Immediate treatment for anaphylactic/anaphylactoid reactions should be available during vaccine use; defer vaccination during the course of a moderate or severely febrile illness; children with chronic illness associated with increased risk of",
"     <i>",
"      Haemophilus influenzae",
"     </i>",
"     type b disease may have impaired anti-PRP antibody responses to conjugate vaccination. Examples include those with HIV infection, immunoglobulin deficiency, anatomic or functional asplenia, and sickle cell disease, as well as recipients of bone marrow transplants and recipients of chemotherapy for malignancy. Syncope has been reported with use of injectable vaccines and may be accompanied by transient visual disturbances, weakness, or tonic-clonic movements. Procedures should be in place to avoid injuries from falling and to restore cerebral perfusion if syncope occurs. In general, household and close contacts of persons with altered immune competence may receive all age-appropriate vaccines.",
"    </p>",
"   </div>",
"   <div class=\"block cyt drugH1Div\" id=\"F13299432\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Metabolism/Transport Effects",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     None known.",
"    </p>",
"   </div>",
"   <div class=\"block dri drugH1Div\" id=\"F178280\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Drug Interactions",
"    </span>",
"    <br/>",
"    <br/>",
"    <div class=\"lexi\" id=\"lexiInteractAddInfo\">",
"     (For additional information:",
"     <a class=\"dip\" href=\"./drug-interaction\" target=\"_blank\">",
"      Launch Lexi-Interact&trade; Drug Interactions Program",
"     </a>",
"     )",
"    </div>",
"    <div class=\"lexi\" id=\"lexiInteractImgB\">",
"     <img border=\"0\" height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"    </div>",
"    <div class=\"clear\">",
"    </div>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Belimumab: May diminish the therapeutic effect of Vaccines (Inactivated).",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Fingolimod: May diminish the therapeutic effect of Vaccines (Inactivated).",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Immunosuppressants: May diminish the therapeutic effect of Vaccines (Inactivated).",
"     <b>",
"      Exceptions:",
"     </b>",
"     Cytarabine (Liposomal).",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"   </div>",
"   <div class=\"block prf drugH1Div\" id=\"F178282\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pregnancy Risk Factor",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     C (",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?16/42/17068\">",
"      show table",
"     </a>",
"     )",
"    </p>",
"   </div>",
"   <div class=\"block pri drugH1Div\" id=\"F178295\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pregnancy Implications",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Reproduction studies have not been conducted. This product is not indicated for use in women of childbearing age.",
"    </p>",
"   </div>",
"   <div class=\"block mop drugH1Div\" id=\"F13929399\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Monitoring Parameters",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Observe for syncope for 15 minutes following administration. If seizure-like activity associated with syncope occurs, maintain patient in supine or Trendelenburg position to reestablish adequate cerebral perfusion.",
"    </p>",
"   </div>",
"   <div class=\"block pha drugH1Div\" id=\"F1059156\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Mechanism of Action",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     See individual agents.",
"    </p>",
"   </div>",
"   <div class=\"block pai drugH1Div\" id=\"F1059164\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Patient Information",
"    </span>",
"    <p>",
"     (For additional information",
"     <a class=\"drug drug_patient\" href=\"UTD.htm?13/26/13729?source=see_link\">",
"      see \"Haemophilus influenzae type b conjugate and hepatitis B vaccine: Patient drug information\"",
"     </a>",
"     )",
"    </p>",
"    <p style=\"text-indent:0em;display:inline\">",
"     May use antipyretics for postdose fever",
"    </p>",
"   </div>",
"   <div class=\"block adi drugH1Div\" id=\"F10278559\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Additional Information",
"    </span>",
"    <p style=\"text-indent:0em;margin-top:0em;display:inline\">",
"     In order to maximize vaccination rates, the ACIP recommends simultaneous administration (ie, &gt;1 vaccine on the same day at different anatomic sites) of all age-appropriate vaccines (live or inactivated) for which a person is eligible at a single visit, unless contraindications exist. If available, the use of combination vaccines is generally preferred over separate injections, taking into consideration provider assessment, patient preference, and potential adverse events. If separate vaccines being used, evaluate product information regarding same syringe compatibility of vaccines. Separate needles and syringes should be used for each injection. The ACIP prefers each dose of specific vaccine in a series come from the same manufacturer if possible (CDC, 2011).",
"    </p>",
"    <p style=\"text-indent:0em;margin-top:2em;\">",
"     For additional information, please refer to the following website:",
"     <a href=\"file://www.cdc.gov/vaccines/vpd-vac/\" target=\"_blank\">",
"      file://www.cdc.gov/vaccines/vpd-vac/",
"     </a>",
"     .",
"    </p>",
"   </div>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <div class=\"reference\">",
"      AAP Steering Committee on Quality Improvement and Management, Subcommittee on Febrile Seizures American Academy of Pediatrics, \"Febrile Seizures: Clinical Practice Guideline for the Long-Term Management of the Child With Simple Febrile Seizures,\"",
"      <i>",
"       Pediatrics",
"      </i>",
"      , 2008, 121(6):1281-6.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?23/49/24340/abstract-text/18519501/pubmed\" id=\"18519501\" target=\"_blank\">",
"        18519501",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      American Academy of Pediatrics Committee on Infectious Diseases, &ldquo;Recommended Immunization Schedules for Children and Adolescents - United States, 2007,&rdquo;",
"      <i>",
"       Pediatrics",
"      </i>",
"      , 2007, 119(1):207-8.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?23/49/24340/abstract-text/17200290/pubmed\" id=\"17200290\" target=\"_blank\">",
"        17200290",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Centers for Disease Control and Prevention (CDC), \"General Recommendations on Immunization. Recommendations of the Advisory Committee on Immunization Practices (ACIP),\"",
"      <i>",
"       MMWR Recomm Rep",
"      </i>",
"      , 2006, 55(RR-15):1-48. Available at:",
"      <a href=\"file://www.cdc.gov/mmwr/preview/mmwrhtml/rr5515a1.htm\" target=\"_blank\">",
"       file://www.cdc.gov/mmwr/preview/mmwrhtml/rr5515a1.htm",
"      </a>",
"      .",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?23/49/24340/abstract-text/17136024/pubmed\" id=\"17136024\" target=\"_blank\">",
"        17136024",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Centers for Disease Control and Prevention, &ldquo;Recommended Childhood and Adolescent Immunization Schedule &minus; United States, July-December 2004,&rdquo;",
"      <i>",
"       MMWR Morb Mortal Wkly Rep",
"      </i>",
"      , 2004, 53(1):Q1-4.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?23/49/24340/abstract-text/14733209/pubmed\" id=\"14733209\" target=\"_blank\">",
"        14733209",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Centers for Disease Control and Prevention (CDC), \"Syncope After Vaccination-United States, January 2005-July 2007,\"",
"      <i>",
"       MMWR Morb Mortal Wkly Rep",
"      </i>",
"      , 2008, 2;57(17):457-60.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?23/49/24340/abstract-text/18451756/pubmed\" id=\"18451756\" target=\"_blank\">",
"        18451756",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      National Center for Immunization and Respiratory Diseases, \"General Recommendations on Immunization - Recommendations of the Advisory Committee on Immunization Practices (ACIP),\"",
"      <i>",
"       MMWR Recomm Rep",
"      </i>",
"      , 2011, 60(2):1-64.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?23/49/24340/abstract-text/21293327/pubmed\" id=\"21293327\" target=\"_blank\">",
"        21293327",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Prymula R, Siegrist CA, Chlibek R, et al, \"Effect of Prophylactic Paracetamol Administration at Time of Vaccination on Febrile Reactions and Antibody Responses in Children: Two Open-Label, Randomised Controlled Trials,\"",
"      <i>",
"       Lancet",
"      </i>",
"      , 2009, 374(9698):1339-50.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?23/49/24340/abstract-text/19837254/pubmed\" id=\"19837254\" target=\"_blank\">",
"        19837254",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 12932 Version 32.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0603-218.28.111.102-5CC63B1F68-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f23_49_24340=[""].join("\n");
var outline_f23_49_24340=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F178299\">",
"      Brand Names: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1059166\">",
"      Therapeutic Category",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1059159\">",
"      Dosing: Usual",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F178286\">",
"      Dosage Forms: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F178273\">",
"      Generic Equivalent Available: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1059170\">",
"      Administration",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1059162\">",
"      Stability",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1059169\">",
"      Use",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F178315\">",
"      Medication Safety Issues",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F178313\">",
"      Adverse Reactions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1059172\">",
"      Contraindications",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1059158\">",
"      Precautions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1059157\">",
"      Warnings",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F13299432\">",
"      Metabolism/Transport Effects",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F178280\">",
"      Drug Interactions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F178282\">",
"      Pregnancy Risk Factor",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F178295\">",
"      Pregnancy Implications",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F13929399\">",
"      Monitoring Parameters",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1059156\">",
"      Mechanism of Action",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1059164\">",
"      Patient Information",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10278559\">",
"      Additional Information",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"DRUG_PED/12932\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"DRUG_PED/12932|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?23/39/24183\" title=\"Lexicomp clinical abbreviations\">",
"      Lexicomp clinical abbreviations",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_general\" href=\"UTD.htm?16/35/16949?source=related_link\">",
"      Haemophilus influenzae type b conjugate and hepatitis B vaccine: Drug information",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_patient\" href=\"UTD.htm?13/26/13729?source=related_link\">",
"      Haemophilus influenzae type b conjugate and hepatitis B vaccine: Patient drug information",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f23_49_24341="Rotator cuff tendinitis and tear";
var content_f23_49_24341=[" <h1 id=\"patTopicTitle\">",
"  Patient information: Rotator cuff tendinitis and tear (Beyond the Basics)",
" </h1>",
" <div id=\"patTopicContributors\">",
"  <div class=\"rcTop\">",
"   <div>",
"   </div>",
"  </div>",
"  <div class=\"rcContent\">",
"   <table>",
"    <tr>",
"     <td>",
"      <a class=\"contributor contributor_credentials patTopicContributorsType\" href=\"UTD.htm?23/49/24341/contributors\">",
"       Authors",
"      </a>",
"      <a class=\"contributor contributor_credentials\" href=\"UTD.htm?23/49/24341/contributors\" id=\"au1781\">",
"       Stephen M Simons, MD, FACSM",
"      </a>",
"      <a class=\"contributor contributor_credentials\" href=\"UTD.htm?23/49/24341/contributors\" id=\"au318\">",
"       Michael Roberts, MPT, CSCS",
"      </a>",
"     </td>",
"     <td>",
"      <a class=\"contributor contributor_credentials patTopicContributorsType\" href=\"UTD.htm?23/49/24341/contributors\">",
"       Section Editor",
"      </a>",
"      <a class=\"contributor contributor_credentials\" href=\"UTD.htm?23/49/24341/contributors\" id=\"se7143\">",
"       Karl B Fields, MD",
"      </a>",
"     </td>",
"     <td>",
"      <a class=\"contributor contributor_credentials patTopicContributorsType\" href=\"UTD.htm?23/49/24341/contributors\">",
"       Deputy Editor",
"      </a>",
"      <a class=\"contributor contributor_credentials\" href=\"UTD.htm?23/49/24341/contributors\" id=\"de97\">",
"       Jonathan Grayzel, MD, FAAEM",
"      </a>",
"     </td>",
"    </tr>",
"   </table>",
"  </div>",
"  <div class=\"rcBottom\">",
"   <div>",
"   </div>",
"  </div>",
" </div>",
" <div class=\"patTopicTool\" id=\"patTopicToolTop\">",
"  <a class=\"toolbutton findicon findInPageLink\" href=\"#\" title=\"Find in Topic\">",
"   Find",
"  </a>",
"  <a class=\"toolbutton printicon\" href=\"UTD.htm?23/49/24341?view=print\" title=\"Print This Topic\">",
"   Print",
"  </a>",
"  <script src=\"file://w.sharethis.com/button/sharethis.js#publisher=357881b8-c7e3-4c31-b7d2-242aeb1528e1&amp;type=website&amp;post_services=care2%2Cfacebook%2Ctwitter%2Cmyspace%2Cdigg%2Cdelicious%2Cfaves%2Creddit%2Cxanga%2Cstumbleupon%2Cblinklist%2Csimpy%2Cyigg%2Ctechnorati%2Cmeneame%2Corkut%2Cmixx%2Cfunp%2Cfresqui%2Cmister_wong%2Cfriendster%2Cfriendfeed%2Clinkedin%2Coknotizie%2Cgoogle_bmarks%2Cyahoo_bmarks%2Cfark%2Cnewsvine%2Clivejournal%2Ctypepad%2Cbus_exchange%2Cpropeller%2Cwordpress%2Cblogger%2Cblogmarks%2Cwindows_live%2Cfurl%2Cybuzz%2Cdiigo\" type=\"text/javascript\">",
"  </script>",
" </div>",
" <div id=\"patTopicMiddle\">",
"  <div id=\"topicContent\">",
"   <div id=\"topicText\">",
"    <p class=\"headingAnchor\" id=\"H1\">",
"     <span class=\"h1\">",
"      ROTATOR CUFF INJURY OVERVIEW",
"     </span>",
"    </p>",
"    <p>",
"     Tendons are tough bands of tissue that connect muscles to bones. Repetitive activities and overuse can injure tendons and lead to pain and impaired function. This is called tendinitis or tendinopathy. Although the most common cause of tendinitis is overuse, it can also be caused by other conditions.",
"    </p>",
"    <p>",
"     Tendinitis is a common problem that is more likely as people age and in people who routinely perform activities that require repetitive movement that increase stress on susceptible tendons. Rotator cuff disease is the most common cause of shoulder pain, particularly in people over age 30. Treatment focuses on resting the injured tendon to allow healing, decreasing inflammation, and correcting imbalances that caused stress on the injured area. In most people, tendinitis resolves with treatment. In some cases, it goes away without treatment.",
"    </p>",
"    <p>",
"     Tendinitis can affect many different tendons in the body. Other types of tendon injury are discussed separately. (See",
"     <a class=\"medical medical_patient\" href=\"UTD.htm?24/36/25153?source=see_link\">",
"      \"Patient information: Biceps tendinitis or tendinopathy (Beyond the Basics)\"",
"     </a>",
"     and",
"     <a class=\"medical medical_patient\" href=\"UTD.htm?43/18/44321?source=see_link\">",
"      \"Patient information: Elbow tendinopathy (tennis and golf elbow) (Beyond the Basics)\"",
"     </a>",
"     .)",
"    </p>",
"    <p class=\"headingAnchor\" id=\"H2\">",
"     <span class=\"h1\">",
"      WHAT IS THE ROTATOR CUFF?",
"     </span>",
"    </p>",
"    <p>",
"     The rotator cuff is composed of four muscles, each of which has a tendon that attaches to the upper arm bone (the humerus).",
"    </p>",
"    <p>",
"     <ul class=\"bulletCompact-block\">",
"      <li>",
"       Supraspinatus",
"      </li>",
"      <li>",
"       Infraspinatus",
"      </li>",
"      <li>",
"       Teres minor",
"      </li>",
"      <li>",
"       Subscapularis",
"      </li>",
"     </ul>",
"    </p>",
"    <p>",
"     These tendons form a cuff around the head of the upper arm bone (humerus) (",
"     <a class=\"graphic graphic_figure graphicRef74486 graphicRef53479 graphicRef63139 \" href=\"UTD.htm?34/8/34954\">",
"      figure 1A-C",
"     </a>",
"     ). These tendons attach to the front and side of the humerus and the greater and lesser tubercles (part of the upper humerus). The muscles associated with these tendons are located in the upper back, where they are attached to the shoulder blade (scapula).",
"    </p>",
"    <p>",
"     The largest component of the rotator cuff is the supraspinatus tendon, which is essential for lifting the arm. The infraspinatus and teres minor rotate the arm outward, while the subscapularis rotates the arm inward.",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H3\">",
"     <span class=\"h2\">",
"      Rotator cuff tendinitis",
"     </span>",
"     &nbsp;&mdash;&nbsp;Rotator cuff tendinitis occurs when the tendons are injured, usually as a result of repetitive overhead reaching, pushing, or lifting with outstretched arms. Athletes who perform overhead activity, such as swimming, tennis, throwing, golf, weightlifting, volleyball, and gymnastics, are also at risk. Tendinitis is usually treated with ice, antiinflammatory drugs, and physical therapy. (See",
"     <a class=\"local\" href=\"#H9\">",
"      'Rotator cuff injury treatment'",
"     </a>",
"     below.)",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H4\">",
"     <span class=\"h2\">",
"      Rotator cuff tear",
"     </span>",
"     &nbsp;&mdash;&nbsp;The rotator cuff tendon(s) may be torn as a result of injury, chronic tendinopathy, or a combination of both. Typically the injury is caused by a fall, direct blow, or a rapid use of force (pulling on a starter cable, for instance).",
"    </p>",
"    <p>",
"     The goals of treatment for a torn rotator cuff are to recover lost strength, improve the function of the shoulder, and treat any underlying tendinitis. Conservative treatment is adequate in the vast majority of people, although younger people with a medium- to large-sized tear, particularly affecting the dominant arm, may be candidates for surgical repair. Surgery may also be recommended for older people who have significant pain related to a rotator cuff tear. (See",
"     <a class=\"local\" href=\"#H28\">",
"      'Surgical repair of rotator cuff tears'",
"     </a>",
"     below.)",
"    </p>",
"    <p>",
"     People with small- to medium-size tears usually improve with physical therapy exercises, stopping painful activities, and, in some cases, injection of a steroid. If shoulder strength and function do not improve after completing three to six months of physical therapy, surgical repair may be considered.",
"    </p>",
"    <p class=\"headingAnchor\" id=\"H5\">",
"     <span class=\"h1\">",
"      ROTATOR CUFF INJURY SYMPTOMS",
"     </span>",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H6\">",
"     <span class=\"h2\">",
"      Tendinitis",
"     </span>",
"     &nbsp;&mdash;&nbsp;People with rotator cuff tendinitis typically complain of shoulder pain at the tip of the shoulder and the upper, outer arm. Specialists often refer to tendinitis as tendinopathy because there is no evidence of inflammation with this injury. The pain is often aggravated by reaching, pushing, pulling, lifting, positioning the arm above the shoulder level, or lying on the side. Painful daily activities may also include putting on a shirt or brushing hair. The pain may prevent comfortable sleep, or awaken a person from sleep, particularly if he or she sleeps on or rolls onto the shoulder.",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H7\">",
"     <span class=\"h2\">",
"      Tear",
"     </span>",
"     &nbsp;&mdash;&nbsp;Symptoms of rotator cuff tear often include pain and weakness of the shoulder, although some people have few or no symptoms. In addition, the severity of the tear does not necessarily correlate with the severity of a person's pain; in other words, a person with a partial tear may have severe pain while a person with a complete tear may have little or no pain.",
"    </p>",
"    <p class=\"headingAnchor\" id=\"H8\">",
"     <span class=\"h1\">",
"      ROTATOR CUFF INJURY TESTS",
"     </span>",
"    </p>",
"    <p>",
"     The diagnosis of rotator cuff tendinitis or tear is usually based upon the person's symptoms and a physical examination.",
"    </p>",
"    <p>",
"     To differentiate rotator cuff tendinitis from tear, the healthcare provider may inject the shoulder joint with a local anesthetic. In people with tendinopathy, the anesthetic will relieve pain and the muscle strength is usually normal. In people with a tear, the anesthetic will relieve the pain, although the muscles are usually weak.",
"    </p>",
"    <p>",
"     In most cases, x-rays and other imaging tests are not needed to diagnose tendinopathy. However, if the person's symptoms do not improve after a course of conservative treatment, an imaging test (eg, x-ray, ultrasound,",
"     <span class=\"nowrap\">",
"      and/or",
"     </span>",
"     MRI) may be recommended to confirm the diagnosis.",
"    </p>",
"    <p>",
"     If a rotator cuff tear is suspected, an imaging test (ultrasound or MRI) is usually recommended to confirm the tear. Initially, smaller tears are treated conservatively, with rest, ice, stretching, and strengthening exercises.",
"    </p>",
"    <p>",
"     If the pain or weakness does not improve or if a large tear is confirmed with an imaging test, most people are referred to a specialist (orthopedic surgeon) for further evaluation and management. (See",
"     <a class=\"local\" href=\"#H28\">",
"      'Surgical repair of rotator cuff tears'",
"     </a>",
"     below.)",
"    </p>",
"    <p class=\"headingAnchor\" id=\"H9\">",
"     <span class=\"h1\">",
"      ROTATOR CUFF INJURY TREATMENT",
"     </span>",
"    </p>",
"    <p>",
"     Treatment of rotator cuff injuries focuses on decreasing pain and swelling of the tendon, preserving normal range of motion, and strengthening the shoulder muscles. The first goal of treatment is to preserve the ability to move the shoulder. In many people, a decreased ability to move the shoulder means that they use the joint less frequently, which can further reduce range of motion and lead to a frozen shoulder. (See",
"     <a class=\"medical medical_patient\" href=\"UTD.htm?36/21/37201?source=see_link\">",
"      \"Patient information: Frozen shoulder (Beyond the Basics)\"",
"     </a>",
"     .)",
"    </p>",
"    <p>",
"     There are two basic options for treatment: conservative, non-surgical treatments and surgery. Conservative treatment is discussed here while surgical treatment is discussed later (see",
"     <a class=\"local\" href=\"#H28\">",
"      'Surgical repair of rotator cuff tears'",
"     </a>",
"     below).",
"    </p>",
"    <p>",
"     Conservative treatment usually includes:",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H10\">",
"     <span class=\"h2\">",
"      Ice",
"     </span>",
"     &nbsp;&mdash;&nbsp;Ice can be used to reduce the inflammation that often occurs in rotator cuff injuries. Ice can be applied over the upper and outer portion of the shoulder muscle for 15 to 20 minutes every four to six hours. The response to ice is variable since the rotator cuff tendons are located deep within the shoulder.",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H11\">",
"     <span class=\"h2\">",
"      Rest",
"     </span>",
"     &nbsp;&mdash;&nbsp;Rest means avoiding activities that aggravate symptoms, including all overhead activities. Avoiding painful activities in general will alleviate strain on the injured area. An example of these activities includes lifting, overhead reaching, and reaching behind (eg, reaching into the backseat or putting on a coat). It is safest to keep the arm down, in front of, and close to the body. Use of an arm sling is not recommended because this may lead to a frozen shoulder.",
"    </p>",
"    <p>",
"     Some general rules to decrease shoulder strain with activities include:",
"    </p>",
"    <p>",
"     <ul class=\"bulletCompact-block\">",
"      <li>",
"       Lift objects close to the body.",
"      </li>",
"      <li>",
"       Only lift light weights and limit lifting to below shoulder level.",
"      </li>",
"      <li>",
"       Do sidestroke or breaststroke when swimming.",
"      </li>",
"      <li>",
"       Throw balls underhand or sidearm.",
"      </li>",
"      <li>",
"       Avoid pushing exercises at the gym (eg, pushups, bench press, flys, shoulder press)",
"      </li>",
"      <li>",
"       Do not serve overhand in tennis.",
"      </li>",
"      <li>",
"       Maintain good posture with writing, assembly work, and other tasks by keeping the shoulder blades down and back",
"      </li>",
"     </ul>",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H12\">",
"     <span class=\"h2\">",
"      Reduce inflammation",
"     </span>",
"     &nbsp;&mdash;&nbsp;A nonsteroidal antiinflammatory medication (eg, ibuprofen or naproxen) is often used to reduce pain and inflammation. The dose of medication needed to reduce inflammation is higher than that recommended for pain relief. You should check with your healthcare provider before using high dose NSAIDs. (See",
"     <a class=\"medical medical_patient\" href=\"UTD.htm?2/13/2262?source=see_link\">",
"      \"Patient information: Nonsteroidal antiinflammatory drugs (NSAIDs) (Beyond the Basics)\"",
"     </a>",
"     .)",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H13\">",
"     <span class=\"h2\">",
"      Heat and massage",
"     </span>",
"     &nbsp;&mdash;&nbsp;Heat and massage help prepare the tissues for range of motion exercises and are recommended before performing these exercises. The best method to warm the tissues is to take a warm shower or bath for 10 to 15 minutes. Local heat (eg, with a moist heating pad or a hot pack warmed in a microwave) is an alternative, although local heat is generally not as effective because of the deep location of the rotator cuff tendons.",
"    </p>",
"    <p>",
"     Light massage to the surrounding tissues is a very effective way to prepare the area for range of motion and strength exercises.",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H14\">",
"     <span class=\"h2\">",
"      Stretching and range of motion exercises",
"     </span>",
"     &nbsp;&mdash;&nbsp;Range of motion exercises are recommended early in the recovery period to help maintain joint mobility and flexibility of the muscles and tendons in the shoulder. Stretching exercises should be performed once per day every day.",
"    </p>",
"    <p>",
"     Exercises should not cause more than a mild level of pain. If you experience pain, decrease the intensity of the stretch or the number of repetitions; anyone who feels sharp or tearing pain should stop exercising immediately and consult with their healthcare provider.",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H15\">",
"     <span class=\"h3\">",
"      Pendulum stretch",
"     </span>",
"     &nbsp;&mdash;&nbsp;The pendulum stretching exercise helps to stretch the space in which the tendons pass, and helps to prevent the development of a frozen shoulder. This exercise can be started almost immediately after a shoulder injury, or after receiving a steroid injection into the shoulder joint. The exercise is performed as follows (",
"     <a class=\"graphic graphic_figure graphicRef50148 \" href=\"UTD.htm?12/37/12895\">",
"      figure 2",
"     </a>",
"     ):",
"    </p>",
"    <p>",
"     <ul class=\"bullet-block\">",
"      <li>",
"       Relax your shoulder muscles",
"      </li>",
"      <li>",
"       While standing or sitting, keep your arm vertical and close to your body (bending over too far may pinch the rotator cuff tendons)",
"      </li>",
"      <li>",
"       Allow your arm to slowly swing forward to back, then side to side, then in small circles in each direction (no greater than 1 foot in any direction). Only minimal pain should be felt.",
"      </li>",
"      <li>",
"       Stretch the arm only (without added weight) for three to seven days. Increase the stretch by adding 1 to 2 lbs (0.5 to 1 kg) per week and gradually increase the diameter of the movements (not to exceed 18 to 24",
"       <span class=\"nowrap\">",
"        inches/45",
"       </span>",
"       to 60 cm).",
"      </li>",
"     </ul>",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H16\">",
"     <span class=\"h3\">",
"      Wand exercises",
"     </span>",
"     &nbsp;&mdash;&nbsp;The goal of this exercise is to fully extend the arm at shoulder height, 90&ordm; from the body. You will need a long wooden rod (or broom stick).",
"    </p>",
"    <p>",
"     <ul class=\"bulletCompact-block\">",
"      <li>",
"       Hold the end of the rod with the hand on the injured side (right in this example) as the left hand holds the rod in the middle.",
"      </li>",
"      <li>",
"       Use the left hand to guide the rod so that the right arm is extended away from the body, until the right hand is at shoulder height (or lower, if pain is felt). Keep the right arm straight at all times.",
"      </li>",
"      <li>",
"       Slowly lower the right arm until it is next to the body. Rest as needed and repeat 15 to 20 times each day.",
"      </li>",
"     </ul>",
"    </p>",
"    <p>",
"     To vary the stretch, use the rod to direct the hand in front of the body (no higher than shoulder height) and slightly behind the body. Do not proceed if this stretch causes pain.",
"    </p>",
"    <p>",
"     Once you are able to fully extend the arm at shoulder height, you can try a modified version of this same exercise.",
"    </p>",
"    <p>",
"     <ul class=\"bulletCompact-block\">",
"      <li>",
"       Start by lying on your back holding the rod against the abdomen with both elbows straight and hands shoulder-width apart.",
"      </li>",
"      <li>",
"       Keeping elbows straight, lift arms up to shoulder height while keeping shoulder blades squeezed down and back together.",
"      </li>",
"      <li>",
"       Return wand to rest on abdomen.",
"      </li>",
"     </ul>",
"    </p>",
"    <p>",
"     Perform 5 to 10 repetitions, lifting the wand to 90 degrees (shoulder height), then if there is no pain, move the wand through a full range of motion (over the head). Increase to two sets of 10 repetitions with a 2-3 second pause at the end of the motion.",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H17\">",
"     <span class=\"h2\">",
"      Posterior capsule stretching",
"     </span>",
"     &nbsp;&mdash;&nbsp;Tightness in the",
"     <span class=\"nowrap\">",
"      ligaments/capsule",
"     </span>",
"     of the shoulder can develop in people with rotator cuff injuries. This tightness can contribute to further movement abnormalities and pain in the shoulder. Tightness is caused by any of the following:",
"    </p>",
"    <p>",
"     <ul class=\"bulletCompact-block\">",
"      <li>",
"       Injury to the shoulder including rotator cuff strains, partial tears or tears",
"      </li>",
"      <li>",
"       Poor posture (forward shoulder posture)",
"      </li>",
"      <li>",
"       History of repetitive throwing or racquet sports",
"      </li>",
"      <li>",
"       Guarded movement as when protecting the shoulder",
"      </li>",
"     </ul>",
"    </p>",
"    <p>",
"     Although the posterior capsule is most effectively stretched passively by a skilled professional, there are 2 ways to stretch the posterior capsule yourself.",
"    </p>",
"    <p>",
"     <ul class=\"bullet-block\">",
"      <li>",
"       Reach your affected arm across your body at chest height. Use your other hand to pull your arm closer to your body. Hold for 30 seconds. Do this regularly throughout the day.",
"      </li>",
"      <li>",
"       Sleeper stretch &ndash; Lie on your back and extend both arms out in front of you, towards the ceiling. Bend your elbows and hold the wrist of your affected arm (right arm in this example) with your left hand. Roll onto your right side with the right hand pointing towards the ceiling. Using your left hand to hold the right wrist, push your right arm down, towards the floor, until you feel a stretch in your right shoulder. Hold for 5 seconds. Repeat 15 to 20 times. As your range of motion increases, you should be able to push your arm down closer to the floor.",
"      </li>",
"     </ul>",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H18\">",
"     <span class=\"h2\">",
"      Muscle strengthening exercises",
"     </span>",
"     &nbsp;&mdash;&nbsp;Muscle strengthening exercises are necessary to improve shoulder muscle strength and help to prevent further injury. You can begin strengthening the shoulder once your shoulder has full range of motion, including overhead activities, with minimal pain. Consult with your provider or physical therapist to determine when to begin strengthening exercises.",
"    </p>",
"    <p>",
"     As pain improves, the level of difficulty of these exercises should be increased. Increased difficulty is necessary to improve muscle strength to a degree that reduces the risk of re-injury. Mild soreness is expected with these exercises, although pain should not continue for more than 24 hours. Sharp or severe pain during or after exercising may indicate a flare of the underlying problem; stop these exercises for a few days if this occurs.",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H19\">",
"     <span class=\"h3\">",
"      Preparing for strengthening exercises",
"     </span>",
"     &nbsp;&mdash;&nbsp;Before performing these exercises, stretch the injured shoulder with the pendulum stretch or wand exercise, described above (see",
"     <a class=\"local\" href=\"#H15\">",
"      'Pendulum stretch'",
"     </a>",
"     above).",
"    </p>",
"    <p>",
"     Rest after stretching for two or three minutes, then perform 15 to 20 repetitions of each exercise slowly, holding for one to two seconds during each exercise. Flexible rubber tubing, a bungee cord, or a large rubber band can be used for each exercise (",
"     <a class=\"graphic graphic_figure graphicRef70846 \" href=\"UTD.htm?26/2/26656\">",
"      figure 3",
"     </a>",
"     ).",
"    </p>",
"    <p>",
"     Do not perform ANY exercise below if you experience any amount of discomfort or pain in the shoulder. Strengthening exercises should not cause ANY pain.",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H20\">",
"     <span class=\"h3\">",
"      Scapular squeezes",
"     </span>",
"     &nbsp;&mdash;&nbsp;Lie on your back with your knees bent and feet flat (",
"     <a class=\"graphic graphic_picture graphicRef65309 \" href=\"UTD.htm?37/24/38287\">",
"      picture 1",
"     </a>",
"     ). Your arms should be straight out, 6 to 12 inches (15 to 30 cm) away from the side of your body, with palms facing upward. Keeping your low back flat against the ground, squeeze your shoulder blades downward and towards each other, towards the spine. Make a conscious effort not to shrug your shoulders and keep the neck relaxed. You should feel the lower muscles between your shoulder blades contracting. Hold for five seconds. Rest as needed then repeat 10 to 15 times. Do this exercise two to three times per day.",
"    </p>",
"    <p>",
"     The difficulty can be increased by performing the squeezes while sitting. Hold a piece of tubing in each hand and pull the hands apart while squeezing the shoulder blades together, as described above.",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H21\">",
"     <span class=\"h3\">",
"      Outward rotation exercise",
"     </span>",
"     &nbsp;&mdash;&nbsp;Hold your elbows at 90 degrees, close to your sides; holding a towel between your torso and the inside of your elbow will cue you to keep your elbow by your side. Hold one end of a long rubber band (eg, Theraband&reg;) in each hand and rotate the affected forearm outward two or three inches, holding for five seconds (",
"     <a class=\"graphic graphic_picture graphicRef53514 \" href=\"UTD.htm?36/14/37089\">",
"      picture 2",
"     </a>",
"     ). Repeat 10 to 15 times.",
"    </p>",
"    <p>",
"     Perform the exercise through all available pain-free ranges of motion. Keep the shoulder blades squeezed down and back while performing this exercise.",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H22\">",
"     <span class=\"h3\">",
"      Inward rotation exercise",
"     </span>",
"     &nbsp;&mdash;&nbsp;Hold your elbow at 90 degrees, close to your side. Hook a rubber band (eg, Theraband&reg;) onto a door handle and grasp with only one hand. Rotate your forearm towards the body two or three inches and hold for five seconds (",
"     <a class=\"graphic graphic_picture graphicRef67577 \" href=\"UTD.htm?3/14/3298\">",
"      picture 3",
"     </a>",
"     ). The forearm swings like a door. Repeat 10 to 15 times.",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H23\">",
"     <span class=\"h3\">",
"      Abduction exercise",
"     </span>",
"     &nbsp;&mdash;&nbsp;Bend your elbow to 90 degrees. Place the rubber band near the elbows. While keeping your shoulder blades squeezed down and backwards, lift your arms up four or five inches away from the body, holding for five seconds (",
"     <a class=\"graphic graphic_picture graphicRef55598 \" href=\"UTD.htm?18/9/18577\">",
"      picture 4",
"     </a>",
"     ). Repeat 10 to 15 times. Avoid shrugging the shoulders while performing this movement.",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H24\">",
"     <span class=\"h3\">",
"      Scapular strengthening",
"     </span>",
"     &nbsp;&mdash;&nbsp;For these exercises, you should lie face down on an elevated surface, like a bed, exercise bench, or large exercise ball. The head should be held in line with the body, hanging over the edge of the bed or bench. Let the arms rest below the body. Extend the arms next to the head to form a \"Y\"; make sure your thumbs are facing up (",
"     <a class=\"graphic graphic_picture graphicRef51174 \" href=\"UTD.htm?0/60/967\">",
"      picture 5",
"     </a>",
"     ) . Hold the position for a second or two, then let the arms return to the floor. Repeat 10 to 15 times. Movements should be steady, smooth, and pain-free.",
"    </p>",
"    <p>",
"     Using the same body position, squeeze your shoulder blades down and backwards towards the spine while moving the arms to form a \"T.\" Raise the arms straight out to each side, parallel to the floor (",
"     <a class=\"graphic graphic_picture graphicRef66200 \" href=\"UTD.htm?13/4/13380\">",
"      picture 6",
"     </a>",
"     ). This can be done with the thumbs up or down. Hold for a second or two, then return the arms to the starting position; repeat 10 to 15 times.",
"    </p>",
"    <p>",
"     Position the arms to form a \"W.\" Hold the arms bent with elbows pointed towards the feet and hands pointed towards the head (",
"     <a class=\"graphic graphic_picture graphicRef71135 \" href=\"UTD.htm?4/1/4117\">",
"      picture 7",
"     </a>",
"     ). Squeeze the shoulder blades and raise the arms until they are parallel with the floor, hold for a second or two, then return arms to the starting position; repeat 10 to 15 times.",
"    </p>",
"    <p>",
"     Position the arms to form an \"L.\" Hold arms bent with upper arms parallel to the floor and hands pointed towards the floor (",
"     <a class=\"graphic graphic_picture graphicRef53445 \" href=\"UTD.htm?14/45/15059\">",
"      picture 8",
"     </a>",
"     ). Rotate the arms such that the forearms become parallel with the floor. Hold for a second or two, then return to the starting position; repeat 10 to 15 times.",
"    </p>",
"    <p>",
"     To increase the difficulty of these exercises, increase the number of repetitions to 20 to 30 times. Using 1 pound weights can further increase the difficulty.",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H25\">",
"     <span class=\"h2\">",
"      Maintenance exercises",
"     </span>",
"     &nbsp;&mdash;&nbsp;Once rehabilitation is complete, it is important to keep the shoulder muscles strong to maintain fitness and prevent a recurrence of pain. Non-athletes may continue to perform the exercises.",
"    </p>",
"    <p>",
"     Athletes may perform exercises that are similar to those required in their sport. As examples, a tennis player may perform a service-type motion using a five pound dumbbell, while a pitcher may perform a throwing motion using a three pound dumbbell.",
"    </p>",
"    <p>",
"     Anyone who performs frequent overhead activities needs to maintain strong shoulder blades and rotator cuff muscles to prevent overuse injuries of these areas. These muscles are essential in preventing aggravation to the tendons.",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H26\">",
"     <span class=\"h2\">",
"      Return to activities",
"     </span>",
"     &nbsp;&mdash;&nbsp;Most people with rotator cuff tendinitis see improvement in pain and function after 6 to 12 weeks of rehabilitation.",
"    </p>",
"    <p class=\"headingAnchor\" id=\"H27\">",
"     <span class=\"h1\">",
"      IF PAIN PERSISTS",
"     </span>",
"    </p>",
"    <p>",
"     If shoulder pain does not improve after several weeks of physical therapy exercises, most clinicians will recommend further evaluation (see",
"     <a class=\"local\" href=\"#H8\">",
"      'Rotator cuff injury tests'",
"     </a>",
"     above).",
"    </p>",
"    <p>",
"     If tendinitis is confirmed with an imaging study, some clinicians will inject a",
"     <span class=\"nowrap\">",
"      steroid/local",
"     </span>",
"     anesthetic mixture into the joint. Although clinical studies of steroid injections do not show that the injection is helpful in all cases, some people do benefit. In these people, pain and inflammation may improve quickly, usually within a few days. If the injection is helpful, it can be repeated once per month for up to three months.",
"    </p>",
"    <p>",
"     If you have another cause for your pain (eg, rotator cuff tear, nerve impingement), you will usually be referred to an orthopedic surgeon for further evaluation and treatment.",
"    </p>",
"    <p class=\"headingAnchor\" id=\"H28\">",
"     <span class=\"h1\">",
"      SURGICAL REPAIR OF ROTATOR CUFF TEARS",
"     </span>",
"    </p>",
"    <p>",
"     The need to surgically repair a torn rotator cuff depends upon your age, activity level, and the severity of your tear. (See",
"     <a class=\"local\" href=\"#H4\">",
"      'Rotator cuff tear'",
"     </a>",
"     above.)",
"    </p>",
"    <p>",
"     <ul class=\"bullet-block\">",
"      <li>",
"       Surgical repair is usually recommended for people with a complete rotator cuff tear, especially if the person is young",
"       <span class=\"nowrap\">",
"        and/or",
"       </span>",
"       active. Surgery is usually recommended soon after the injury, if possible, to prevent the tendon and muscle from shrinking.",
"      </li>",
"      <li>",
"       Conservative treatment is usually recommended first if you do not have a complete rotator cuff tear or are older, less active, or if there is minimal pain. Conservative treatments (eg, stretching and strengthening exercises, injection of a steroid) are usually recommended first.",
"      </li>",
"      <li>",
"       Surgery may be recommended if you do not improve after stretching and strengthening exercises and you have persistent pain, limited strength, have arthritis or spurs that cause pain and interferes with rehabilitation, or if a new injury occurs and you have a previous rotator cuff injury.",
"      </li>",
"     </ul>",
"    </p>",
"    <p>",
"     There are several ways to repair the rotator cuff, including open and arthroscopic techniques.",
"    </p>",
"    <p>",
"     <ul class=\"bulletCompact-block\">",
"      <li>",
"       Open repairs require a 3 to 4 inch incision in the skin over the shoulder.",
"      </li>",
"      <li>",
"       Arthroscopic surgery requires several (2 or 3) smaller incisions, through which a telescope-like device with a camera and light (called an arthroscope) and other instruments are inserted.",
"      </li>",
"     </ul>",
"    </p>",
"    <p>",
"     The advantage of arthroscopic surgery is that there is usually less pain and a faster return to normal activities, including sports.",
"    </p>",
"    <p>",
"     Most surgeries are performed in a hospital or surgical center, after you are given general anesthesia. The surgery takes one to two hours. Most people can go home several hours after the surgery is completed.",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H29\">",
"     <span class=\"h2\">",
"      Return to activities",
"     </span>",
"     &nbsp;&mdash;&nbsp;After surgical repair, most people require 6 months of rehabilitation before strength and shoulder function return to normal. Post-surgical rehabilitation is necessary and use of the shoulder must be limited. Immediately after surgery, you will be allowed to use the affected arm with your elbow at your side for eating, using the keyboard, using the telephone, and driving. Above-the-shoulder activities are not usually allowed for three months after surgery.",
"    </p>",
"    <p>",
"     Sporting activities can be gradually restarted, including golfing at four months, light weight lifting at four months, swimming at five months, and throwing and tennis playing at five to six months.",
"    </p>",
"    <p class=\"headingAnchor\" id=\"H30\">",
"     <span class=\"h1\">",
"      WHERE TO GET MORE INFORMATION",
"     </span>",
"    </p>",
"    <p>",
"     Your healthcare provider is the best source of information for questions and concerns related to your medical problem.",
"    </p>",
"    <p>",
"     This article will be updated as needed on our web site (",
"     <a class=\"external\" href=\"file://www.uptodate.com/patients\">",
"      www.uptodate.com/patients",
"     </a>",
"     ). Related topics for patients, as well as selected articles written for healthcare professionals, are also available. Some of the most relevant are listed below.",
"     <br/>",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H2413266652\">",
"     <span class=\"h2\">",
"      Patient level information",
"     </span>",
"     &nbsp;&mdash;&nbsp;UpToDate offers two types of patient education materials.",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H431190\">",
"     <span class=\"h3\">",
"      The Basics",
"     </span>",
"     &nbsp;&mdash;&nbsp;The Basics patient education pieces answer the four or five key questions a patient might have about a given condition. These articles are best for patients who want a general overview and who prefer short, easy-to-read materials.",
"    </p>",
"    <p>",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?28/53/29522?source=see_link\">",
"      Patient information: Rotator cuff injury (The Basics)",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?2/32/2563?source=see_link\">",
"      Patient information: Biceps tendinopathy (The Basics)",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?22/26/22946?source=see_link\">",
"      Patient information: Frozen shoulder (The Basics)",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?37/47/38642?source=see_link\">",
"      Patient information: Elbow tendinopathy (tennis and golf elbow) (The Basics)",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?25/35/26162?source=see_link\">",
"      Patient information: Shoulder impingement (The Basics)",
"     </a>",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H431205\">",
"     <span class=\"h3\">",
"      Beyond the Basics",
"     </span>",
"     &nbsp;&mdash;&nbsp;Beyond the Basics patient education pieces are longer, more sophisticated, and more detailed. These articles are best for patients who want in-depth information and are comfortable with some medical jargon.",
"    </p>",
"    <p>",
"     <a class=\"medical medical_patient\" href=\"UTD.htm?24/36/25153?source=see_link\">",
"      Patient information: Biceps tendinitis or tendinopathy (Beyond the Basics)",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_patient\" href=\"UTD.htm?43/18/44321?source=see_link\">",
"      Patient information: Elbow tendinopathy (tennis and golf elbow) (Beyond the Basics)",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_patient\" href=\"UTD.htm?36/21/37201?source=see_link\">",
"      Patient information: Frozen shoulder (Beyond the Basics)",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_patient\" href=\"UTD.htm?2/13/2262?source=see_link\">",
"      Patient information: Nonsteroidal antiinflammatory drugs (NSAIDs) (Beyond the Basics)",
"     </a>",
"     <br/>",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H31\">",
"     <span class=\"h2\">",
"      Professional level information",
"     </span>",
"     &nbsp;&mdash;&nbsp;Professional level articles are designed to keep doctors and other health professionals up-to-date on the latest medical findings. These articles are thorough, long, and complex, and they contain multiple references to the research on which they are based. Professional level articles are best for people who are comfortable with a lot of medical terminology and who want to read the same materials their doctors are reading.",
"    </p>",
"    <p>",
"     <a class=\"medical medical_review\" href=\"UTD.htm?35/7/35961?source=see_link\">",
"      Evaluation of the patient with shoulder complaints",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_review\" href=\"UTD.htm?33/7/33912?source=see_link\">",
"      Frozen shoulder (adhesive capsulitis)",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_review\" href=\"UTD.htm?6/46/6887?source=see_link\">",
"      Presentation and diagnosis of rotator cuff tears",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_review\" href=\"UTD.htm?20/50/21289?source=see_link\">",
"      Rotator cuff tendinopathy",
"     </a>",
"     <br/>",
"     <br/>",
"     The following organizations also provide reliable health information.",
"    </p>",
"    <p>",
"     <ul class=\"bullet-block\">",
"      <li>",
"       National Library of Medicine",
"      </li>",
"     </ul>",
"    </p>",
"    <p>",
"     &nbsp; &nbsp; &nbsp;(",
"     <a class=\"external\" href=\"file://www.nlm.nih.gov/medlineplus/healthtopics.html\">",
"      www.nlm.nih.gov/medlineplus/healthtopics.html",
"     </a>",
"     )",
"    </p>",
"    <p>",
"     <ul class=\"bullet-block\">",
"      <li>",
"       American Academy of Orthopaedic Surgeons",
"      </li>",
"     </ul>",
"    </p>",
"    <p>",
"     &nbsp; &nbsp; &nbsp;(",
"     <a class=\"external\" href=\"file://orthoinfo.aaos.org/\">",
"      file://orthoinfo.aaos.org/",
"     </a>",
"     )",
"    </p>",
"    <p>",
"     <ul class=\"bullet-block\">",
"      <li>",
"       National Institute of Arthritis and Musculoskeletal and Skin Disease",
"      </li>",
"     </ul>",
"    </p>",
"    <p>",
"     &nbsp; &nbsp; &nbsp;(",
"     <a class=\"external\" href=\"file://www.niams.nih.gov/\">",
"      www.niams.nih.gov",
"     </a>",
"     )",
"    </p>",
"    <p>",
"     <ul class=\"bullet-block\">",
"      <li>",
"       American Physical Therapy Association",
"      </li>",
"     </ul>",
"    </p>",
"    <p>",
"     &nbsp; &nbsp; &nbsp;(",
"     <a class=\"external\" href=\"file://www.apta.org/\">",
"      www.apta.org",
"     </a>",
"     )",
"    </p>",
"    <p>",
"     <ul class=\"bullet-block\">",
"      <li>",
"       Arthritis Foundation",
"      </li>",
"     </ul>",
"    </p>",
"    <p>",
"     &nbsp; &nbsp; &nbsp;(",
"     <a class=\"external\" href=\"file://www.arthritis.org/\">",
"      www.arthritis.org",
"     </a>",
"     )",
"    </p>",
"    <p>",
"     [",
"     <a class=\"abstract\" href=\"UTD.htm?23/49/24341/abstract/1-3\">",
"      1-3",
"     </a>",
"     ]",
"    </p>",
"   </div>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Jan 14, 2013.",
"  </div>",
"  <div class=\"patTopicTool\" id=\"patTopicToolBottom\">",
"   <a class=\"toolbutton findicon findInPageLink\" href=\"#\" title=\"Find in Topic\">",
"    Find",
"   </a>",
"   <a class=\"toolbutton printicon\" href=\"UTD.htm?23/49/24341?view=print\" title=\"Print This Topic\">",
"    Print",
"   </a>",
"  </div>",
"  <div id=\"disclaimer\">",
"   The content on the UpToDate website is not intended nor recommended as a substitute",
"for medical advice, diagnosis, or treatment.  Always seek the advice of your own physician or",
"other qualified health care professional regarding any medical questions or conditions.  The",
"use of this website is governed by the",
"   <a href=\"/home/terms-use\" target=\"_blank\">",
"    UpToDate Terms of Use",
"   </a>",
"   &copy;2013 UpToDate, Inc.",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <div id=\"patTopicRefHeader\">",
"    <div id=\"patTopicRefHeaderHeader\">",
"     References",
"    </div>",
"    <div id=\"patTopicRefHeaderTop\">",
"     <a href=\"#top\">",
"      <img alt=\"\" src=\"./../images/top_arrow.myextg\">",
"       Top",
"      </img>",
"     </a>",
"    </div>",
"   </div>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/49/24341/abstract/1\">",
"      Kluger R, Mayrhofer R, Kr&ouml;ner A, et al. Sonographic versus magnetic resonance arthrographic evaluation of full-thickness rotator cuff tears in millimeters. J Shoulder Elbow Surg 2003; 12:110.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/49/24341/abstract/2\">",
"      Green S, Buchbinder R, Hetrick S. Physiotherapy interventions for shoulder pain. Cochrane Database Syst Rev 2003; :CD004258.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/49/24341/abstract/3\">",
"      Buchbinder R, Green S, Youd JM. Corticosteroid injections for shoulder pain. Cochrane Database Syst Rev 2003; :CD004016.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
" </div>",
" <!-- patTopicMiddle -->",
"</div>"].join("\n");
var script_f23_49_24341=[""].join("\n");
var outline_f23_49_24341=[" <div class=\"patTopicFancyTop\">",
"  <div class=\"rcTop\">",
"   <div>",
"   </div>",
"  </div>",
"  <div class=\"rcContent\">",
"   <p>",
"    Contents of this article",
"   </p>",
"  </div>",
" </div>",
" <div class=\"patTopicFancySpacer\">",
" </div>",
" <div class=\"patTopicOutline\">",
"  <div class=\"rcbBottom\">",
"   <div class=\"rcbLeft\">",
"    <div class=\"rcbRight\">",
"     <div class=\"rcbBottomLeft\">",
"      <div class=\"rcbBottomRight rcbBottomRightBottomOnly\">",
"       <div id=\"outline\">",
"        <ul>",
"         <li class=\"plainItem\">",
"          <a href=\"#H1\">",
"           ROTATOR CUFF INJURY OVERVIEW",
"          </a>",
"         </li>",
"         <li class=\"plainItem\">",
"          <a href=\"#H2\">",
"           WHAT IS THE ROTATOR CUFF?",
"          </a>",
"         </li>",
"         <li class=\"plainItem\">",
"          <a href=\"#H5\">",
"           ROTATOR CUFF INJURY SYMPTOMS",
"          </a>",
"         </li>",
"         <li class=\"plainItem\">",
"          <a href=\"#H8\">",
"           ROTATOR CUFF INJURY TESTS",
"          </a>",
"         </li>",
"         <li class=\"plainItem\">",
"          <a href=\"#H9\">",
"           ROTATOR CUFF INJURY TREATMENT",
"          </a>",
"         </li>",
"         <li class=\"plainItem\">",
"          <a href=\"#H27\">",
"           IF PAIN PERSISTS",
"          </a>",
"         </li>",
"         <li class=\"plainItem\">",
"          <a href=\"#H28\">",
"           SURGICAL REPAIR OF ROTATOR CUFF TEARS",
"          </a>",
"         </li>",
"         <li class=\"plainItem\">",
"          <a href=\"#H30\">",
"           WHERE TO GET MORE INFORMATION",
"          </a>",
"         </li>",
"         <li class=\"plainItem\">",
"          <a href=\"#references\">",
"           REFERENCES",
"          </a>",
"         </li>",
"        </ul>",
"       </div>",
"       <h1>",
"        GRAPHICS",
"       </h1>",
"       <div id=\"relatedGraphics\">",
"        <ul>",
"         <li class=\"plainItem\">",
"          FIGURES",
"         </li>",
"         <li class=\"bulletItem\">",
"          <a class=\"graphic graphic_figure\" href=\"UTD.htm?15/19/15670\" title=\"figure 1A\">",
"           Anterior view of shoulder anatomy",
"          </a>",
"         </li>",
"         <li class=\"bulletItem\">",
"          <a class=\"graphic graphic_figure\" href=\"UTD.htm?42/2/43044\" title=\"figure 1B\">",
"           Shoulder anat lateral PI",
"          </a>",
"         </li>",
"         <li class=\"bulletItem\">",
"          <a class=\"graphic graphic_figure\" href=\"UTD.htm?26/56/27524\" title=\"figure 1C\">",
"           Shoulder anat posterior PI",
"          </a>",
"         </li>",
"         <li class=\"bulletItem\">",
"          <a class=\"graphic graphic_figure\" href=\"UTD.htm?12/37/12895\" title=\"figure 2\">",
"           Pendulum stretch exercise PI",
"          </a>",
"         </li>",
"         <li class=\"bulletItem\">",
"          <a class=\"graphic graphic_figure\" href=\"UTD.htm?26/2/26656\" title=\"figure 3\">",
"           Shoulder strength PI",
"          </a>",
"         </li>",
"         <li class=\"plainItem\">",
"          PICTURES",
"         </li>",
"         <li class=\"bulletItem\">",
"          <a class=\"graphic graphic_picture\" href=\"UTD.htm?37/24/38287\" title=\"picture 1\">",
"           Scapular squeeze PI",
"          </a>",
"         </li>",
"         <li class=\"bulletItem\">",
"          <a class=\"graphic graphic_picture\" href=\"UTD.htm?36/14/37089\" title=\"picture 2\">",
"           Outward rotation PI",
"          </a>",
"         </li>",
"         <li class=\"bulletItem\">",
"          <a class=\"graphic graphic_picture\" href=\"UTD.htm?3/14/3298\" title=\"picture 3\">",
"           Inward rotation exercise PI",
"          </a>",
"         </li>",
"         <li class=\"bulletItem\">",
"          <a class=\"graphic graphic_picture\" href=\"UTD.htm?18/9/18577\" title=\"picture 4\">",
"           Lifting exercise PI",
"          </a>",
"         </li>",
"         <li class=\"bulletItem\">",
"          <a class=\"graphic graphic_picture\" href=\"UTD.htm?0/60/967\" title=\"picture 5\">",
"           Scapular strength Y PI",
"          </a>",
"         </li>",
"         <li class=\"bulletItem\">",
"          <a class=\"graphic graphic_picture\" href=\"UTD.htm?13/4/13380\" title=\"picture 6\">",
"           Scapular strength T PI",
"          </a>",
"         </li>",
"         <li class=\"bulletItem\">",
"          <a class=\"graphic graphic_picture\" href=\"UTD.htm?4/1/4117\" title=\"picture 7\">",
"           Scapular strength W PI",
"          </a>",
"         </li>",
"         <li class=\"bulletItem\">",
"          <a class=\"graphic graphic_picture\" href=\"UTD.htm?14/45/15059\" title=\"picture 8\">",
"           Scapular strength L PI",
"          </a>",
"         </li>",
"        </ul>",
"       </div>",
"      </div>",
"     </div>",
"    </div>",
"   </div>",
"  </div>",
" </div>"].join("\n");
var title_f23_49_24342="Transthoracic echocardiography for the evaluation of chest pain in the emergency department";
var content_f23_49_24342=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"3\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Transthoracic echocardiography for the evaluation of chest pain in the emergency department",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?23/49/24342/contributors\">",
"     Author",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?23/49/24342/contributors\">",
"     Neil J Weissman, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?23/49/24342/contributors\">",
"     Section Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?23/49/24342/contributors\">",
"     Warren J Manning, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?23/49/24342/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?23/49/24342/contributors\">",
"     Brian C Downey, MD, FACC",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"UTD.htm?23/49/24342/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Jun 7, 2012.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Accurate assessment of chest pain in the emergency department requires a thorough knowledge of the differential diagnosis and appropriate use of diagnostic tools. It is essential not to miss an aortic dissection, pulmonary embolus, or acute myocardial infarction, and to avoid overtreating pericarditis or musculoskeletal pain. Transthoracic echocardiography (TTE) is often underutilized in this setting. TTE has the advantages of being readily accessible, portable, noninvasive, and fast; it may detect significant findings that are misdiagnosed or not detected on initial clinical evaluation. In one study of 124 patients, it identified a patient with a significant abnormality with a sensitivity, specificity, positive and negative predictive value, and overall accuracy of 84, 88, 89, 83, and 86 percent, respectively [",
"    <a class=\"abstract\" href=\"UTD.htm?23/49/24342/abstract/1\">",
"     1",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    In 2003, a task force of the American College of Cardiology (ACC), the American Heart Association (AHA), and the American Society of Echocardiography (ASE) recommended echocardiography in patients with chest pain in the following settings [",
"    <a class=\"abstract\" href=\"UTD.htm?23/49/24342/abstract/2\">",
"     2",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      For diagnosis of underlying cardiac disease in patients with chest pain and clinical evidence of valvular, pericardial, or myocardial disease",
"     </li>",
"     <li>",
"      For evaluation of chest pain in patients with suspected acute myocardial ischemia, when baseline ECG and other laboratory markers are nondiagnostic and when the study can be obtained during pain or within minutes after its abatement",
"     </li>",
"     <li>",
"      For evaluation of chest pain in patients with suspected aortic dissection",
"     </li>",
"     <li>",
"      For evaluation of patients with chest pain and hemodynamic instability unresponsive to simple therapeutic measures",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    The task force recommended",
"    <strong>",
"     against",
"    </strong>",
"    the routine use of echocardiography for diagnosis of chest pain in patients with electrocardiographic changes diagnostic of myocardial ischemia or infarction.",
"   </p>",
"   <p>",
"    The role of TTE in the emergent diagnosis of chest pain of differing etiologies will be reviewed here (",
"    <a class=\"graphic graphic_table graphicRef54763 \" href=\"UTD.htm?11/12/11467\">",
"     table 1",
"    </a>",
"    ). (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?14/50/15144?source=see_link\">",
"     \"Pathophysiology and clinical presentation of ischemic chest pain\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?2/9/2201?source=see_link\">",
"     \"Major causes of musculoskeletal chest pain\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     REGIONAL WALL MOTION ABNORMALITIES IN MYOCARDIAL ISCHEMIA OR INFARCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Regional wall motion abnormalities (RWMAs) can be visualized echocardiographically within seconds of a coronary artery occlusion [",
"    <a class=\"abstract\" href=\"UTD.htm?23/49/24342/abstract/3\">",
"     3",
"    </a>",
"    ], and occurs prior to the onset of electrocardiographic changes or the development of symptoms (",
"    <a class=\"graphic graphic_figure graphicRef79335 \" href=\"UTD.htm?32/60/33741\">",
"     figure 1",
"    </a>",
"    and",
"    <a class=\"graphic graphic_movie graphicRef70619 \" href=\"UTD.htm?24/50/25380\">",
"     movie 1",
"    </a>",
"    and",
"    <a class=\"graphic graphic_movie graphicRef50724 \" href=\"UTD.htm?37/33/38419\">",
"     movie 2",
"    </a>",
"    and",
"    <a class=\"graphic graphic_movie graphicRef72843 \" href=\"UTD.htm?29/44/30403\">",
"     movie 3",
"    </a>",
"    and",
"    <a class=\"graphic graphic_movie graphicRef62247 \" href=\"UTD.htm?19/9/19604\">",
"     movie 4",
"    </a>",
"    )&nbsp;[",
"    <a class=\"abstract\" href=\"UTD.htm?23/49/24342/abstract/4\">",
"     4",
"    </a>",
"    ]. These RWMAs are created by a localized decrease in amplitude and rate of myocardial excursion, along with a blunted degree of myocardial thickening. Since ischemic RWMAs develop prior to symptoms, chest pain in the absence of RWMAs should not be from active myocardial ischemia. However, the converse is not true; the presence of RWMAs does not establish the diagnosis of ischemia. There are numerous reasons for RWMAs, including a prior myocardial infarction, focal myocarditis, prior surgery, right ventricular volume overload, left bundle branch block, Wolff-Parkinson-White and ventricular preexcitation, and cardiomyopathy. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?11/6/11369?source=see_link&amp;anchor=H2#H2\">",
"     \"Role of echocardiography in acute myocardial infarction\", section on 'Diagnosis of MI'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Considering the observations that RWMAs are an early sign of myocardial ischemia and that the absence of RWMAs effectively rules out ischemia, a group of investigators prospectively studied the utility of echocardiography in the triage of patients with chest pain [",
"    <a class=\"abstract\" href=\"UTD.htm?23/49/24342/abstract/5\">",
"     5",
"    </a>",
"    ]. Among 180 consecutive patients presenting to the emergency department at an academic hospital who met inclusion criteria, 94 percent had adequate echocardiograms. Sixty of 169 (36 percent) had no regional or global dysfunction and 22 (13 percent) had global hypokinesis without RWMAs. The following results were noted:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Of the 88 patients without RWMAs, only 2 (2 percent) subsequently \"ruled in\" for a non-Q wave myocardial infarction by cardiac enzymes, without clinical sequelae (",
"      <a class=\"graphic graphic_figure graphicRef53696 \" href=\"UTD.htm?43/2/44077\">",
"       figure 2",
"      </a>",
"      ).",
"     </li>",
"     <li>",
"      Of the 87 patients with RWMAs, 27 (31 percent) had an acute myocardial infarction. The initial ECG was diagnostic (ST elevation with or without Q waves) in nine of these patients, and eight had an electrocardiogram that was not interpretable for an acute MI (due to LBBB, pacing, or left ventricular hypertrophy with strain). Thirteen patients subsequently developed pathologic Q waves.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Thus, one strategy for screening chest pain patients for RWMAs with echocardiography would be as follows.",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      If an adequate echocardiogram can be obtained and there are no RWMAs, it is relative safe to discharge the patient from the emergency department.",
"     </li>",
"     <li>",
"      Patients with RWMAs should be admitted for further observation and treatment. Those patients with a suspicious chest pain syndrome in whom an adequate echocardiogram cannot be obtained would also warrant observation.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    This scheme could provide a screening mechanism to reduce the number of admissions that use ECG and clinical criteria alone, and would also identify acute mechanical complications of a myocardial infarction. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?38/19/39225?source=see_link\">",
"     \"Mechanical complications of acute myocardial infarction\"",
"    </a>",
"    .) However, using RWMA to screen for ischemia rather than waiting for cardiac enzymes is not perfect. The preceding study missed 2 percent of infarcts when defined by elevated cardiac enzymes [",
"    <a class=\"abstract\" href=\"UTD.htm?23/49/24342/abstract/5\">",
"     5",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    There are also other limitations to screening with echocardiography. It is reasonable only if a high quality echocardiogram can be obtained, and the echocardiogram is interpreted by an experienced echocardiographer available 24 hours a day. Furthermore, even if the echocardiographic procedure is technically feasible, some patients with a small myocardial infarction who spontaneously reperfused, but may still have an unstable lesion, could potentially be discharged under this protocol.",
"   </p>",
"   <p>",
"    Despite these limitations, the 2003",
"    <span class=\"nowrap\">",
"     ACC/AHA/ASE",
"    </span>",
"    task force gave a class I recommendation to the use of echocardiography for evaluation of chest pain in patients with suspected acute myocardial ischemia, when baseline ECG and other laboratory markers are nondiagnostic and when the study can be obtained during pain or within minutes after its abatement [",
"    <a class=\"abstract\" href=\"UTD.htm?23/49/24342/abstract/2\">",
"     2",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    <a class=\"drug drug_general\" href=\"UTD.htm?24/57/25494?source=see_link\">",
"     Dobutamine",
"    </a>",
"    stress echocardiography may provide additional information in patients with chest pain, a negative initial serum assay for myocardial infarction, a nonischemic ECG, and a normal resting echocardiogram. One study in 163 such patients found that dobutamine stress echocardiography had a sensitivity, specificity, and negative predictive accuracy of 90, 89, and 99 percent, respectively, versus clinical and catheterization studies [",
"    <a class=\"abstract\" href=\"UTD.htm?23/49/24342/abstract/6\">",
"     6",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    TTE may also be of use for predicting subsequent complications in patients admitted to the hospital for chest pain. One study performed TTE with Doppler in 466 such patients who had neither trauma nor chest x-ray abnormalities to determine the relationship between echocardiographic parameters and subsequent predischarge complications [",
"    <a class=\"abstract\" href=\"UTD.htm?23/49/24342/abstract/7\">",
"     7",
"    </a>",
"    ]. An acute myocardial infarction was diagnosed in 14 percent, while 33 percent had unstable angina. In a multivariate analysis, the wall motion index based on RWMAs was an incremental predictor of risk of a complication such as recurrent ischemic pain, heart failure, or arrhythmias (odds ratio 2.2 per unit), especially in patients with an acute infarction (odds ratio 3.5).",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h1\">",
"     AORTIC DISSECTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;The echocardiographic diagnosis of an aortic dissection usually requires a transesophageal approach since the transthoracic echo is limited in its ability to adequately image the distal ascending aorta, transverse aorta, or descending thoracic aorta. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?25/19/25914?source=see_link\">",
"     \"Clinical manifestations and diagnosis of aortic dissection\"",
"    </a>",
"    .) However, TTE is useful in two situations:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      The diagnosis of dissection is established if an intimal flap is visualized on TTE (",
"      <a class=\"graphic graphic_diagnosticimage graphicRef51784 \" href=\"UTD.htm?22/2/22575\">",
"       image 1",
"      </a>",
"      ).",
"     </li>",
"     <li>",
"      Further investigation, such as transesophageal echocardiography, is warranted if the dissection is not visualized, but there are echocardiographic findings associated with a dissection (",
"      <a class=\"graphic graphic_movie graphicRef69234 \" href=\"UTD.htm?0/19/304\">",
"       movie 5",
"      </a>",
"      ). The TTE findings associated with an aortic dissection include:",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Enlarged aortic root (greater than 35 mm at the annulus, sinuses of Valsalva or sino-tubular junction)",
"     </li>",
"     <li>",
"      Aortic insufficiency, usually from annular dilation and poor coaptation of the aortic cusps",
"     </li>",
"     <li>",
"      Pericardial effusion of any size with or without cardiac tamponade",
"     </li>",
"     <li>",
"      Inferior-posterior RWMA, which is due to extension of the dissection down the right coronary artery, leading to occlusion of antegrade flow and myocardial ischemia",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    The 2003",
"    <span class=\"nowrap\">",
"     ACC/AHA/ASE",
"    </span>",
"    task force gave a class I recommendation to the use of echocardiography for evaluation of chest pain in patients with suspected aortic dissection [",
"    <a class=\"abstract\" href=\"UTD.htm?23/49/24342/abstract/2\">",
"     2",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    It is important to emphasize that the lack of associated transthoracic echocardiographic findings does not exclude an aortic dissection. Thus, if a dissection is clinically suspected based upon history, physical examination or chest x-ray, a transesophageal echocardiogram or MRI must be performed. If there is a low clinical suspicion, however, the lack of associated findings adds confidence to the placement of dissection lower on the differential diagnosis.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4\">",
"    <span class=\"h1\">",
"     PERICARDIAL DISEASE",
"    </span>",
"    &nbsp;&mdash;&nbsp;Pericarditis is an inflammation of the pericardium which causes pleuritic chest pain, a pericardial friction rub, and ECG abnormalities. Regardless of the etiology, pericardial inflammation may be associated with an accumulation of fluid between the visceral and parietal pericardium which is easily visualized on the echocardiogram. The absence of a pericardial effusion, however, does not exclude pericarditis. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?36/47/37625?source=see_link\">",
"     \"Clinical presentation and diagnostic evaluation of acute pericarditis\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Small effusions (less than 100 mL) tend to accumulate behind the posterior wall in the AV groove. Larger effusions (100 to 500 mL) tend to extend laterally, apically, and anteriorly. The size of the effusion is more often associated with the duration and etiology of the pericardial inflammation, rather than the severity. Even small effusions can compromise right atrial and ventricular filling and lead to cardiac tamponade. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?3/59/4025?source=see_link\">",
"     \"Diagnosis and treatment of pericardial effusion\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?18/52/19273?source=see_link&amp;anchor=H22#H22\">",
"     \"Cardiac tamponade\", section on 'Echocardiography'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Echocardiography is the diagnostic test of choice to rapidly identify a pericardial effusion, the relationship between the effusion and cardiac structures, and the physiologic changes associated with tamponade (",
"    <a class=\"graphic graphic_movie graphicRef73179 \" href=\"UTD.htm?26/14/26863\">",
"     movie 6",
"    </a>",
"    and",
"    <a class=\"graphic graphic_movie graphicRef76287 \" href=\"UTD.htm?10/29/10708\">",
"     movie 7",
"    </a>",
"    and",
"    <a class=\"graphic graphic_movie graphicRef66715 \" href=\"UTD.htm?31/42/32420\">",
"     movie 8",
"    </a>",
"    and",
"    <a class=\"graphic graphic_movie graphicRef74765 \" href=\"UTD.htm?37/37/38483\">",
"     movie 9",
"    </a>",
"    ). With an increase in pericardial effusion pressure above right atrial pressure, there is an invagination of the RA free wall. As pericardial pressure rises above right ventricular end-diastolic pressure, the RV free wall invaginates during diastole. These anatomic hallmarks of cardiac tamponade are accompanied by a respirophasic change in RV and left ventricular filling velocities detected by Doppler and may be associated by pulsus paradoxus on physical examination. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?10/57/11158?source=see_link\">",
"     \"Pulsus paradoxus in pericardial disease\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The 2003",
"    <span class=\"nowrap\">",
"     ACC/AHA/ASE",
"    </span>",
"    task force gave a class I recommendation to the use of echocardiography for diagnosis in patients with chest pain and clinical evidence of pericardial disease [",
"    <a class=\"abstract\" href=\"UTD.htm?23/49/24342/abstract/2\">",
"     2",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Patients with chronic pericarditis and an effusion frequently develop a fibrinous exudate which forms an echodense layer on the pericardial surface. Intrapericardial fibrous bands may develop across the parietal and visceral pericardial surfaces and appear to divide the pericardial space into compartments (",
"    <a class=\"graphic graphic_movie graphicRef73179 \" href=\"UTD.htm?26/14/26863\">",
"     movie 6",
"    </a>",
"    ). Pericardial calcification, as in tuberculous pericarditis, can also be detected with echocardiography.",
"   </p>",
"   <p>",
"    Fibrinous deposition should be differentiated from metastatic tumor infiltration of the pericardium with an associated effusion. The pericardium is the most common cardiac site for metastases and occurs most often with carcinoma of the lung, breast, malignant melanoma, and",
"    <span class=\"nowrap\">",
"     lymphoma/leukemia.",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5\">",
"    <span class=\"h1\">",
"     PULMONARY EMBOLUS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Pulmonary embolism can result in elevated right ventricular afterload that leads to pulmonary arterial hypertension and right heart failure. Echocardiography is useful in detecting pulmonary hypertension and establishing its cause. In the appropriate clinical setting of new onset chest pain and dyspnea, the following echocardiographic findings are suggestive of a pulmonary embolus [",
"    <a class=\"abstract\" href=\"UTD.htm?23/49/24342/abstract/8\">",
"     8",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Dilated pulmonary artery, right ventricle and right atrium.",
"     </li>",
"     <li>",
"      Hypokinetic right ventricle.",
"     </li>",
"     <li>",
"      Moderate or severe tricuspid regurgitation with an elevated velocity; measurement of the tricuspid regurgitant velocity with continuous wave Doppler allows calculation of the RA-RV pressure gradient, using the modified Bernoulli equation of 4v(2), and therefore estimation of the pulmonary systolic pressure.",
"     </li>",
"     <li>",
"      Systolic septal flattening, viewed in the parasternal short axis view, indicative of elevated right ventricular pressure.",
"     </li>",
"     <li>",
"      Absence of significant left heart abnormalities that can cause pulmonary hypertension.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Right ventricular hypertrophy, which is commonly seen with secondary pulmonary hypertension due to chronic pulmonary emboli, is not present with an acute embolus unless it is superimposed upon chronic emboli (",
"    <a class=\"graphic graphic_movie graphicRef67911 \" href=\"UTD.htm?19/59/20402\">",
"     movie 10",
"    </a>",
"    ).",
"   </p>",
"   <p>",
"    The above findings are suggestive, but not independently diagnostic of pulmonary embolus. Similarly, the lack of echocardiographic evidence for pulmonary hypertension does not exclude a pulmonary embolus. An acute embolus, for example, may cause sudden right ventricular failure before the ventricle has the ability to generate an elevated pulmonary arterial pressure. Alternatively, small emboli may not be sufficient to cause an elevation in pulmonary arterial pressure. Thus, the echocardiogram is not used as an initial diagnostic test if pulmonary embolus is suspected clinically. If, however, a TTE is obtained in the course of the evaluation for other suspected causes of chest pain, and pulmonary hypertension is detected with normal left-sided structures, then a diagnosis of pulmonary embolus should be pursued with other diagnostic tests (",
"    <a class=\"graphic graphic_movie graphicRef55501 \" href=\"UTD.htm?9/18/9506\">",
"     movie 11",
"    </a>",
"    ).",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6\">",
"    <span class=\"h1\">",
"     CHEST WALL TRAUMA",
"    </span>",
"    &nbsp;&mdash;&nbsp;Traumatic heart disease is usually diagnosed from the history and then assessed with echocardiography.",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Nonpenetrating cardiac injury most often involves some degree of pericarditis or pericardial injury. Even in the absence of a pericardial tear, laceration or rupture, there may be an effusion from pericardial inflammation.",
"     </li>",
"     <li>",
"      A myocardial contusion, especially of the anterior right-sided structures, is a common complication of blunt chest trauma, which usually goes unrecognized because of the lack of specific symptoms. In this setting, echocardiography will detect regional wall motion abnormalities at the site of contusion, with possible chamber enlargement, with or without an associated effusion [",
"      <a class=\"abstract\" href=\"UTD.htm?23/49/24342/abstract/9\">",
"       9",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Uncommon complications of chest wall trauma, such as valvular, coronary arterial, and papillary muscle lacerations or ruptures, and intracardiac shunts, may all be detected by TTE with Doppler [",
"      <a class=\"abstract\" href=\"UTD.htm?23/49/24342/abstract/10\">",
"       10",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      The rare patient that survives cardiac rupture long enough to undergo evaluation will have a large hemopericardial effusion detected on echocardiography.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Thus, early use of echocardiography in the symptomatic patient after chest wall trauma, or in the asymptomatic trauma patient with an abnormal ECG or chest x-ray, will facilitate the diagnosis and determine the extent and degree of cardiac injury.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7\">",
"    <span class=\"h1\">",
"     ESTABLISHING PROGNOSIS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Similar to its use in other groups of patients, the echocardiogram provides information that is useful for predicting long-term survival in patients presenting to the emergency department with chest pain. One study evaluated 448 patients with acute chest pain admitted to the hospital from the emergency department who were then followed for 35 months [",
"    <a class=\"abstract\" href=\"UTD.htm?23/49/24342/abstract/11\">",
"     11",
"    </a>",
"    ]. Independent predictors of survival were moderate or severe left ventricular dysfunction (mortality rate ratio 3.2) and more than mild valvular (aortic, mitral, or tricuspid) regurgitation (mortality rate ratio 2.0) (",
"    <a class=\"graphic graphic_figure graphicRef66118 \" href=\"UTD.htm?34/56/35726\">",
"     figure 3",
"    </a>",
"    )&nbsp;[",
"    <a class=\"abstract\" href=\"UTD.htm?23/49/24342/abstract/11\">",
"     11",
"    </a>",
"    ]. Only 59 percent of patients with moderate or severe valvular regurgitation had a murmur on physical examination.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2182184548\">",
"    <span class=\"h1\">",
"     SUMMARY AND RECOMMENDATIONS",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Transthoracic echocardiography (TTE) can be used in the setting of acute chest pain to evaluate for regional wall motion abnormalities (RWMA).In the absence of&nbsp;RWMA with a good quality echocardiogram, myocardial ischemia is essentially ruled out. (See",
"      <a class=\"local\" href=\"#H2\">",
"       'Regional wall motion abnormalities in myocardial ischemia or infarction'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      While TTE is only occasionally diagnostic in the patient with suspected aortic dissection, transesophageal echocardiography (TEE) is an ideal diagnostic test. (See",
"      <a class=\"local\" href=\"#H3\">",
"       'Aortic dissection'",
"      </a>",
"      above and",
"      <a class=\"medical medical_review\" href=\"UTD.htm?25/19/25914?source=see_link&amp;anchor=H17#H17\">",
"       \"Clinical manifestations and diagnosis of aortic dissection\", section on 'Diagnosis'",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      For patients with suspected pericardial disease, in particular pericardial effusion with hemodynamic compromise, TTE can identify the presence or absence of a pericardial effusion and any hemodynamic features suggestive of cardiac tamponade. (See",
"      <a class=\"local\" href=\"#H4\">",
"       'Pericardial disease'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      TTE can identify cardiac complications from blunt chest wall trauma such as myocardial contusion. (See",
"      <a class=\"local\" href=\"#H6\">",
"       'Chest wall trauma'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/49/24342/abstract/1\">",
"      Kimura BJ, Bocchicchio M, Willis CL, Demaria AN. Screening cardiac ultrasonographic examination in patients with suspected cardiac disease in the emergency department. Am Heart J 2001; 142:324.",
"     </a>",
"    </li>",
"    <li>",
"     Cheitlin MD, Armstrong WF, Aurigemma GP, et al. ACC/AHA/ASE 2003 guideline for the clinical application of echocardiography www.acc.org/qualityandscience/clinical/statements.htm (Accessed on August 24, 2006).",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/49/24342/abstract/3\">",
"      Hauser AM, Gangadharan V, Ramos RG, et al. Sequence of mechanical, electrocardiographic and clinical effects of repeated coronary artery occlusion in human beings: echocardiographic observations during coronary angioplasty. J Am Coll Cardiol 1985; 5:193.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/49/24342/abstract/4\">",
"      Beller GA. Myocardial perfusion imaging for detection of silent myocardial ischemia. Am J Cardiol 1988; 61:22F.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/49/24342/abstract/5\">",
"      Sabia P, Afrookteh A, Touchstone DA, et al. Value of regional wall motion abnormality in the emergency room diagnosis of acute myocardial infarction. A prospective study using two-dimensional echocardiography. Circulation 1991; 84:I85.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/49/24342/abstract/6\">",
"      Trippi JA, Lee KS, Kopp G, et al. Dobutamine stress tele-echocardiography for evaluation of emergency department patients with chest pain. J Am Coll Cardiol 1997; 30:627.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/49/24342/abstract/7\">",
"      Fleischmann KE, Lee TH, Come PC, et al. Echocardiographic prediction of complications in patients with chest pain. Am J Cardiol 1997; 79:292.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/49/24342/abstract/8\">",
"      Kasper W, Meinertz T, Henkel B, et al. Echocardiographic findings in patients with proved pulmonary embolism. Am Heart J 1986; 112:1284.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/49/24342/abstract/9\">",
"      Miller FA Jr, Seward JB, Gersh BJ, et al. Two-dimensional echocardiographic findings in cardiac trauma. Am J Cardiol 1982; 50:1022.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/49/24342/abstract/10\">",
"      Jackson DH, Murphy GW. Nonpenetrating cardiac trauma. Mod Conc Cardiovasc Dis 1976; 45:123.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/49/24342/abstract/11\">",
"      Fleischmann KE, Lee RT, Come PC, et al. Impact of valvular regurgitation and ventricular dysfunction on long-term survival in patients with chest pain. Am J Cardiol 1997; 80:1266.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 1478 Version 3.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [1105-213.131.41.98-09444732DF-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f23_49_24342=[""].join("\n");
var outline_f23_49_24342=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H2182184548\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY &amp; RECOMMENDATIONS",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      REGIONAL WALL MOTION ABNORMALITIES IN MYOCARDIAL ISCHEMIA OR INFARCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      AORTIC DISSECTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H4\">",
"      PERICARDIAL DISEASE",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H5\">",
"      PULMONARY EMBOLUS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H6\">",
"      CHEST WALL TRAUMA",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H7\">",
"      ESTABLISHING PROGNOSIS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2182184548\">",
"      SUMMARY AND RECOMMENDATIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"CARD/1478\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"CARD/1478|DiagnosticImage\">",
"      <a href=\"#\" title=\"DIAGNOSTIC IMAGES\">",
"       DIAGNOSTIC IMAGES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_diagnosticimage\" href=\"UTD.htm?22/2/22575\" title=\"diagnostic image 1\">",
"      Aortic dissection TTE",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"CARD/1478|FIG\">",
"      <a href=\"#\" title=\"FIGURES\">",
"       FIGURES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?32/60/33741\" title=\"figure 1\">",
"      Time course cardiac ischemia",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?43/2/44077\" title=\"figure 2\">",
"      Echo for chest pain in ER",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?34/56/35726\" title=\"figure 3\">",
"      Valvular regurg survival",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"CARD/1478|MOV\">",
"      <a href=\"#\" title=\"MOVIES\">",
"       MOVIES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_movie\" href=\"UTD.htm?24/50/25380\" title=\"movie 1\">",
"      Anterior wall MI four chamber echo 1",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_movie\" href=\"UTD.htm?37/33/38419\" title=\"movie 2\">",
"      Anterior wall MI four chamber echo 2",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_movie\" href=\"UTD.htm?29/44/30403\" title=\"movie 3\">",
"      Anterior wall dyskinesis post MI four chamber echo",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_movie\" href=\"UTD.htm?19/9/19604\" title=\"movie 4\">",
"      Left ventricular aneurysm four chamber echocardiogram 1",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_movie\" href=\"UTD.htm?0/19/304\" title=\"movie 5\">",
"      Aortic dissection transesophageal echocardiogram",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_movie\" href=\"UTD.htm?26/14/26863\" title=\"movie 6\">",
"      Pericardial effusion subcostal echocardiogram",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_movie\" href=\"UTD.htm?10/29/10708\" title=\"movie 7\">",
"      Pericardial effusion parasternal long axis echocardiogram",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_movie\" href=\"UTD.htm?31/42/32420\" title=\"movie 8\">",
"      Pericardial effusion four chamber echocardiogram",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_movie\" href=\"UTD.htm?37/37/38483\" title=\"movie 9\">",
"      Pericardial effusion with tamponade subcostal echocardiogram",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_movie\" href=\"UTD.htm?19/59/20402\" title=\"movie 10\">",
"      Pulmonary hypertension short axis echo",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_movie\" href=\"UTD.htm?9/18/9506\" title=\"movie 11\">",
"      Pulmonary hypertension four chamber echocardiogram",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"CARD/1478|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?11/12/11467\" title=\"table 1\">",
"      Chest pain in ER",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?18/52/19273?source=related_link\">",
"      Cardiac tamponade",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?25/19/25914?source=related_link\">",
"      Clinical manifestations and diagnosis of aortic dissection",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?36/47/37625?source=related_link\">",
"      Clinical presentation and diagnostic evaluation of acute pericarditis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?3/59/4025?source=related_link\">",
"      Diagnosis and treatment of pericardial effusion",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?2/9/2201?source=related_link\">",
"      Major causes of musculoskeletal chest pain",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?38/19/39225?source=related_link\">",
"      Mechanical complications of acute myocardial infarction",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?14/50/15144?source=related_link\">",
"      Pathophysiology and clinical presentation of ischemic chest pain",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?10/57/11158?source=related_link\">",
"      Pulsus paradoxus in pericardial disease",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?11/6/11369?source=related_link\">",
"      Role of echocardiography in acute myocardial infarction",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f23_49_24343="Beau lines 2";
var content_f23_49_24343=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=DERM%2F85706%7EDERM%2F78502&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=DERM%2F85706%7EDERM%2F78502&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 524px\">",
"   <div class=\"ttl\">",
"    Transverse grooves of the nail plate (Beau lines)",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 504px; height: 378px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: www.visualdx.com. Copyright Logical Images, Inc.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Beau's line",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 432px; height: 325px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    The transverse groove on the nail plate is a Beau's line.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: www.visualdx.com. Copyright Logical Images, Inc.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f23_49_24343=[""].join("\n");
var outline_f23_49_24343=null;
var title_f23_49_24344="Theophylline: Pediatric drug information";
var content_f23_49_24344=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"4\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"drugTitle\">",
"   Theophylline: Pediatric drug information",
"  </div>",
"  <div id=\"lexiTitleImg\">",
"   <img height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"  </div>",
"  <div class=\"clear\">",
"  </div>",
"  <div id=\"drugCopy\">",
"   Copyright 1978-2013 Lexicomp, Inc. All rights reserved.",
"  </div>",
"  <div id=\"topicText\">",
"   (For additional information",
"   <a class=\"drug drug_general\" href=\"UTD.htm?29/31/30200?source=see_link\">",
"    see \"Theophylline: Drug information\"",
"   </a>",
"   and",
"   <a class=\"drug drug_patient\" href=\"UTD.htm?1/7/1141?source=see_link\">",
"    see \"Theophylline: Patient drug information\"",
"   </a>",
"   )",
"   <br/>",
"   For abbreviations and symbols that may be used in Lexicomp (",
"   <a class=\"graphic graphic_table\" href=\"UTD.htm?23/39/24183\">",
"    show table",
"   </a>",
"   )",
"   <div class=\"list ubnlist drugH1Div drugBrandNames\" id=\"F226552\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Brand Names: U.S.",
"    </span>",
"    <ul>",
"     <li>",
"      Elixophyllin&reg; Elixir;",
"     </li>",
"     <li>",
"      Theo-24&reg;",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"list cbnlist drugH1Div drugBrandNames\" id=\"F226553\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Brand Names: Canada",
"    </span>",
"    <ul>",
"     <li>",
"      Apo-Theo LA&reg;;",
"     </li>",
"     <li>",
"      Novo-Theophyl SR;",
"     </li>",
"     <li>",
"      PMS-Theophylline;",
"     </li>",
"     <li>",
"      Pulmophylline;",
"     </li>",
"     <li>",
"      ratio-Theo-Bronc;",
"     </li>",
"     <li>",
"      Teva-Theophylline SR;",
"     </li>",
"     <li>",
"      Theo ER;",
"     </li>",
"     <li>",
"      Theolair;",
"     </li>",
"     <li>",
"      Uniphyl",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"list_set htclist drugH1Div drugBrandNames\" id=\"F1062538\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Therapeutic Category",
"    </span>",
"    <ul>",
"     <li>",
"      <span class=\"list-set-name\">",
"       Antiasthmatic",
"      </span>",
"     </li>",
"     <li>",
"      <span class=\"list-set-name\">",
"       Bronchodilator",
"      </span>",
"     </li>",
"     <li>",
"      <span class=\"list-set-name\">",
"       Respiratory Stimulant",
"      </span>",
"     </li>",
"     <li>",
"      <span class=\"list-set-name\">",
"       Theophylline Derivative",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"block don drugH1Div\" id=\"F11445184\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosing: Neonatal",
"    </span>",
"    <p style=\"text-indent:0em;\">",
"     <b>",
"      Note:",
"     </b>",
"     Dose should be calculated using ideal body weight and individualized by serum concentrations. Due to longer half-life than older patients, the time to achieve steady-state serum levels is prolonged in neonates (see theophylline half-life table); serum theophylline levels should be drawn after 48-72 hours of therapy (usually 72 hours in neonates); repeat levels are indicated 3 days after each change in dosage or weekly if on a stabilized dosage. If renal function decreased, consider dose reduction and additional monitoring.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;margin-top:2em;\">",
"     Apnea of prematurity: Oral:",
"     <b>",
"      Note:",
"     </b>",
"     A fast-release product should be used:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;\">",
"     Loading dose: 5-6 mg/kg/dose (Bhatta-Metta, 2003)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;\">",
"     Maintenance: 2-6  mg/kg/day divided every 8-12 hours (Bhatta-Mehta, 2003; Henderson-Smart, 2011; Skouroliakou, 2009)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;\">",
"     Manufacturer recommendations:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:6em;\">",
"     Loading dose: 4.6 mg/kg/dose",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:6em;\">",
"     Maintenance:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:8em;\">",
"     Premature neonates PNA &lt;24 days: 1 mg/kg/dose every 12 hours",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:8em;\">",
"     Premature neonates PNA &ge;24 days: 1.5 mg/kg/dose every 12 hours",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:8em;\">",
"     Full-term infants: Total daily dose (mg) = [(0.2 x age in weeks) +5] x (weight in kg); divide dose into 3 equal amounts and administer at 8-hour intervals",
"    </p>",
"   </div>",
"   <div class=\"block dos drugH1Div\" id=\"F1062531\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosing: Usual",
"    </span>",
"    <p>",
"     (For additional information",
"     <a class=\"drug drug_general\" href=\"UTD.htm?29/31/30200?source=see_link\">",
"      see \"Theophylline: Drug information\"",
"     </a>",
"     )",
"    </p>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Doses should be individualized based on steady-state serum concentrations and ideal body weight (for obese patients). Oral:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Loading dose:",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Infants and Children: Treatment of acute bronchospasm: (to achieve a serum concentration of about 10 mcg/mL; loading doses should be given using a rapidly absorbed oral product",
"     <b>",
"      not",
"     </b>",
"     a sustained release product):",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     If no theophylline has been administered in the previous 24 hours: 5 mg/kg theophylline",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     If theophylline has been administered in the previous 24 hours: 2.5 mg/kg theophylline may be given in emergencies when serum concentrations are not available",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     A modified loading dose (mg/kg) may be calculated (when the serum concentration is known) by: [Blood concentration desired - blood concentration measured] divided by 2 (for every 1 mg/kg theophylline given, the blood concentration will rise by approximately 2 mcg/mL)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Maintenance dose:",
"     </b>",
"     See table.",
"    </p>",
"    <table border=\"1\" frame=\"border\" rules=\"all\">",
"     <caption style=\"text-align:center;\">",
"      Maintenance Dose for Acute Symptoms",
"     </caption>",
"     <col align=\"left\" width=\"320\">",
"     </col>",
"     <col align=\"center\" width=\"150\">",
"     </col>",
"     <thead valign=\"middle\">",
"      <tr>",
"       <th align=\"center\">",
"        <p style=\"text-indent:0em;\">",
"         Population Group",
"        </p>",
"       </th>",
"       <th align=\"center\">",
"        <p style=\"text-indent:0em;\">",
"         Oral Theophylline",
"        </p>",
"        <p style=\"text-indent:0em;\">",
"         (mg/kg/day)",
"        </p>",
"       </th>",
"      </tr>",
"     </thead>",
"     <tfoot>",
"      <tr>",
"       <td align=\"left\" colspan=\"2\">",
"        <p style=\"text-indent:0em;\">",
"         <sup>",
"          A",
"         </sup>",
"         <b>",
"          Alternative dosing regimen for full-term infants &lt;1 year of age:",
"         </b>",
"        </p>",
"       </td>",
"      </tr>",
"      <tr>",
"       <td align=\"left\" colspan=\"2\">",
"        <p style=\"text-indent:0em;margin-left:2em;\">",
"         Total daily dose (mg) = [(0.2 x age in weeks) + 5] x weight (kg).",
"        </p>",
"       </td>",
"      </tr>",
"      <tr>",
"       <td align=\"left\" colspan=\"2\">",
"        <p style=\"text-indent:0em;margin-left:2em;\">",
"         Postnatal age 4-6 weeks: Total daily dose divided every 8 hours.",
"        </p>",
"       </td>",
"      </tr>",
"      <tr>",
"       <td align=\"left\" colspan=\"2\">",
"        <p style=\"text-indent:0em;margin-left:2em;\">",
"         Postnatal age &gt;26 weeks: Total daily dose divided every 6 hours.",
"        </p>",
"       </td>",
"      </tr>",
"     </tfoot>",
"     <tbody valign=\"top\">",
"      <tr>",
"       <td align=\"left\">",
"        <p style=\"text-indent:0em;\">",
"         Infants 4-6 wk",
"        </p>",
"        <p style=\"text-indent:0em;\">",
"         (for apnea/bradycardia)",
"        </p>",
"       </td>",
"       <td align=\"center\">",
"        <p style=\"text-indent:0em;\">",
"         4",
"         <sup>",
"          A",
"         </sup>",
"        </p>",
"       </td>",
"      </tr>",
"      <tr>",
"       <td align=\"left\">",
"        <p style=\"text-indent:0em;\">",
"         6 wk to 6 mo",
"        </p>",
"       </td>",
"       <td align=\"center\">",
"        <p style=\"text-indent:0em;\">",
"         10",
"         <sup>",
"          A",
"         </sup>",
"        </p>",
"       </td>",
"      </tr>",
"      <tr>",
"       <td align=\"left\">",
"        <p style=\"text-indent:0em;\">",
"         Infants 6 mo to 1 y",
"        </p>",
"       </td>",
"       <td align=\"center\">",
"        <p style=\"text-indent:0em;\">",
"         12-18",
"         <sup>",
"          A",
"         </sup>",
"        </p>",
"       </td>",
"      </tr>",
"      <tr>",
"       <td align=\"left\">",
"        <p style=\"text-indent:0em;\">",
"         Children 1-9 y",
"        </p>",
"       </td>",
"       <td align=\"center\">",
"        <p style=\"text-indent:0em;\">",
"         20-24",
"        </p>",
"       </td>",
"      </tr>",
"      <tr>",
"       <td align=\"left\">",
"        <p style=\"text-indent:0em;\">",
"         Children 9-12 y, adolescent daily smokers of cigarettes or marijuana, and otherwise healthy adult smokers &lt;50 y",
"        </p>",
"       </td>",
"       <td align=\"center\">",
"        <p style=\"text-indent:0em;\">",
"         16",
"        </p>",
"       </td>",
"      </tr>",
"      <tr>",
"       <td align=\"left\">",
"        <p style=\"text-indent:0em;\">",
"         Adolescents 12-16 y (nonsmokers)",
"        </p>",
"       </td>",
"       <td align=\"center\">",
"        <p style=\"text-indent:0em;\">",
"         13",
"        </p>",
"       </td>",
"      </tr>",
"      <tr>",
"       <td align=\"left\">",
"        <p style=\"text-indent:0em;\">",
"         Otherwise healthy nonsmoking adults (including elderly patients)",
"        </p>",
"       </td>",
"       <td align=\"center\">",
"        <p style=\"text-indent:0em;\">",
"         10",
"        </p>",
"        <p style=\"text-indent:0em;\">",
"         (not to exceed",
"        </p>",
"        <p style=\"text-indent:0em;\">",
"         900 mg/day)",
"        </p>",
"       </td>",
"      </tr>",
"      <tr>",
"       <td align=\"left\">",
"        <p style=\"text-indent:0em;\">",
"         Cardiac decompensation, cor pulmonale, and/or liver dysfunction",
"        </p>",
"       </td>",
"       <td align=\"center\">",
"        <p style=\"text-indent:0em;\">",
"         5",
"        </p>",
"        <p style=\"text-indent:0em;\">",
"         (not to exceed",
"        </p>",
"        <p style=\"text-indent:0em;\">",
"         400 mg/day)",
"        </p>",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     These recommendations, based on mean clearance rates for age or risk factors, were calculated to achieve a serum concentration of 10 mcg/mL (5 mcg/mL for newborns with apnea/bradycardia). In infants, a fast-release oral product can be used. The total daily dose can be divided every 12 hours in newborns and every 6-8 hours in infants. In children and healthy adults, a slow-release product can be used. The total daily dose can be divided every 8-12 hours.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Dose should be further adjusted based on serum concentrations. Guidelines for drawing theophylline serum concentrations are shown in the table.",
"    </p>",
"    <table border=\"1\" frame=\"border\" rules=\"all\">",
"     <caption style=\"text-align:center;\">",
"      Guidelines for Drawing Theophylline Serum Samples",
"     </caption>",
"     <col align=\"left\" width=\"193\">",
"     </col>",
"     <col align=\"left\" width=\"274\">",
"     </col>",
"     <thead valign=\"middle\">",
"      <tr>",
"       <th align=\"center\">",
"        <p style=\"text-indent:0em;\">",
"         Dosage Form",
"        </p>",
"       </th>",
"       <th align=\"center\">",
"        <p style=\"text-indent:0em;\">",
"         Time to Draw Sample",
"         <sup>",
"          A",
"         </sup>",
"        </p>",
"       </th>",
"      </tr>",
"     </thead>",
"     <tfoot valign=\"middle\">",
"      <tr>",
"       <td align=\"left\" colspan=\"2\">",
"        <p style=\"text-indent:0em;\">",
"         <sup>",
"          A",
"         </sup>",
"         The time to achieve steady-state serum concentrations is prolonged in patients with longer half-lives (eg, infants and adults with cardiac or liver failure (see theophylline half-life table). In these patients, serum theophylline concentrations should be drawn after 48-72 hours of therapy; serum concentrations may need to be done prior to steady-state to assess the patient's current progress or evaluate potential toxicity.",
"        </p>",
"       </td>",
"      </tr>",
"     </tfoot>",
"     <tbody valign=\"top\">",
"      <tr>",
"       <td align=\"left\">",
"        <p style=\"text-indent:0em;\">",
"         I.V. bolus",
"        </p>",
"       </td>",
"       <td align=\"left\">",
"        <p style=\"text-indent:0em;\">",
"         30 min after end of 30-min infusion",
"        </p>",
"       </td>",
"      </tr>",
"      <tr>",
"       <td align=\"left\">",
"        <p style=\"text-indent:0em;\">",
"         I.V. continuous infusion",
"        </p>",
"       </td>",
"       <td align=\"left\">",
"        <p style=\"text-indent:0em;\">",
"         12-24 h after initiation of infusion",
"        </p>",
"       </td>",
"      </tr>",
"      <tr>",
"       <td align=\"left\">",
"        <p style=\"text-indent:0em;\">",
"         P.O. liquid, fast-release formulation",
"        </p>",
"       </td>",
"       <td align=\"left\">",
"        <p style=\"text-indent:0em;\">",
"         Peak: 1 h postdose after at least 1 day of therapy",
"        </p>",
"        <p style=\"text-indent:0em;\">",
"         Trough: Just before a dose after at least 1 day of therapy",
"        </p>",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"block foc drugH1Div\" id=\"F226525\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosage Forms: U.S.",
"    </span>",
"    <p style=\"text-indent:0em;text-align:justify;display:inline\">",
"     Excipient information presented when available (limited, particularly for generics); consult specific product labeling.  [DSC] = Discontinued product",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Capsule, extended release, oral:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Theo-24&reg;: 100 mg, 200 mg, 300 mg, 400 mg [24 hours]",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Infusion, premixed in D",
"     <sub>",
"      5",
"     </sub>",
"     W: 400 mg (500 mL); 800 mg (500 mL [DSC])",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Solution, oral: 80 mg/15 mL (15 mL, 473 mL)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Elixophyllin&reg; Elixir: 80 mg/15 mL (473 mL) [contains ethanol 20%; mixed fruit flavor]",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Tablet, extended release, oral: 100 mg, 200 mg, 300 mg, 400 mg, 450 mg, 600 mg",
"    </p>",
"   </div>",
"   <div class=\"block geq drugH1Div\" id=\"F226511\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Generic Equivalent Available: U.S.",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Yes: Extended release tablet, infusion, solution",
"    </p>",
"   </div>",
"   <div class=\"block adm drugH1Div\" id=\"F1062543\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Administration",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Oral: Sustained release preparations should be administered with a full glass of water, whole or cut by half only; do not crush; sustained release capsule forms may be opened and sprinkled on soft foods; do not chew or crush beads",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Parenteral: Premade I.V. infusion bags for continuous infusion usage; rate of infusion dependent upon dosage; loading doses using I.V. infusion should be administered over 20-30 minutes",
"    </p>",
"   </div>",
"   <div class=\"block scp drugH1Div\" id=\"F226605\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Compatibility",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Stable in D",
"     <sub>",
"      5",
"     </sub>",
"     W.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Y-site administration: Compatible:",
"     </b>",
"     Acyclovir, ampicillin, ampicillin/sulbactam, aztreonam, bivalirudin, cefazolin, cefotetan, ceftriaxone, cimetidine, cisatracurium, clindamycin, clonidine, dexamethasone sodium phosphate, dexmedetomidine, diltiazem, dobutamine, dopamine, doxycycline, erythromycin lactobionate, famotidine, fenoldopam, fentanyl, fluconazole, gentamicin, haloperidol, heparin, hetastarch in lactate electrolyte injection (Hextend&reg;), hydrocortisone sodium succinate, lidocaine, linezolid, methyldopate, methylprednisolone sodium succinate, metronidazole, micafungin, midazolam, milrinone, nafcillin, nitroglycerin, nitroprusside, oxaliplatin, penicillin G potassium, piperacillin, potassium chloride, ranitidine, remifentanil, ticarcillin/clavulanate potassium, tigecycline, tobramycin, vancomycin.",
"     <b>",
"      Incompatible:",
"     </b>",
"     Cefepime, hetastarch in NS, phenytoin.",
"     <b>",
"      Variable (consult detailed reference):",
"     </b>",
"     Ceftazidime.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Compatibility in syringe: Incompatible:",
"     </b>",
"     Ceftriaxone.",
"    </p>",
"   </div>",
"   <div class=\"block use drugH1Div\" id=\"F1062542\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Use",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Treatment of symptoms and reversible airway obstruction due to chronic asthma, chronic bronchitis, or COPD; treatment of idiopathic apnea of prematurity in neonates",
"    </p>",
"   </div>",
"   <div class=\"block arm drugH1Div\" id=\"F226604\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Adverse Reactions",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Adverse events observed at therapeutic serum levels:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Cardiovascular: Flutter, tachycardia",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Central nervous system: Headache, hyperactivity (children), insomnia, restlessness, seizures, status epilepticus (nonconvulsive)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Endocrine &amp; metabolic: Hypercalcemia (with concomitant hyperthyroid disease)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Gastrointestinal: Nausea, reflux or ulcer aggravation, vomiting",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Genitourinary: Difficulty urinating (elderly males with prostatism)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Neuromuscular &amp; skeletal: Tremor",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Renal: Diuresis (transient)",
"    </p>",
"   </div>",
"   <div class=\"block coi drugH1Div\" id=\"F1062546\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Contraindications",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Hypersensitivity to theophylline or any component",
"    </p>",
"   </div>",
"   <div class=\"block pre drugH1Div\" id=\"F1062530\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Precautions",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Use with caution in patients with peptic ulcer, hyperthyroidism, seizure disorders, hypertension, and patients with cardiac arrhythmias (excluding bradyarrhythmias)",
"    </p>",
"   </div>",
"   <div class=\"block war drugH1Div\" id=\"F1062529\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Warnings",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     If a patient develops signs and symptoms of theophylline toxicity (eg, persistent, repetitive vomiting), a serum theophylline concentration should be measured and subsequent doses held; due to potential saturation of theophylline clearance at serum concentrations within or (in some patients) less than the therapeutic range, dosage adjustments should be made in small increments (maximum dosage adjustment: 25%); due to wide interpatient variability, theophylline serum concentration measurements must be used to optimize therapy and prevent serious toxicity",
"    </p>",
"   </div>",
"   <div class=\"block cyt drugH1Div\" id=\"F226596\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Metabolism/Transport Effects",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     <b>",
"      Substrate",
"     </b>",
"     of CYP1A2 (major), CYP2C9 (minor), CYP2D6 (minor), CYP2E1 (major), CYP3A4 (major);",
"     <b>",
"      Note:",
"     </b>",
"     Assignment of Major/Minor substrate status based on clinically relevant drug interaction potential;",
"     <b>",
"      Inhibits",
"     </b>",
"     CYP1A2 (weak)",
"    </p>",
"   </div>",
"   <div class=\"block dri drugH1Div\" id=\"F226520\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Drug Interactions",
"    </span>",
"    <br/>",
"    <br/>",
"    <div class=\"lexi\" id=\"lexiInteractAddInfo\">",
"     (For additional information:",
"     <a class=\"dip\" href=\"./drug-interaction\" target=\"_blank\">",
"      Launch Lexi-Interact&trade; Drug Interactions Program",
"     </a>",
"     )",
"    </div>",
"    <div class=\"lexi\" id=\"lexiInteractImgB\">",
"     <img border=\"0\" height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"    </div>",
"    <div class=\"clear\">",
"    </div>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Abiraterone Acetate: May increase the serum concentration of CYP1A2 Substrates.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Adalimumab: May decrease the serum concentration of Theophylline Derivatives.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Adenosine: Theophylline Derivatives may diminish the therapeutic effect of Adenosine.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Allopurinol: May increase the serum concentration of Theophylline Derivatives.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Aminoglutethimide: May increase the metabolism of Theophylline Derivatives.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Antithyroid Agents: May increase the serum concentration of Theophylline Derivatives.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     AtoMOXetine: May enhance the hypertensive effect of Sympathomimetics. AtoMOXetine may enhance the tachycardic effect of Sympathomimetics.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Barbiturates: May decrease the serum concentration of Theophylline Derivatives.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Benzodiazepines: Theophylline Derivatives may diminish the therapeutic effect of Benzodiazepines.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Beta-Blockers (Beta1 Selective): May diminish the bronchodilatory effect of Theophylline Derivatives. Management: Monitor for reduced theophylline efficacy during concomitant use with any beta-blocker.  Beta-1 selective agents are less likely to antagonize theophylline than nonselective agents, but selectivity may be lost at higher doses.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Beta-Blockers (Nonselective): May diminish the bronchodilatory effect of Theophylline Derivatives.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Cannabinoids: May enhance the tachycardic effect of Sympathomimetics.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     CarBAMazepine: Theophylline Derivatives may decrease the serum concentration of CarBAMazepine. CarBAMazepine may decrease the serum concentration of Theophylline Derivatives.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Cimetidine: May decrease the metabolism of Theophylline Derivatives.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Conivaptan: May increase the serum concentration of CYP3A4 Substrates.",
"     <i>",
"      Risk X: Avoid combination",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Contraceptives (Estrogens): May increase the serum concentration of Theophylline Derivatives.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     CYP1A2 Inducers (Strong): May increase the metabolism of CYP1A2 Substrates. Management: Consider an alternative for one of the interacting drugs. Some combinations may be specifically contraindicated. Consult appropriate manufacturer labeling.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     CYP1A2 Inhibitors (Moderate): May decrease the metabolism of CYP1A2 Substrates.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     CYP1A2 Inhibitors (Strong): May decrease the metabolism of CYP1A2 Substrates.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     CYP3A4 Inducers (Strong): May increase the metabolism of CYP3A4 Substrates. Management: Consider an alternative for one of the interacting drugs. Some combinations may be specifically contraindicated. Consult appropriate manufacturer labeling.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     CYP3A4 Inhibitors (Moderate): May decrease the metabolism of CYP3A4 Substrates.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     CYP3A4 Inhibitors (Strong): May decrease the metabolism of CYP3A4 Substrates.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Cyproterone: May decrease the serum concentration of CYP1A2 Substrates.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Cyproterone: May decrease the serum concentration of CYP2E1 Substrates.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Dasatinib: May increase the serum concentration of CYP3A4 Substrates.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Deferasirox: May increase the serum concentration of Theophylline.",
"     <i>",
"      Risk X: Avoid combination",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Disulfiram: May increase the serum concentration of Theophylline Derivatives.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Febuxostat: May increase serum concentrations of the active metabolite(s) of Theophylline Derivatives. Specifically, concentrations of 1-methylxanthine, a metabolite of unknown clinical importance, may become elevated. Management: The U.S. febuxostat labeling recommends using caution in patients receiving concomitant theophylline due to risks of increased theophylline metabolite exposure. The Canadian febuxostat labeling contraindicates its use with theophylline.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     FluvoxaMINE: May decrease the metabolism of Theophylline Derivatives.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Formoterol: Theophylline Derivatives may enhance the adverse/toxic effect of Formoterol. Theophylline Derivatives may enhance the hypokalemic effect of Formoterol.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Fosphenytoin: Theophylline Derivatives may decrease the serum concentration of Fosphenytoin. Fosphenytoin may decrease the serum concentration of Theophylline Derivatives.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Herbs (CYP3A4 Inducers): May increase the metabolism of CYP3A4 Substrates. Management: Consider avoiding CYP3A4 inducing herbs in order to avoid therapeutic failure of the substrate. Some combinations may be specifically contraindicated. Consult appropriate manufacturer labeling.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Indacaterol: Theophylline Derivatives may enhance the adverse/toxic effect of Indacaterol. Theophylline Derivatives may enhance the hypokalemic effect of Indacaterol.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Interferons: May decrease the metabolism of Theophylline Derivatives.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Iobenguane I 123: Sympathomimetics may diminish the therapeutic effect of Iobenguane I 123.",
"     <i>",
"      Risk X: Avoid combination",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Isoniazid: May increase the serum concentration of Theophylline Derivatives.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Isoproterenol: May decrease the serum concentration of Theophylline Derivatives.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Ivacaftor: May increase the serum concentration of CYP3A4 Substrates.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Linezolid: May enhance the hypertensive effect of Sympathomimetics. Management: Reduce initial doses of sympathomimetic agents, and closely monitor for enhanced pressor response, in patients receiving linezolid.  Specific dose adjustment recommendations are not presently available.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Lithium: Theophylline Derivatives may decrease the serum concentration of Lithium.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Macrolide Antibiotics: May decrease the metabolism of Theophylline Derivatives.",
"     <b>",
"      Exceptions:",
"     </b>",
"     Azithromycin (Systemic); Fidaxomicin; Spiramycin; Telithromycin.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Methotrexate: May increase the serum concentration of Theophylline Derivatives.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Mexiletine: May decrease the metabolism of Theophylline Derivatives.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Mifepristone: May increase the serum concentration of CYP3A4 Substrates. Management: Minimize doses of CYP3A4 substrates, and monitor for increased concentrations/toxicity, during and 2 weeks following treatment with mifepristone. Avoid cyclosporine, dihydroergotamine, ergotamine, fentanyl, pimozide, quinidine, sirolimus, and tacrolimus.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Pancuronium: Theophylline Derivatives may enhance the adverse/toxic effect of Pancuronium. Theophylline Derivatives may diminish the neuromuscular-blocking effect of Pancuronium.  Management: Pancuronium dosage adjustment may be necessary to induce paralysis  in patients receiving concomitant theophylline derivatives. Monitor closely for adverse effects (e.g., cardiac effects) with concomitant use of these agents.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Pentoxifylline: May increase the serum concentration of Theophylline Derivatives.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Phenytoin: Theophylline Derivatives may decrease the serum concentration of Phenytoin. Phenytoin may decrease the serum concentration of Theophylline Derivatives.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Propafenone: May increase the serum concentration of Theophylline Derivatives.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Protease Inhibitors: May decrease the serum concentration of Theophylline Derivatives.",
"     <b>",
"      Exceptions:",
"     </b>",
"     Fosamprenavir.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     QuiNINE: May increase the serum concentration of Theophylline Derivatives.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Quinolone Antibiotics: May decrease the metabolism of Theophylline Derivatives. Ciprofloxacin and enoxacin are of greatest concern.  Theophylline/quinolone therapy might augment the seizure-producing potential of each of the individual agents.",
"     <b>",
"      Exceptions:",
"     </b>",
"     Gemifloxacin; Levofloxacin (Systemic); Lomefloxacin; Moxifloxacin (Systemic); Nalidixic Acid; Sparfloxacin.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Regadenoson: Theophylline may diminish the vasodilatory effect of Regadenoson.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Sympathomimetics: May enhance the adverse/toxic effect of other Sympathomimetics.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Thiabendazole: May decrease the metabolism of Theophylline Derivatives.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Thyroid Products: May increase the metabolism of Theophylline Derivatives.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Ticlopidine: May decrease the metabolism of Theophylline Derivatives.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Tocilizumab: May decrease the serum concentration of CYP3A4 Substrates.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Zafirlukast: Theophylline Derivatives may decrease the serum concentration of Zafirlukast. Zafirlukast may increase the serum concentration of Theophylline Derivatives.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Zileuton: May increase the serum concentration of Theophylline.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"   </div>",
"   <div class=\"block foi drugH1Div\" id=\"F1062549\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Food Interactions",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Food does not appreciably affect the absorption of liquid, fast-release products and most sustained release products; however, food may induce a sudden release (dose-dumping) of once-daily sustained release products resulting in an increase in serum drug concentrations and potential toxicity; avoid excessive amounts of caffeine; avoid extremes of dietary protein and carbohydrate intake; limit charcoal-broiled foods and caffeinated beverages",
"    </p>",
"   </div>",
"   <div class=\"block prf drugH1Div\" id=\"F226521\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pregnancy Risk Factor",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     C (",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?16/42/17068\">",
"      show table",
"     </a>",
"     )",
"    </p>",
"   </div>",
"   <div class=\"block pri drugH1Div\" id=\"F226536\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pregnancy Implications",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Teratogenic effects were observed in animal reproduction studies. Theophylline crosses the placenta; adverse effects may be seen in the newborn. Use is generally safe when used at the recommended doses (serum concentrations 5-12 mcg/mL) however maternal adverse events may be increased and efficacy may be decreased in pregnant women. Theophylline metabolism may change during pregnancy; the half-life is similar to that observed in otherwise healthy, nonsmoking adults with asthma during the first and second trimesters (~8.7 hours), but may increase to 13 hours (range: 8-18 hours) during the third trimester. The volume of distribution is also increased during the third trimester. Monitor serum levels. The recommendations for the use of theophylline in pregnant women with asthma are similar to those used in nonpregnant adults (National Heart, Lung, and Blood Institute Guidelines, 2004).",
"    </p>",
"   </div>",
"   <div class=\"block mop drugH1Div\" id=\"F1062537\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Monitoring Parameters",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Respiratory rate, heart rate, serum theophylline concentration, arterial or capillary blood gases (if applicable); number and severity of apnea spells (apnea of prematurity)",
"    </p>",
"   </div>",
"   <div class=\"block rer drugH1Div\" id=\"F1062541\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Reference Range",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Therapeutic concentrations:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Asthma: 10-15 mcg/mL (peak concentration)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Apnea of prematurity: 6-14 mcg/mL",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Toxic concentration: &gt;20 mcg/mL",
"    </p>",
"   </div>",
"   <div class=\"block pha drugH1Div\" id=\"F1062528\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Mechanism of Action",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Competitively inhibits two isoenzymes of the enzyme phosphodiesterase resulting in increased concentrations of cyclic adenine monophosphate (cAMP) which may be responsible for most of theophylline's effects; effects on the myocardium and neuromuscular transmission may be due to the intracellular translocation of ionized calcium; overall, theophylline produces the following effects: relaxation of the smooth muscle of the respiratory tract, suppression of the response of airways to stimuli, increases the force of contraction of diaphragmatic muscles; pulmonary, coronary, and renal artery dilation; CNS stimulation, diuresis, stimulation of catecholamine release, gastric acid secretion, and relaxation of biliary and GI smooth muscle",
"    </p>",
"   </div>",
"   <div class=\"block phk drugH1Div\" id=\"F1062545\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pharmacokinetics (Adult data unless noted)",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Absorption: Oral: Rapid and complete with up to 100% absorption depending upon the formulation used",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Distribution: V",
"     <sub>",
"      d",
"     </sub>",
"     : 0.45 L/kg; distributes into breast milk; breast milk to plasma ratio: 0.67; crosses the placenta and into the CSF",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Protein binding: 40%; decreased protein binding in neonates (due to a greater percentage of fetal albumin), hepatic cirrhosis, uncorrected acidemia, women in third trimester of pregnancy, and geriatric patients",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Metabolism: In the liver by demethylation and oxidation; theophylline is metabolized to caffeine (active); in neonates this theophylline-derived caffeine accumulates (due to decreased hepatic metabolism) and significant concentrations of caffeine may occur; a substantial decrease in serum caffeine concentrations occurs after 40 weeks postmenstrual age",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Half-life: See table.",
"    </p>",
"    <table border=\"1\" frame=\"border\" rules=\"all\">",
"     <caption style=\"text-align:center;\">",
"      Theophylline Clearance and Half-Life With Respect to Age and Altered Physiological States",
"      <sup>",
"       A",
"      </sup>",
"     </caption>",
"     <col align=\"left\" width=\"225\">",
"     </col>",
"     <col align=\"center\" width=\"140\">",
"     </col>",
"     <col align=\"center\" width=\"135\">",
"     </col>",
"     <thead valign=\"middle\">",
"      <tr>",
"       <th align=\"center\">",
"        <p style=\"text-indent:0em;\">",
"         Patient Group",
"        </p>",
"       </th>",
"       <th align=\"center\">",
"        <p style=\"text-indent:0em;\">",
"         Mean Clearance",
"        </p>",
"        <p style=\"text-indent:0em;\">",
"         (mL/kg/min)",
"        </p>",
"       </th>",
"       <th align=\"center\">",
"        <p style=\"text-indent:0em;\">",
"         Mean Half-life",
"        </p>",
"        <p style=\"text-indent:0em;\">",
"         (h)",
"        </p>",
"       </th>",
"      </tr>",
"     </thead>",
"     <tfoot valign=\"middle\">",
"      <tr>",
"       <td align=\"left\" colspan=\"3\">",
"        <p style=\"text-indent:0em;\">",
"         <sup>",
"          A",
"         </sup>",
"         From Hendeles L, 1995.",
"        </p>",
"       </td>",
"      </tr>",
"      <tr>",
"       <td align=\"left\" colspan=\"3\">",
"        <p style=\"text-indent:0em;\">",
"         <sup>",
"          B",
"         </sup>",
"         Either not reported or not reported in a comparable format.",
"        </p>",
"       </td>",
"      </tr>",
"      <tr>",
"       <td align=\"left\" colspan=\"3\">",
"        <p style=\"text-indent:0em;\">",
"         <sup>",
"          C",
"         </sup>",
"         Maturation of clearance in premature infants and term infants is most closely related to postmenstrual age (PMA); adult clearance values are reached at approximately 55 weeks PMA and higher pediatric values at approximately 60 weeks PMA (Kraus, 1993).",
"        </p>",
"       </td>",
"      </tr>",
"     </tfoot>",
"     <tbody valign=\"top\">",
"      <tr>",
"       <td align=\"left\" valign=\"middle\">",
"        <p style=\"text-indent:0em;\">",
"         Premature infants",
"        </p>",
"       </td>",
"       <td align=\"center\" valign=\"middle\">",
"       </td>",
"       <td align=\"center\" valign=\"middle\">",
"       </td>",
"      </tr>",
"      <tr>",
"       <td align=\"left\" valign=\"middle\">",
"        <p style=\"text-indent:0em;margin-left:2em;\">",
"         postnatal age 3-15 d",
"        </p>",
"       </td>",
"       <td align=\"center\" valign=\"middle\">",
"        <p style=\"text-indent:0em;\">",
"         0.29",
"        </p>",
"       </td>",
"       <td align=\"center\" valign=\"middle\">",
"        <p style=\"text-indent:0em;\">",
"         30",
"        </p>",
"       </td>",
"      </tr>",
"      <tr>",
"       <td align=\"left\" valign=\"middle\">",
"        <p style=\"text-indent:0em;margin-left:2em;\">",
"         postnatal age 25-57 d",
"        </p>",
"       </td>",
"       <td align=\"center\" valign=\"middle\">",
"        <p style=\"text-indent:0em;\">",
"         0.64",
"        </p>",
"       </td>",
"       <td align=\"center\" valign=\"middle\">",
"        <p style=\"text-indent:0em;\">",
"         20",
"        </p>",
"       </td>",
"      </tr>",
"      <tr>",
"       <td align=\"left\" valign=\"middle\">",
"        <p style=\"text-indent:0em;\">",
"         Term infants",
"        </p>",
"       </td>",
"       <td align=\"center\" valign=\"middle\">",
"       </td>",
"       <td align=\"center\" valign=\"middle\">",
"       </td>",
"      </tr>",
"      <tr>",
"       <td align=\"left\" valign=\"middle\">",
"        <p style=\"text-indent:2em;\">",
"         postnatal age 1-2 d",
"        </p>",
"       </td>",
"       <td align=\"center\" valign=\"middle\">",
"        <p style=\"text-indent:0em;\">",
"         Not reported",
"         <sup>",
"          B",
"         </sup>",
"        </p>",
"       </td>",
"       <td align=\"center\" valign=\"middle\">",
"        <p style=\"text-indent:0em;\">",
"         25",
"        </p>",
"       </td>",
"      </tr>",
"      <tr>",
"       <td align=\"left\" valign=\"top\">",
"        <p style=\"text-indent:0em;margin-left:2em;\">",
"         postnatal age 3-30 wk",
"         <sup>",
"          C",
"         </sup>",
"        </p>",
"       </td>",
"       <td align=\"center\" valign=\"top\">",
"        <p style=\"text-indent:0em;\">",
"         Not reported",
"         <sup>",
"          B",
"         </sup>",
"        </p>",
"       </td>",
"       <td align=\"center\" valign=\"top\">",
"        <p style=\"text-indent:0em;\">",
"         11",
"        </p>",
"       </td>",
"      </tr>",
"      <tr>",
"       <td align=\"left\" valign=\"middle\">",
"        <p style=\"text-indent:0em;\">",
"         Children",
"        </p>",
"       </td>",
"       <td align=\"center\" valign=\"middle\">",
"       </td>",
"       <td align=\"center\" valign=\"middle\">",
"       </td>",
"      </tr>",
"      <tr>",
"       <td align=\"left\" valign=\"middle\">",
"        <p style=\"text-indent:2em;\">",
"         1-4 y",
"        </p>",
"       </td>",
"       <td align=\"center\" valign=\"middle\">",
"        <p style=\"text-indent:0em;\">",
"         1.7",
"        </p>",
"       </td>",
"       <td align=\"center\" valign=\"middle\">",
"        <p style=\"text-indent:0em;\">",
"         3.4",
"        </p>",
"       </td>",
"      </tr>",
"      <tr>",
"       <td align=\"left\" valign=\"middle\">",
"        <p style=\"text-indent:2em;\">",
"         4-12 y",
"        </p>",
"       </td>",
"       <td align=\"center\" valign=\"middle\">",
"        <p style=\"text-indent:0em;\">",
"         1.6",
"        </p>",
"       </td>",
"       <td align=\"center\" valign=\"middle\">",
"        <p style=\"text-indent:0em;\">",
"         Not reported",
"         <sup>",
"          B",
"         </sup>",
"        </p>",
"       </td>",
"      </tr>",
"      <tr>",
"       <td align=\"left\" valign=\"top\">",
"        <p style=\"text-indent:2em;\">",
"         13-15 y",
"        </p>",
"       </td>",
"       <td align=\"center\" valign=\"top\">",
"        <p style=\"text-indent:0em;\">",
"         0.9",
"        </p>",
"       </td>",
"       <td align=\"center\" valign=\"top\">",
"        <p style=\"text-indent:0em;\">",
"         Not reported",
"         <sup>",
"          B",
"         </sup>",
"        </p>",
"       </td>",
"      </tr>",
"      <tr>",
"       <td align=\"left\" valign=\"top\">",
"        <p style=\"text-indent:2em;\">",
"         16-17 y",
"        </p>",
"       </td>",
"       <td align=\"center\" valign=\"top\">",
"        <p style=\"text-indent:0em;\">",
"         1.4",
"        </p>",
"       </td>",
"       <td align=\"center\" valign=\"top\">",
"        <p style=\"text-indent:0em;\">",
"         3.7 (range: 1.5-5.9)",
"        </p>",
"       </td>",
"      </tr>",
"      <tr>",
"       <td align=\"left\" valign=\"middle\">",
"        <p style=\"text-indent:0em;\">",
"         Adults",
"        </p>",
"       </td>",
"       <td align=\"center\" valign=\"middle\">",
"       </td>",
"       <td align=\"center\" valign=\"middle\">",
"       </td>",
"      </tr>",
"      <tr>",
"       <td align=\"left\" valign=\"middle\">",
"        <p style=\"text-indent:2em;\">",
"         16-60 (nonsmoking)",
"        </p>",
"       </td>",
"       <td align=\"center\" valign=\"middle\">",
"        <p style=\"text-indent:0em;\">",
"         0.65",
"        </p>",
"       </td>",
"       <td align=\"center\" valign=\"middle\">",
"        <p style=\"text-indent:0em;\">",
"         8.2",
"        </p>",
"       </td>",
"      </tr>",
"      <tr>",
"       <td align=\"left\" valign=\"middle\">",
"        <p style=\"text-indent:0em;margin-left:2em;\">",
"         &gt;60 y (nonsmoking, healthy)",
"        </p>",
"       </td>",
"       <td align=\"center\" valign=\"middle\">",
"        <p style=\"text-indent:0em;\">",
"         0.41",
"        </p>",
"       </td>",
"       <td align=\"center\" valign=\"middle\">",
"        <p style=\"text-indent:0em;\">",
"         9.8",
"        </p>",
"       </td>",
"      </tr>",
"      <tr>",
"       <td align=\"left\" valign=\"middle\">",
"        <p style=\"text-indent:0em;\">",
"         Acute pulmonary edema",
"        </p>",
"       </td>",
"       <td align=\"center\" valign=\"middle\">",
"        <p style=\"text-indent:0em;\">",
"         0.33",
"        </p>",
"       </td>",
"       <td align=\"center\" valign=\"middle\">",
"        <p style=\"text-indent:0em;\">",
"         19",
"        </p>",
"       </td>",
"      </tr>",
"      <tr>",
"       <td align=\"left\" valign=\"top\">",
"        <p style=\"text-indent:0em;\">",
"         Cystic fibrosis (14-28 y)",
"        </p>",
"       </td>",
"       <td align=\"center\" valign=\"top\">",
"        <p style=\"text-indent:0em;\">",
"         1.25",
"        </p>",
"       </td>",
"       <td align=\"center\" valign=\"top\">",
"        <p style=\"text-indent:0em;\">",
"         6",
"        </p>",
"       </td>",
"      </tr>",
"      <tr>",
"       <td align=\"left\" valign=\"top\">",
"        <p style=\"text-indent:0em;\">",
"         Liver disease",
"        </p>",
"       </td>",
"       <td align=\"center\" valign=\"top\">",
"       </td>",
"       <td align=\"center\" valign=\"top\">",
"       </td>",
"      </tr>",
"      <tr>",
"       <td align=\"left\" valign=\"top\">",
"        <p style=\"text-indent:2em;\">",
"         acute hepatitis",
"        </p>",
"       </td>",
"       <td align=\"center\" valign=\"top\">",
"        <p style=\"text-indent:0em;\">",
"         0.35",
"        </p>",
"       </td>",
"       <td align=\"center\" valign=\"top\">",
"        <p style=\"text-indent:0em;\">",
"         19.2",
"        </p>",
"       </td>",
"      </tr>",
"      <tr>",
"       <td align=\"left\" valign=\"top\">",
"        <p style=\"text-indent:2em;\">",
"         cholestasis",
"        </p>",
"       </td>",
"       <td align=\"center\" valign=\"top\">",
"        <p style=\"text-indent:0em;\">",
"         0.65",
"        </p>",
"       </td>",
"       <td align=\"center\" valign=\"top\">",
"        <p style=\"text-indent:0em;\">",
"         14.4",
"        </p>",
"       </td>",
"      </tr>",
"      <tr>",
"       <td align=\"left\" valign=\"top\">",
"        <p style=\"text-indent:2em;\">",
"         cirrhosis",
"        </p>",
"       </td>",
"       <td align=\"center\" valign=\"top\">",
"        <p style=\"text-indent:0em;\">",
"         0.31",
"        </p>",
"       </td>",
"       <td align=\"center\" valign=\"top\">",
"        <p style=\"text-indent:0em;\">",
"         32",
"        </p>",
"       </td>",
"      </tr>",
"      <tr>",
"       <td align=\"left\" valign=\"top\">",
"        <p style=\"text-indent:0em;\">",
"         Sepsis with multiorgan failure",
"        </p>",
"       </td>",
"       <td align=\"center\" valign=\"top\">",
"        <p style=\"text-indent:0em;\">",
"         0.46",
"        </p>",
"       </td>",
"       <td align=\"center\" valign=\"top\">",
"        <p style=\"text-indent:0em;\">",
"         18.8",
"        </p>",
"       </td>",
"      </tr>",
"      <tr>",
"       <td align=\"left\" valign=\"top\">",
"        <p style=\"text-indent:0em;\">",
"         Hypothyroid",
"        </p>",
"       </td>",
"       <td align=\"center\" valign=\"top\">",
"        <p style=\"text-indent:0em;\">",
"         0.38",
"        </p>",
"       </td>",
"       <td align=\"center\" valign=\"top\">",
"        <p style=\"text-indent:0em;\">",
"         11.6",
"        </p>",
"       </td>",
"      </tr>",
"      <tr>",
"       <td align=\"left\" valign=\"top\">",
"        <p style=\"text-indent:0em;\">",
"         Hyperthyroid",
"        </p>",
"       </td>",
"       <td align=\"center\" valign=\"top\">",
"        <p style=\"text-indent:0em;\">",
"         0.8",
"        </p>",
"       </td>",
"       <td align=\"center\" valign=\"top\">",
"        <p style=\"text-indent:0em;\">",
"         4.5",
"        </p>",
"       </td>",
"      </tr>",
"      <tr>",
"       <td align=\"left\" valign=\"top\">",
"        <p style=\"text-indent:0em;\">",
"         COPD &gt;60 y,",
"        </p>",
"        <p style=\"text-indent:0em;\">",
"         nonsmoking &gt;1 y",
"        </p>",
"       </td>",
"       <td align=\"center\" valign=\"middle\">",
"        <p style=\"text-indent:0em;\">",
"         0.54",
"        </p>",
"       </td>",
"       <td align=\"center\" valign=\"middle\">",
"        <p style=\"text-indent:0em;\">",
"         11",
"        </p>",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Elimination: In urine; children &gt;3 months and adults excrete 10% in urine as unchanged drug; neonates excrete approximately 50% of the dose unchanged in urine",
"    </p>",
"   </div>",
"   <div class=\"block pai drugH1Div\" id=\"F1062536\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Patient Information",
"    </span>",
"    <p>",
"     (For additional information",
"     <a class=\"drug drug_patient\" href=\"UTD.htm?1/7/1141?source=see_link\">",
"      see \"Theophylline: Patient drug information\"",
"     </a>",
"     )",
"    </p>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Contact physician whenever nausea, vomiting, persistent headache, or irregular heartbeats occur; notify physician if a new illness develops (especially if high fevers); do not alter time, dose, or frequency of administration without physician knowledge; avoid drinking or eating of large quantities of caffeine-containing beverages or food",
"    </p>",
"   </div>",
"   <div class=\"block adi drugH1Div\" id=\"F1062547\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Additional Information",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Due to improved theophylline clearance during the first year of life, serum concentration determinations and dosage adjustments may be needed to optimize therapy",
"    </p>",
"   </div>",
"   <div class=\"block exp drugH1Div\" id=\"F10951004\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Extemporaneous Preparations",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     <b>",
"      Note:",
"     </b>",
"     An alcohol-containing commercial oral solution is available (80 mg/15mL).",
"    </p>",
"    <p style=\"text-indent:0em;margin-top:2em;\">",
"     A 5 mg/mL oral suspension may be made with tablets. Crush one 300 mg extended release tablet in a mortar and reduce to a fine powder. Add small portions of a 1:1 mixture of Ora-Sweet&reg; and Ora-Plus&reg; and mix to a uniform paste; mix while adding the vehicle in equal proportions to",
"     <b>",
"      almost",
"     </b>",
"     60 mL; transfer to a calibrated bottle, rinse mortar with vehicle, and add sufficient quantity of vehicle to make 60 mL. Label \"shake well\". Stable for 90 days at room temperature.",
"    </p>",
"    <div class=\"reference\">",
"     Johnson CE, VanDeKoppel S, and Myers E, \"Stability of Anhydrous Theophylline in Extemporaneously Prepared Alcohol-Free Oral Suspensions,\"",
"     <i>",
"      Am J Health-Syst Pharm",
"     </i>",
"     , 2005, 62(23):2518-20.",
"     <span class=\"pubmed-id\">",
"      16303910",
"     </span>",
"    </div>",
"   </div>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <div class=\"reference\">",
"      Bhatt-Mehta V and Schumacher RE, &ldquo;Treatment of Apnea of Prematurity,&rdquo;",
"      <i>",
"       Paediatr Drugs",
"      </i>",
"      , 2003, 5(3):195-210.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?23/49/24344/abstract-text/12608884 /pubmed\" id=\"12608884 \" target=\"_blank\">",
"        12608884",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Hendeles L, Jenkins J, and Temple R, &ldquo;Revised FDA Labeling Guideline for Theophylline Oral Dosage Forms,&rdquo;",
"      <i>",
"       Pharmacotherapy",
"      </i>",
"      , 1995, 15(4):409-427.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?23/49/24344/abstract-text/7479193 /pubmed\" id=\"7479193 \" target=\"_blank\">",
"        7479193",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Henderson-Smart DJ and De Paoli AG, \"Methylxanthine Treatment for Apnoea in Preterm Infants,\"",
"      <i>",
"       Cochrane Database Syst Rev",
"      </i>",
"      , 2010, 12:CD000140.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?23/49/24344/abstract-text/21154343/pubmed\" id=\"21154343\" target=\"_blank\">",
"        21154343",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Kearney TE, Manoguerra AS, Curtis GP, et al, &ldquo;Theophylline Toxicity and the Beta-Adrenergic System,&rdquo;",
"      <i>",
"       Ann Intern Med",
"      </i>",
"      , 1985, 102(6):766-9.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?23/49/24344/abstract-text/2986507/pubmed\" id=\"2986507\" target=\"_blank\">",
"        2986507",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Kraus DM, Fischer JH, Reitz SJ, et al, &ldquo;Alterations in Theophylline Metabolism During the First Year of Life,&rdquo;",
"      <i>",
"       Clin Pharmacol Ther",
"      </i>",
"      , 1993, 54(4):351-9.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?23/49/24344/abstract-text/8222476 /pubmed\" id=\"8222476 \" target=\"_blank\">",
"        8222476",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      National Asthma Education and Prevention Program (NAEPP), &ldquo;Expert Panel Report 3 (EPR-3): Guidelines for the Diagnosis and Management of Asthma,&rdquo;",
"      <i>",
"       Clinical Practice Guidelines",
"      </i>",
"      , National Institutes of Health, National Heart, Lung, and Blood Institute, NIH Publication No. 08-4051, prepublication 2007; available at file://www.nhlbi.nih.gov/guidelines/asthma/asthgdln.htm.",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Skouroliakou M, Bacopoulou F, and Markantonis SL, \"Caffeine Versus Theophylline for Apnea of Prematurity: A Randomised Controlled Trial,\"",
"      <i>",
"       J Paediatr Child Health",
"      </i>",
"      , 2009, 45(10):587-92.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?23/49/24344/abstract-text/19751376/pubmed\" id=\"19751376\" target=\"_blank\">",
"        19751376",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Upton RA, &ldquo;Pharmacokinetic Interactions Between Theophylline and Other Medication (Part I),&rdquo;",
"      <i>",
"       Clin Pharmacokinet",
"      </i>",
"      , 1991, 20(1):66-80.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?23/49/24344/abstract-text/1674242/pubmed\" id=\"1674242\" target=\"_blank\">",
"        1674242",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 12831 Version 44.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [1102-222.190.118.195-812927D4EA-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f23_49_24344=[""].join("\n");
var outline_f23_49_24344=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F226552\">",
"      Brand Names: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F226553\">",
"      Brand Names: Canada",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1062538\">",
"      Therapeutic Category",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F11445184\">",
"      Dosing: Neonatal",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1062531\">",
"      Dosing: Usual",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F226525\">",
"      Dosage Forms: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F226511\">",
"      Generic Equivalent Available: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1062543\">",
"      Administration",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F226605\">",
"      Compatibility",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1062542\">",
"      Use",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F226604\">",
"      Adverse Reactions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1062546\">",
"      Contraindications",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1062530\">",
"      Precautions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1062529\">",
"      Warnings",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F226596\">",
"      Metabolism/Transport Effects",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F226520\">",
"      Drug Interactions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1062549\">",
"      Food Interactions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F226521\">",
"      Pregnancy Risk Factor",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F226536\">",
"      Pregnancy Implications",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1062537\">",
"      Monitoring Parameters",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1062541\">",
"      Reference Range",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1062528\">",
"      Mechanism of Action",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1062545\">",
"      Pharmacokinetics (Adult data unless noted)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1062536\">",
"      Patient Information",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1062547\">",
"      Additional Information",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10951004\">",
"      Extemporaneous Preparations",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"DRUG_PED/12831\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"DRUG_PED/12831|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?23/39/24183\" title=\"Lexicomp clinical abbreviations\">",
"      Lexicomp clinical abbreviations",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_general\" href=\"UTD.htm?29/31/30200?source=related_link\">",
"      Theophylline: Drug information",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_patient\" href=\"UTD.htm?1/7/1141?source=related_link\">",
"      Theophylline: Patient drug information",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f23_49_24345="Ankle fractures in children";
var content_f23_49_24345=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/wk_utd-rgb.myextg\" width=\"220px\">",
"   </img>",
"  </div>",
"  <div id=\"printHeaderText\">",
"   Official reprint from  UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"   <a href=\"file://www.uptodate.com\">",
"    www.uptodate.com",
"   </a>",
"   <br>",
"    &copy;2013 UpToDate",
"    <sup>",
"     &reg;",
"    </sup>",
"   </br>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"3\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Ankle fractures in children",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?23/49/24345/contributors\">",
"     Author",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?23/49/24345/contributors\">",
"     Kathy Boutis, MD, FRCPC, FAAP, MSc",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?23/49/24345/contributors\">",
"     Section Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?23/49/24345/contributors\">",
"     Richard G Bachur, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?23/49/24345/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?23/49/24345/contributors\">",
"     James F Wiley, II, MD, MPH",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"UTD.htm?23/49/24345/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Jan 6, 2012.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Lower extremity injuries are a common pediatric problem that requires accurate diagnosis and treatment for optimal outcomes [",
"    <a class=\"abstract\" href=\"UTD.htm?23/49/24345/abstract/1\">",
"     1",
"    </a>",
"    ]. Proper care requires detailed general knowledge about musculoskeletal pathology in children, judicious use of plain radiography, and recognition of those fractures that require urgent orthopedic treatment [",
"    <a class=\"abstract\" href=\"UTD.htm?23/49/24345/abstract/2,3\">",
"     2,3",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     EPIDEMIOLOGY",
"    </span>",
"    &nbsp;&mdash;&nbsp;Ankle fractures are among the most common acute injuries of the lower extremity in children. They also account for up to 40 percent of all injuries to the skeletally immature athlete [",
"    <a class=\"abstract\" href=\"UTD.htm?23/49/24345/abstract/4\">",
"     4",
"    </a>",
"    ]. Ankle fractures occur more often in boys than girls. Many fractures arise from activities such as basketball, soccer, inline skating, and riding motorized scooters [",
"    <a class=\"abstract\" href=\"UTD.htm?23/49/24345/abstract/4,5\">",
"     4,5",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Distal fibular physeal fractures are the most common types of pediatric ankle fracture and are associated with a relatively low risk for long-term complications [",
"    <a class=\"abstract\" href=\"UTD.htm?23/49/24345/abstract/6\">",
"     6",
"    </a>",
"    ]. In contrast, distal tibial physeal fractures are associated with a higher risk for long-term complications [",
"    <a class=\"abstract\" href=\"UTD.htm?23/49/24345/abstract/4\">",
"     4",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h1\">",
"     RELEVANT ANATOMY",
"    </span>",
"    &nbsp;&mdash;&nbsp;Anatomically, the ankle joint is best thought of as a hinge, with the talus held in place by the distal tibia (medial malleolus) and distal fibula (lateral malleolus). Immediately above the joint, but below the tibial physis, these bones are held together by strong syndesmotic ligaments. Additional stability is achieved through the medial and lateral ligamentous complexes (",
"    <a class=\"graphic graphic_figure graphicRef51952 \" href=\"UTD.htm?34/57/35728\">",
"     figure 1",
"    </a>",
"    and",
"    <a class=\"graphic graphic_figure graphicRef72462 \" href=\"UTD.htm?0/9/159\">",
"     figure 2",
"    </a>",
"    ). (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?35/33/36376?source=see_link\">",
"     \"Overview of ankle fractures in adults\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Medially, the superficial and deep fibers of the deltoid ligament extend from the malleolus to the talus, navicular, and calcaneus (",
"      <a class=\"graphic graphic_figure graphicRef51952 \" href=\"UTD.htm?34/57/35728\">",
"       figure 1",
"      </a>",
"      ). This thick triangular ligament resists eversion of the ankle joint (",
"      <a class=\"graphic graphic_figure graphicRef60173 \" href=\"UTD.htm?0/8/140\">",
"       figure 3",
"      </a>",
"      ).",
"     </li>",
"     <li>",
"      The lateral ligamentous complex consists of three distinct bands that resist excessive inversion of the ankle (",
"      <a class=\"graphic graphic_figure graphicRef60173 \" href=\"UTD.htm?0/8/140\">",
"       figure 3",
"      </a>",
"      ). These include the anterior and posterior talofibular ligaments and the calcaneofibular ligament (",
"      <a class=\"graphic graphic_figure graphicRef72462 \" href=\"UTD.htm?0/9/159\">",
"       figure 2",
"      </a>",
"      ).",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    The majority of the ankle's stability comes from these ligaments, which are stronger than the adjacent physes (",
"    <a class=\"graphic graphic_figure graphicRef79444 \" href=\"UTD.htm?26/18/26918\">",
"     figure 4",
"    </a>",
"    ). It should be noted that the medial and lateral ligaments arise directly from the tibial and fibular epiphyses. This anatomy accounts for the high percentage of physeal injuries about the ankle, which are caused by inversion and eversion stress (",
"    <a class=\"graphic graphic_figure graphicRef60173 \" href=\"UTD.htm?0/8/140\">",
"     figure 3",
"    </a>",
"    )&nbsp;[",
"    <a class=\"abstract\" href=\"UTD.htm?23/49/24345/abstract/1,4\">",
"     1,4",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4\">",
"    <span class=\"h2\">",
"     Distal tibial physis",
"    </span>",
"    &nbsp;&mdash;&nbsp;The distal tibial physis accounts for approximately 3 to 4 mm of limb growth per year and 15 to 20 percent of final leg length [",
"    <a class=\"abstract\" href=\"UTD.htm?23/49/24345/abstract/7\">",
"     7",
"    </a>",
"    ]. The physis develops between 6 and 24 months of age [",
"    <a class=\"abstract\" href=\"UTD.htm?23/49/24345/abstract/4\">",
"     4",
"    </a>",
"    ]. A separation of the physis, beginning at approximately two years of age, divides it into medial and lateral portions [",
"    <a class=\"abstract\" href=\"UTD.htm?23/49/24345/abstract/7\">",
"     7",
"    </a>",
"    ]. The medial malleolus begins to form at approximately seven to eight years of age and is fully ossified by the age of 10 years [",
"    <a class=\"abstract\" href=\"UTD.htm?23/49/24345/abstract/4,7\">",
"     4,7",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The distal physis begins to close around 12 years in girls and 14 years in boys [",
"    <a class=\"abstract\" href=\"UTD.htm?23/49/24345/abstract/4\">",
"     4",
"    </a>",
"    ]. Closure begins centrally, extends medially, and is completed laterally over the course of 18 months [",
"    <a class=\"abstract\" href=\"UTD.htm?23/49/24345/abstract/4,7\">",
"     4,7",
"    </a>",
"    ]. This pattern of closure has important implications for the types of tibial fractures seen in late adolescence. (See",
"    <a class=\"local\" href=\"#H17\">",
"     'Juvenile Tillaux fracture'",
"    </a>",
"    below and",
"    <a class=\"local\" href=\"#H18\">",
"     'Triplane fracture'",
"    </a>",
"    below.)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5\">",
"    <span class=\"h2\">",
"     Distal fibular physis",
"    </span>",
"    &nbsp;&mdash;&nbsp;The distal fibular physis appears between 9 and 24 months of age at the level of the ankle joint [",
"    <a class=\"abstract\" href=\"UTD.htm?23/49/24345/abstract/4\">",
"     4",
"    </a>",
"    ]. Closure generally occurs approximately one to two years after distal tibial physis closure.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6\">",
"    <span class=\"h1\">",
"     MECHANISM OF INJURY",
"    </span>",
"    &nbsp;&mdash;&nbsp;Ankle fractures may occur with the ankle inverted or everted and with the foot neutral, plantar flexed, or dorsiflexed (",
"    <a class=\"graphic graphic_figure graphicRef60173 \" href=\"UTD.htm?0/8/140\">",
"     figure 3",
"    </a>",
"    ).",
"   </p>",
"   <p>",
"    \"Rolling of the ankle,\" or an inversion injury, is the most common cause of ankle fracture in children. Frequently, this mechanism occurs when the child trips on stairs, a street curb, uneven ground, or during sports play (eg, basketball, soccer, American football). Inversion injury typically causes a fracture of the fibula. If the force is extreme (eg, foot and ankle entrapment during a motor vehicle collision) or the foot is maximally plantar- or dorsiflexed at the time of impact, then the tibia may also be involved. In these instances, the ankle joint is often unstable.",
"   </p>",
"   <p>",
"    Eversion injuries are less common but are associated with fractures of the tibia and fibula with accompanying instability of the ankle joint.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7\">",
"    <span class=\"h1\">",
"     CLINICAL FEATURES",
"    </span>",
"    &nbsp;&mdash;&nbsp;Emergent conditions, such as an open fracture, neurovascular compromise, or fracture with dislocation, must be treated immediately. (See",
"    <a class=\"local\" href=\"#H21\">",
"     'Initial management'",
"    </a>",
"    below.)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8\">",
"    <span class=\"h2\">",
"     History",
"    </span>",
"    &nbsp;&mdash;&nbsp;In addition to the mechanism of injury, the physician's history should ascertain the following [",
"    <a class=\"abstract\" href=\"UTD.htm?23/49/24345/abstract/4,7\">",
"     4,7",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Site of the most significant pain",
"     </li>",
"     <li>",
"      Other injured areas (eg, lumbar spine, hip, knee)",
"     </li>",
"     <li>",
"      Length of time from injury to presentation",
"     </li>",
"     <li>",
"      Neurovascular symptoms (eg, paresthesias, numbness, foot pallor)",
"     </li>",
"     <li>",
"      Ability to bear weight after injury",
"     </li>",
"     <li>",
"      History of any previous injury or surgery",
"     </li>",
"     <li>",
"      Related orthopedic comorbidities (eg, myelomeningocele, cerebral palsy)",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    An ankle fracture, particularly one sustained in a fall from a height, may mask other injuries, especially spinal column fractures.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9\">",
"    <span class=\"h2\">",
"     Physical examination",
"    </span>",
"    &nbsp;&mdash;&nbsp;A complete evaluation of the entire lower extremity should be conducted before assuming that the injury is confined to the ankle, especially in a child who is less than five years of age",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    is nonverbal [",
"    <a class=\"abstract\" href=\"UTD.htm?23/49/24345/abstract/1\">",
"     1",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    After an ankle injury, there is often swelling and pain. Patients who have sustained major trauma (",
"    <a class=\"graphic graphic_table graphicRef57293 \" href=\"UTD.htm?0/42/684\">",
"     table 1",
"    </a>",
"    ) are at risk for multiple traumatic injuries and warrant a complete physical examination and appropriate ancillary studies. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?39/11/40119?source=see_link&amp;anchor=H7#H7\">",
"     \"Approach to the initially stable child with blunt or penetrating injury\", section on 'Approach to blunt trauma'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?29/16/29962?source=see_link&amp;anchor=H8#H8\">",
"     \"Trauma management: Approach to the unstable child\", section on 'Initial approach'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Once other injuries are excluded, the examination can focus on the ankle. Analgesia prior to examination (eg,",
"    <a class=\"drug drug_pediatric\" href=\"UTD.htm?7/48/7946?source=see_link\">",
"     ibuprofen",
"    </a>",
"    10",
"    <span class=\"nowrap\">",
"     mg/kg;",
"    </span>",
"    maximum dose 800 mg for mild pain or intravenous",
"    <a class=\"drug drug_pediatric\" href=\"UTD.htm?31/30/32233?source=see_link\">",
"     morphine",
"    </a>",
"    0.1 to 0.15",
"    <span class=\"nowrap\">",
"     mg/kg;",
"    </span>",
"    maximum single dose: 10 mg for moderate or severe pain) will often facilitate the child's cooperation. We suggest that the clinician avoid the oral route for patients likely to require sedation or general anesthesia for fracture reduction or repair.",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Inspection &ndash; Clinicians should inspect the injured ankle for swelling, deformity, or skin abnormalities (eg, lacerations (possible open fracture), tenting, or blistering (caused by rapid stretching of the skin))",
"      <br/>",
"      <br/>",
"      The amount of swelling is not a reliable guide to the presence of a fracture, especially a Salter-Harris I fracture.",
"      <br/>",
"      <br/>",
"      Patients with obvious deformity or malalignment of the foot relative to the lower leg are at greater risk for neurovascular compromise due to the presence of a fracture or fractures that have caused an unstable ankle joint (",
"      <a class=\"graphic graphic_picture graphicRef82323 \" href=\"UTD.htm?8/55/9072\">",
"       picture 1",
"      </a>",
"      ).",
"     </li>",
"     <li>",
"      Palpation &ndash; Palpation should include all of the bones of the lower leg, ankle, and foot. Clinicians should palpate the ankle looking for the point of maximal tenderness and other tender areas. The distal tibial and fibular physes deserve particular attention because the distal fibular physis, in particular, is the most common area of ankle injury in children. Testing for ligamentous laxity can be deferred until after radiographs are obtained; it is often not tolerated in the setting of an acute fracture. Evaluation of the ligaments of the ankle is discussed separately. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?33/31/34296?source=see_link&amp;anchor=H8#H8\">",
"       \"Ankle sprain\", section on 'Clinical evaluation'",
"      </a>",
"      .)",
"      <br/>",
"      <br/>",
"      Significant tenderness, both medially and laterally, implies that the ankle is potentially unstable due to bimalleolar fracture with injury to the deltoid ligament and lateral complex, even in patients without obvious deformity (",
"      <a class=\"graphic graphic_figure graphicRef51952 \" href=\"UTD.htm?34/57/35728\">",
"       figure 1",
"      </a>",
"      and",
"      <a class=\"graphic graphic_figure graphicRef72462 \" href=\"UTD.htm?0/9/159\">",
"       figure 2",
"      </a>",
"      ). These patients should not ambulate.",
"      <br/>",
"      <br/>",
"      The examination of the distal tibia and fibula should include a careful examination in the area of the anterior joint line in addition to the medial and lateral malleoli, especially in older school-age children and young teenagers. Subtle juvenile Tillaux fractures may present with isolated tenderness in the anterior joint line and swelling extending over the distal fibula, while evaluation of the medial malleolus is normal. (See",
"      <a class=\"local\" href=\"#H17\">",
"       'Juvenile Tillaux fracture'",
"      </a>",
"      below.)",
"      <br/>",
"      <br/>",
"      The clinician should also palpate the base of the proximal fifth metatarsal in patients with inversion injuries in order to assess for avulsion fractures and Jones fractures in this area. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?14/35/14903?source=see_link\">",
"       \"Metatarsal and toe fractures in children\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Neurovascular assessment &ndash; Neurovascular examination requires comparison of findings in both feet.",
"      <br/>",
"      <br/>",
"      The clinician should palpate the posterior tibial and dorsalis pedis pulse and determine capillary refill. Although pain may interfere with interpretation, the ability to extend and flex the toes tests the deep peroneal (fibular) and tibial nerves, respectively.",
"      <br/>",
"      <br/>",
"      Sensory evaluation involves testing of the following nerves in the indicated sites:",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"hyphen-block\">",
"     <li>",
"      Deep peroneal (fibular) nerve (between the first and second toes on the dorsum)",
"     </li>",
"     <li>",
"      Superficial peroneal (fibular) nerve (remainder of the dorsal foot)",
"     </li>",
"     <li>",
"      Tibial nerve (sole of foot) which branches beneath the ankle to the:",
"     </li>",
"     <li>",
"      Medial planter nerve (medial plantar surface from great toe to middle of the 4th toe)",
"     </li>",
"     <li>",
"      Lateral plantar nerve (lateral plantar surface from middle 4th toe to 5th toe)",
"     </li>",
"     <li>",
"      Sural nerve (lateral foot)",
"     </li>",
"     <li>",
"      Saphenous nerve (medial foot)",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10\">",
"    <span class=\"h3\">",
"     Assessment of ankle stability",
"    </span>",
"    &nbsp;&mdash;&nbsp;Once emergent conditions have been excluded, the first priority in the evaluation of ankle injuries is to determine whether the joint is stable and can be managed nonoperatively, or whether the joint is unstable and must be referred. Typically, an ankle injury is stable if it meets the following criteria:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Pain is isolated to the lateral or medial malleolus.",
"     </li>",
"     <li>",
"      There is no marked swelling, deformity, or malalignment of the lower leg and foot.",
"     </li>",
"     <li>",
"      There is no associated ligamentous injury.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    An ankle injury is unstable if two or more sites of fracture or ligamentous disruption are suspected, such as a lateral malleolar fracture with deltoid ligament disruption or a bimalleolar fracture. (See",
"    <a class=\"local\" href=\"#H24\">",
"     'Indications for orthopedic consultation or referral'",
"    </a>",
"    below.)",
"   </p>",
"   <p>",
"    Patients with gross deformity (",
"    <a class=\"graphic graphic_picture graphicRef82323 \" href=\"UTD.htm?8/55/9072\">",
"     picture 1",
"    </a>",
"    ), severe pain, or concern for an unstable joint, should not be asked to perform active range of motion of the ankle joint or to walk.",
"   </p>",
"   <p>",
"    If the ankle injury appears stable, the range of motion of the knee, hip, ankle, and subtalar joints (midfoot and toes) should be determined and the ability to ambulate should be assessed.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H11\">",
"    <span class=\"h2\">",
"     Clinical decision rules for radiography",
"    </span>",
"    &nbsp;&mdash;&nbsp;Although ankle injuries are common in children, a systematic review found that, at most, 17 percent of these injuries will result in a visible bony fracture on radiograph [",
"    <a class=\"abstract\" href=\"UTD.htm?23/49/24345/abstract/8\">",
"     8",
"    </a>",
"    ]. Despite the low positive yield of x-rays, most of these children undergo radiography. For example, on average, 80 percent of children under 18 years of age received a foot or ankle radiograph when seeking emergency care in Ontario, Canada during 2008 [",
"    <a class=\"abstract\" href=\"UTD.htm?23/49/24345/abstract/9\">",
"     9",
"    </a>",
"    ]. As a result, clinical decision rules have been developed in an attempt to minimize the number of potentially unnecessary studies.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H12\">",
"    <span class=\"h3\">",
"     Ottawa Ankle Rules",
"    </span>",
"    &nbsp;&mdash;&nbsp;The Ottawa Ankle Rules (OAR) were initially derived, validated, and implemented in adults and have a reported sensitivity approaching 100 percent in this population (",
"    <a class=\"graphic graphic_figure graphicRef69818 \" href=\"UTD.htm?32/53/33618\">",
"     figure 5",
"    </a>",
"    ). Utilization of these rules in adults may reduce ankle radiography by as much as 30 percent without missing significant fractures. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?33/31/34296?source=see_link&amp;anchor=H19#H19\">",
"     \"Ankle sprain\", section on 'Ottawa ankle rules'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    We suggest that children under 16 years NOT routinely undergo screening with the OAR to determine the need for radiography. If despite this, clinicians choose to use the OAR in children, they should explain to the patient and caregiver that a small number of fractures are missed by either OAR assessment alone or radiography at the time of injury [",
"    <a class=\"abstract\" href=\"UTD.htm?23/49/24345/abstract/10\">",
"     10",
"    </a>",
"    ]. The caregiver should understand that the clinical course is also of significant importance in determining whether a fracture is present and that diagnosis may ultimately require a radiograph at seven to ten days when bone healing is apparent.",
"   </p>",
"   <p>",
"    A systematic review of 12 studies found a pooled sensitivity of 98.5 percent (95% CI 97.3-99.2) for the OAR in a total of 3130 children over two years of age, of whom 670 (21 percent) had fractures [",
"    <a class=\"abstract\" href=\"UTD.htm?23/49/24345/abstract/8\">",
"     8",
"    </a>",
"    ]. Specificity had a range of 8 to 47 percent among the studies and a pooled estimate was not performed because of significant heterogeneity among the studies. The missed fracture rate given a negative OAR assessment was 1.2 percent (95% CI 0.6-2.3 percent) [",
"    <a class=\"abstract\" href=\"UTD.htm?23/49/24345/abstract/8\">",
"     8",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Estimated reduction in radiography was 25 percent based on these findings; however, it is likely that the actual reduction in radiography would be lower than 25 percent in practice for the following reasons:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      All except one study in this meta-analysis showed a reduction in radiography between 5 and 25 percent [",
"      <a class=\"abstract\" href=\"UTD.htm?23/49/24345/abstract/8\">",
"       8",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      The one study that showed a reduction of 44 percent, also reported a relatively low sensitivity of 83 percent, compared with the other studies in which sensitivity ranged from 94 to 100 percent [",
"      <a class=\"abstract\" href=\"UTD.htm?23/49/24345/abstract/11\">",
"       11",
"      </a>",
"      ]. This finding suggests that the OAR were applied differently in this one study and that the high reduction in plain radiographs seen in this study would be difficult to replicate.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Overall, the estimated reduction in radiography when using the OAR is lower in children than in adults. This finding is likely true because a Salter-Harris I fracture of the distal fibula is the most common clinical diagnosis in the pediatric population [",
"    <a class=\"abstract\" href=\"UTD.htm?23/49/24345/abstract/12\">",
"     12",
"    </a>",
"    ]. In contrast, ankle sprain is the most common injury in adults [",
"    <a class=\"abstract\" href=\"UTD.htm?23/49/24345/abstract/13\">",
"     13",
"    </a>",
"    ]. The adult ankle sprain often presents with a clinical picture that does not meet criteria for radiography according to the OAR. However, in children, the Salter-Harris I fracture presents with tenderness over the lateral malleolus. Thus, more children than adults will be referred for radiography using the OAR because of the different injury patterns and presentations unique to children.",
"   </p>",
"   <p>",
"    Therefore, while the use of the OAR in children is unlikely to miss any significant fractures (fracture fragment &gt;3 mm in size), it is also less likely to reduce radiographic testing beyond those seen when no clinical rules are used, in contrast to the experience in adults. Thus, the clinical utility of the OAR is less certain in children and awaits measurement through implementation studies. In addition, some clinicians may be reluctant to use the OAR in children because they do not wish to risk missing any fracture [",
"    <a class=\"abstract\" href=\"UTD.htm?23/49/24345/abstract/10\">",
"     10",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H13\">",
"    <span class=\"h3\">",
"     Other clinical decision rules",
"    </span>",
"    &nbsp;&mdash;&nbsp;The Two-Part Malleolar Zone (PMZ) [",
"    <a class=\"abstract\" href=\"UTD.htm?23/49/24345/abstract/14\">",
"     14",
"    </a>",
"    ] and the Low Risk Exam Ankle Rules (LRE) [",
"    <a class=\"abstract\" href=\"UTD.htm?23/49/24345/abstract/12\">",
"     12",
"    </a>",
"    ] constitute two additional sets of rules formulated to identify children between two and sixteen years of age who should undergo radiography. However, clinical utility of these rules remains uncertain since the LRE is lacking in implementation study data, and there is no formal validation study of the PMZ.",
"   </p>",
"   <p>",
"    One prospective study compared the sensitivity and specificity of the Ottawa Ankle Rules (OAR), LRE, and PMZ in 272 children less than 16 years of age who came to a single emergency department with acute ankle trauma [",
"    <a class=\"abstract\" href=\"UTD.htm?23/49/24345/abstract/15\">",
"     15",
"    </a>",
"    ]. Since the original definition of \"clinically significant fracture\" varied for each of these rules, the investigators of this research created a new definition of \"clinically significant\" and compared performance of these rules using this new definition. Thus, in this study, any radiographically visible fracture was considered \"clinically significant\" irrespective of size or location of fracture. A total of 47 radiographically visible fractures and 33 Salter-Harris I fractures were ultimately diagnosed in these patients. The PMZ and LRE were less sensitive than the OAR for detecting radiographically visible fractures (sensitivity 94 and 87 percent versus 100 percent, respectively). In keeping with most other research, however, the relative reduction of x-rays from the OAR was only 10 percent. Thus, if one uses the definition of \"clinically significant\" as reported in this study, these preliminary data suggest that neither the PMZ nor the LRE is superior to the OAR in identifying radiographically evident ankle fractures in children. (See",
"    <a class=\"local\" href=\"#H12\">",
"     'Ottawa Ankle Rules'",
"    </a>",
"    above.)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H14\">",
"    <span class=\"h1\">",
"     RADIOGRAPHIC DIAGNOSIS",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H15\">",
"    <span class=\"h2\">",
"     Plain radiographs",
"    </span>",
"    &nbsp;&mdash;&nbsp;Standard ankle radiographs consist of the following views:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Anterior-posterior (AP)",
"     </li>",
"     <li>",
"      Lateral",
"     </li>",
"     <li>",
"      Mortise",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    The mortise view is taken from anterior to posterior with the leg internally rotated 20 degrees. This highlights the dome of the talus and the position of the malleoli. This view is critical for detecting ligamentous disruption between the tibia and the fibula (syndesmotic rupture) or other evidence of ankle joint instability, and it allows full visualization of the distal tibial physis.",
"   </p>",
"   <p>",
"    The clinician should order all three views because in 15 to 20 percent of children with ankle fractures, the bony abnormality will only be apparent on one view [",
"    <a class=\"abstract\" href=\"UTD.htm?23/49/24345/abstract/16\">",
"     16",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    If the pain is localized to the foot, especially the midfoot zone (navicular) or the base of the fifth metatarsal, then dedicated AP, lateral, and oblique foot films are also indicated. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?14/35/14903?source=see_link\">",
"     \"Metatarsal and toe fractures in children\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    A careful physical examination of the ankle in conjunction with radiographic review is critical. This approach directs the clinician to the appropriate area of injury and facilitates radiographic interpretation. For example, in patients with nondisplaced Salter-Harris I fractures of the tibia",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    fibula, there is no visible fracture on initial radiographs. Diagnosis of this injury requires correlation of the clinical finding of growth plate tenderness with other radiographic evidence such as adjacent soft tissue swelling or widening of the growth plate [",
"    <a class=\"abstract\" href=\"UTD.htm?23/49/24345/abstract/16\">",
"     16",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Similarly, subtle juvenile Tillaux fractures may present with tenderness isolated to the anterior joint line and swelling extending over the distal fibula, while palpation of the medial malleolus is free of any tenderness",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    swelling. The physical examination aids the clinician in recognizing this fracture on plain radiograph. (See",
"    <a class=\"local\" href=\"#H17\">",
"     'Juvenile Tillaux fracture'",
"    </a>",
"    below.)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H16\">",
"    <span class=\"h2\">",
"     Classification of fractures",
"    </span>",
"    &nbsp;&mdash;&nbsp;The Salter-Harris classification system provides the easiest and most commonly used method of describing ankle fractures (",
"    <a class=\"graphic graphic_figure graphicRef54582 \" href=\"UTD.htm?20/55/21361\">",
"     figure 6",
"    </a>",
"    )&nbsp;[",
"    <a class=\"abstract\" href=\"UTD.htm?23/49/24345/abstract/7\">",
"     7",
"    </a>",
"    ]. This system grades physeal fractures as types I through V. Complications of physeal injury include growth arrest, permanent decreased range of motion, and angular deformity. Salter-Harris I and II ankle fractures are at lower risk for these complications than those that are Salter-Harris III or higher. Higher grades of Salter-Harris fracture often require operative repair. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?19/40/20104?source=see_link&amp;anchor=H15#H15\">",
"     \"General principles of fracture management: Fracture patterns and description in children\", section on 'Physeal fracture description'",
"    </a>",
"    and",
"    <a class=\"local\" href=\"#H21\">",
"     'Initial management'",
"    </a>",
"    below.)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H17\">",
"    <span class=\"h3\">",
"     Juvenile Tillaux fracture",
"    </span>",
"    &nbsp;&mdash;&nbsp;This fracture represents a Salter-Harris III physeal injury that involves the anterolateral portion of the tibia. It typically occurs in children between 12 and 14 years of age as they approach skeletal maturity and have a partially fused tibial physis (",
"    <a class=\"graphic graphic_diagnosticimage graphicRef76290 \" href=\"UTD.htm?29/50/30511\">",
"     image 1",
"    </a>",
"    )&nbsp;[",
"    <a class=\"abstract\" href=\"UTD.htm?23/49/24345/abstract/7\">",
"     7",
"    </a>",
"    ]. The typical mechanism of injury is inversion of the ankle with the foot pointed away from the midline (supination with external rotation). This mechanism leads to avulsion of the lateral tibial epiphysis that is attached to the anterior inferior tibiofibular ligament (",
"    <a class=\"graphic graphic_figure graphicRef76624 \" href=\"UTD.htm?10/1/10257\">",
"     figure 7",
"    </a>",
"    ). The uninvolved medial portion of the epiphysis is closed.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H18\">",
"    <span class=\"h3\">",
"     Triplane fracture",
"    </span>",
"    &nbsp;&mdash;&nbsp;Triplane fracture describes a Salter-Harris IV fracture of the tibia that occurs in the sagittal, coronal, and transverse planes and creates between two and four fracture fragments (",
"    <a class=\"graphic graphic_diagnosticimage graphicRef67327 \" href=\"UTD.htm?28/14/28901\">",
"     image 2",
"    </a>",
"    )&nbsp;[",
"    <a class=\"abstract\" href=\"UTD.htm?23/49/24345/abstract/7,17\">",
"     7,17",
"    </a>",
"    ]. Children with these fractures have an average age of 13 years. The mechanism of injury is debated but many orthopedists feel it involves inversion of the ankle with extreme turning out of the foot (supination with external rotation) [",
"    <a class=\"abstract\" href=\"UTD.htm?23/49/24345/abstract/17\">",
"     17",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H19\">",
"    <span class=\"h2\">",
"     Computed tomography",
"    </span>",
"    &nbsp;&mdash;&nbsp;Indications for computed tomography (CT) of the ankle include [",
"    <a class=\"abstract\" href=\"UTD.htm?23/49/24345/abstract/18\">",
"     18",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Triplane fracture (",
"      <a class=\"graphic graphic_diagnosticimage graphicRef67327 \" href=\"UTD.htm?28/14/28901\">",
"       image 2",
"      </a>",
"      )&nbsp;(see",
"      <a class=\"local\" href=\"#H18\">",
"       'Triplane fracture'",
"      </a>",
"      above)",
"     </li>",
"     <li>",
"      Displaced Salter-Harris III fracture (see",
"      <a class=\"local\" href=\"#H17\">",
"       'Juvenile Tillaux fracture'",
"      </a>",
"      above)",
"     </li>",
"     <li>",
"      Salter-Harris IV fractures",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    With these fractures, CT is not needed for initial management in the emergency department but provides key information for later operative repair.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H20\">",
"    <span class=\"h2\">",
"     Magnetic resonance imaging",
"    </span>",
"    &nbsp;&mdash;&nbsp;Magnetic resonance imaging (MRI) of ankle injuries is rarely performed as part of the acute evaluation. Although MRI can better discern between a sprain and a growth plate or ossified bone injury when compared with a plain radiograph [",
"    <a class=\"abstract\" href=\"UTD.htm?23/49/24345/abstract/19,20\">",
"     19,20",
"    </a>",
"    ], the information typically does not change initial management. MRI may be useful in children whose radiographic imaging remains normal but whose recovery from injury is prolonged.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H21\">",
"    <span class=\"h1\">",
"     INITIAL MANAGEMENT",
"    </span>",
"    &nbsp;&mdash;&nbsp;The goals for initial care of ankle fractures in children are to reverse neurovascular compromise, provide analgesia, and promptly identify injuries that warrant urgent referral to an orthopedist.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H22\">",
"    <span class=\"h2\">",
"     Absent pulse",
"    </span>",
"    &nbsp;&mdash;&nbsp;The clinician should promptly identify children with vascular insufficiency and emergently involve an orthopedic surgeon with appropriate pediatric expertise. Rarely, these children may require partial closed reduction in the emergency department by the emergency clinician or orthopedist in an attempt to restore distal circulation. Patients who display a cold, white, or cyanotic foot despite reduction attempts require urgent operative treatment.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H23\">",
"    <span class=\"h2\">",
"     Analgesia and initial care",
"    </span>",
"    &nbsp;&mdash;&nbsp;For children with no signs of neurovascular compromise, initial therapy consists of measures to reduce swelling, pain management, and restriction of ambulation.",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Based on limited data in humans and animals [",
"      <a class=\"abstract\" href=\"UTD.htm?23/49/24345/abstract/21\">",
"       21",
"      </a>",
"      ], we suggest trying to reduce swelling with an insulated ice pack, bandage, and elevation.",
"     </li>",
"     <li>",
"      Oral analgesia (eg,",
"      <a class=\"drug drug_pediatric\" href=\"UTD.htm?7/48/7946?source=see_link\">",
"       ibuprofen",
"      </a>",
"      10",
"      <span class=\"nowrap\">",
"       mg/kg)",
"      </span>",
"      may suffice for patients with mild pain who have suffered a nondisplaced ankle fracture, especially a Salter-Harris I fracture or an avulsion fracture of the distal fibula. Parenteral analgesia (eg, intravenous",
"      <a class=\"drug drug_pediatric\" href=\"UTD.htm?31/30/32233?source=see_link\">",
"       morphine",
"      </a>",
"      0.1 to 0.15",
"      <span class=\"nowrap\">",
"       mg/kg;",
"      </span>",
"      maximum single dose: 10 mg) is most appropriate for initial pain control in patients with moderate to severe pain and should be given prior to radiographic evaluation. We suggest that the clinician avoid the oral route for patients likely to require sedation or general anesthesia for fracture reduction or repair.",
"     </li>",
"     <li>",
"      If the patient is suspected of having an ankle fracture, a radiograph is recommended. Weightbearing should be discouraged until a final diagnosis of the type of injury is determined. (See",
"      <a class=\"local\" href=\"#H7\">",
"       'Clinical features'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Patients with significant deformity or concern for an unstable ankle joint should not be allowed to bear weight on the affected leg.",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H24\">",
"    <span class=\"h1\">",
"     INDICATIONS FOR ORTHOPEDIC CONSULTATION OR REFERRAL",
"    </span>",
"    &nbsp;&mdash;&nbsp;The clinician should obtain prompt orthopedic consultation for children with any of the following ankle fractures:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Fractures with neurovascular compromise",
"     </li>",
"     <li>",
"      Open fractures",
"     </li>",
"     <li>",
"      Salter-Harris III (including juvenile Tillaux fractures), IV (including Triplane fractures), or V physeal fractures",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    In addition, patients with displaced Salter-Harris I or II physeal fractures typically undergo orthopedic reduction at the initial emergency department visit, although these injuries will heal well as long as reduction occurs within one week.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H25\">",
"    <span class=\"h1\">",
"     DEFINITIVE CARE",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H26\">",
"    <span class=\"h2\">",
"     Distal fibula fractures",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      <strong>",
"       Nondisplaced Salter-Harris I or II and avulsion fractures",
"      </strong>",
"      &ndash; These fractures typically result from inversion ankle stress in the skeletally immature child (",
"      <a class=\"graphic graphic_figure graphicRef60173 \" href=\"UTD.htm?0/8/140\">",
"       figure 3",
"      </a>",
"      ). These injuries are stable and are at very low risk for any long-term complications such as refracture, growth arrest, malunion,",
"      <span class=\"nowrap\">",
"       and/or",
"      </span>",
"      osteoarthritis [",
"      <a class=\"abstract\" href=\"UTD.htm?23/49/24345/abstract/6\">",
"       6",
"      </a>",
"      ]. With Salter-Harris I fractures, the strong lateral ankle ligaments create a Type I fracture through the distal fibular physis (",
"      <a class=\"graphic graphic_figure graphicRef79444 \" href=\"UTD.htm?26/18/26918\">",
"       figure 4",
"      </a>",
"      and",
"      <a class=\"graphic graphic_figure graphicRef54582 \" href=\"UTD.htm?20/55/21361\">",
"       figure 6",
"      </a>",
"      ). The radiographs are typically negative except for soft tissue swelling over the growth plate (",
"      <a class=\"graphic graphic_diagnosticimage graphicRef70423 \" href=\"UTD.htm?30/46/31456\">",
"       image 3",
"      </a>",
"      ) or subtle growth plate widening. The diagnosis is confirmed clinically by tenderness localized to the area above the distal fibula (not the ankle ligaments) and by evidence of a healing fracture on plain radiographs performed 7 to 10 days after the injury.",
"      <br/>",
"      <br/>",
"      However, there is considerable overlap between the clinical findings associated with Salter-Harris I fractures and other ankle injuries. Thus, Salter-Harris I fractures may be overdiagnosed during the initial evaluation. For example, of 198 children clinically diagnosed with Salter-Harris I fracture of the distal fibula in the emergency department, 22 percent were reclassified as ankle sprains by an orthopaedic surgeon within 10 days of the injury [",
"      <a class=\"abstract\" href=\"UTD.htm?23/49/24345/abstract/22\">",
"       22",
"      </a>",
"      ]. In a small observational study of 18 children clinically diagnosed with a Salter-Harris I fracture of the distal fibula, 16 ultimately were diagnosed with a ligamentous injury or bone contusion based upon magnetic resonance imaging and plain radiographs and none were found to have a Type I fracture [",
"      <a class=\"abstract\" href=\"UTD.htm?23/49/24345/abstract/23\">",
"       23",
"      </a>",
"      ]. Regardless of the accuracy of the initial diagnosis, immobilization is appropriate for patients with suspected Salter-Harris I fractures as described below.",
"      <br/>",
"      <br/>",
"      Salter-Harris II fractures are similar to Salter-Harris I fractures except that there is a fracture extending into the metaphyseal cortex that produces a triangular fragment known as the Thurston-Holland or corner sign.",
"      <br/>",
"      <br/>",
"      Avulsion fractures occur when a small piece of bone is pulled off of the distal fibula by the lateral ligamentous complex.",
"      <br/>",
"      <br/>",
"      We suggest that children with nondisplaced Salter-Harris I or II or avulsion fractures of the distal fibula receive immobilization with a removable ankle brace, (eg, AirCast Air-Stirrup ankle brace&reg;) (",
"      <a class=\"graphic graphic_picture graphicRef78043 \" href=\"UTD.htm?14/23/14706\">",
"       picture 2",
"      </a>",
"      ), posterior plaster splint, or tubular bandage [",
"      <a class=\"abstract\" href=\"UTD.htm?23/49/24345/abstract/6,24\">",
"       6,24",
"      </a>",
"      ]. Children with appropriate capability may be given crutches and be made nonweightbearing until pain subsides.",
"      <br/>",
"      <br/>",
"      Despite the benign nature of these injuries, these fractures have traditionally been managed using a below-knee cast for three to four weeks [",
"      <a class=\"abstract\" href=\"UTD.htm?23/49/24345/abstract/17\">",
"       17",
"      </a>",
"      ]. Disadvantages to this approach include delay in returning to normal activities, patient discomfort, development of a tight cast, skin ulceration, and, rarely, compartment syndrome [",
"      <a class=\"abstract\" href=\"UTD.htm?23/49/24345/abstract/6,24,25\">",
"       6,24,25",
"      </a>",
"      ]. Theoretically, a cast offers greater protection than alternative means of immobilization such as a removable ankle brace or tubular bandage. However, the fibula is not prone to refracture. Thus, some researchers have challenged the necessity of this rigid and prolonged immobilization for these relatively minor injuries. Instead, they favor treatment that addresses symptoms rather than the potential for complications [",
"      <a class=\"abstract\" href=\"UTD.htm?23/49/24345/abstract/6,24\">",
"       6,24",
"      </a>",
"      ].",
"      <br/>",
"      <br/>",
"      As an example, a randomized trial of 104 children with non-displaced distal fibular Salter-Harris I, II, or avulsion fractures found that a greater proportion of the 54 children who received a removable ankle brace had returned to normal baseline activity at four weeks when compared with the 50 children who received a fiberglass below-knee walking cast (81 versus 60 percent) [",
"      <a class=\"abstract\" href=\"UTD.htm?23/49/24345/abstract/6\">",
"       6",
"      </a>",
"      ]. In addition, the removable brace was superior with respect to patient preferences and was also cost-effective [",
"      <a class=\"abstract\" href=\"UTD.htm?23/49/24345/abstract/6\">",
"       6",
"      </a>",
"      ].",
"      <br/>",
"      <br/>",
"      Anticipated recovery time constitutes key anticipatory guidance for families. These injuries are still fractures, and pain is expected to persist for two to four weeks, limiting activities to some degree. However, pain does gradually abate in this time frame in the vast majority of children. Return to full activities, including competitive sports, typically occurs by 6 to 12 weeks.",
"     </li>",
"     <li>",
"      <strong>",
"       Displaced Salter-Harris I or II",
"      </strong>",
"      &ndash; Displaced Salter-Harris I or II fractures require prompt orthopedic consultation for reduction and casting.",
"     </li>",
"     <li>",
"      <strong>",
"       Salter-Harris III through V",
"      </strong>",
"      &ndash; These fractures of the fibula are very rare and have not been reported to occur as isolated injuries [",
"      <a class=\"abstract\" href=\"UTD.htm?23/49/24345/abstract/16\">",
"       16",
"      </a>",
"      ]. When present, they require prompt orthopedic evaluation along with the concomitant tibial injury. Treatment is focused on management of the tibia fracture. Fibular injuries are usually stable once the tibial fracture is reduced (",
"      <a class=\"graphic graphic_figure graphicRef54582 \" href=\"UTD.htm?20/55/21361\">",
"       figure 6",
"      </a>",
"      )&nbsp;[",
"      <a class=\"abstract\" href=\"UTD.htm?23/49/24345/abstract/7\">",
"       7",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H27\">",
"    <span class=\"h2\">",
"     Distal tibia fractures",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      <strong>",
"       Nondisplaced Salter-Harris I or II",
"      </strong>",
"      &ndash; Salter-Harris I injuries of the tibia are rare and present with tenderness and swelling over the distal tibial physis (",
"      <a class=\"graphic graphic_figure graphicRef79444 \" href=\"UTD.htm?26/18/26918\">",
"       figure 4",
"      </a>",
"      and",
"      <a class=\"graphic graphic_figure graphicRef54582 \" href=\"UTD.htm?20/55/21361\">",
"       figure 6",
"      </a>",
"      ).",
"      <br/>",
"      <br/>",
"      Salter-Harris II tibial fractures are much more common and may occur with inversion, eversion, or plantar flexion mechanisms (",
"      <a class=\"graphic graphic_figure graphicRef60173 \" href=\"UTD.htm?0/8/140\">",
"       figure 3",
"      </a>",
"      ). Salter-Harris II fractures are similar to Salter-Harris I fractures except that there is a fracture extending into the metaphyseal cortex that produces a triangular fragment known as the Thurston-Holland or corner sign (",
"      <a class=\"graphic graphic_diagnosticimage graphicRef56106 \" href=\"UTD.htm?21/12/21711\">",
"       image 4",
"      </a>",
"      ).",
"      <br/>",
"      <br/>",
"      Initial management of these fractures consists of immobilization in a below-knee posterior splint or below-knee cast and no weightbearing pending evaluation and continued care by an orthopedist with pediatric expertise [",
"      <a class=\"abstract\" href=\"UTD.htm?23/49/24345/abstract/1\">",
"       1",
"      </a>",
"      ]. Children with appropriate capability should be given crutches. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?14/54/15208?source=see_link&amp;anchor=H23#H23\">",
"       \"Splinting of musculoskeletal injuries\", section on 'Posterior leg splint'",
"      </a>",
"      .)",
"      <br/>",
"      <br/>",
"      Orthopedic treatment for these children usually requires a short leg cast for two to three weeks followed by a short leg walking cast for an additional two to three weeks. Return to full activities typically occurs by 10 to 12 weeks.",
"     </li>",
"     <li>",
"      <strong>",
"       Displaced Salter-Harris I or II",
"      </strong>",
"      &ndash; Displaced Salter-Harris I or II fractures of the tibia require prompt orthopedic consultation for reduction and cast immobilization with ongoing care directed by an orthopedist with pediatric expertise. While often reducible in the emergency department, those which are not anatomically reduced may have periosteum or torn deltoid ligament interposed in the fracture site and require open operative treatment.",
"     </li>",
"     <li>",
"      <strong>",
"       Salter-Harris III",
"      </strong>",
"      &ndash; The juvenile Tillaux fracture represents the most common Salter-Harris III fracture and typically occurs in young teenagers. The mechanism of injury commonly involves inversion of the ankle with the foot pointed away from the midline (supination with external rotation) (",
"      <a class=\"graphic graphic_figure graphicRef60173 \" href=\"UTD.htm?0/8/140\">",
"       figure 3",
"      </a>",
"      and",
"      <a class=\"graphic graphic_diagnosticimage graphicRef76290 \" href=\"UTD.htm?29/50/30511\">",
"       image 1",
"      </a>",
"      ). This mechanism leads to avulsion of the lateral tibial epiphysis that is attached to the anterior inferior tibiofibular ligament (",
"      <a class=\"graphic graphic_figure graphicRef76624 \" href=\"UTD.htm?10/1/10257\">",
"       figure 7",
"      </a>",
"      ). The uninvolved medial portion of the epiphysis is closed.",
"      <br/>",
"      <br/>",
"      Rarely, a Salter-Harris III fracture occurs in the medial malleolus before physeal closure; this most often follows an injury with eversion stress and is typically accompanied by a fracture of the distal fibula.",
"      <br/>",
"      <br/>",
"      In addition to plain radiographs, computed tomography of these fractures is often indicated to evaluate the extent of displacement. Juvenile Tillaux fractures with &gt;2 mm of displacement warrant urgent orthopedic consultation for closed or open reduction. Some of these fractures may require percutaneous pinning to maintain reduction [",
"      <a class=\"abstract\" href=\"UTD.htm?23/49/24345/abstract/17\">",
"       17",
"      </a>",
"      ].After discussion with an orthopedist, children with non-displaced Salter-Harris III fractures, as determined by computed tomography, may be given crutches and placed in a posterior below-knee splint or cast pending evaluation and continued care by an orthopedist with pediatric expertise within one week.",
"      <br/>",
"      <br/>",
"      Patients with nondisplaced Salter-Harris III fractures typically undergo long leg casting for four to six weeks with conversion to a short leg cast or boot for an additional two to four weeks. Weightbearing is initiated based on radiographic healing and clinical examination. Patients should anticipate eight weeks of nonweightbearing. Return to full activities frequently occurs by 10 to 12 weeks. Patients with displaced fractures requiring reduction",
"      <span class=\"nowrap\">",
"       and/or",
"      </span>",
"      instrumentation warrant close ongoing orthopedic care to ensure adequate reduction and to determine the optimal timing for hardware removal and return to normal activities.",
"     </li>",
"     <li>",
"      <strong>",
"       Salter-Harris type IV",
"      </strong>",
"      &ndash; Type IV fractures involve the joint and urgent orthopedic consultation is usually indicated. If located medially, these are caused by inversion stress and are shearing type injuries that usually need fixation.",
"      <br/>",
"      <br/>",
"      Triplane fracture describes a Salter-Harris IV fracture of the tibia that occurs in the sagittal, coronal, and transverse planes and creates between two and four fracture fragments (",
"      <a class=\"graphic graphic_diagnosticimage graphicRef67327 \" href=\"UTD.htm?28/14/28901\">",
"       image 2",
"      </a>",
"      )&nbsp;[",
"      <a class=\"abstract\" href=\"UTD.htm?23/49/24345/abstract/7,17\">",
"       7,17",
"      </a>",
"      ]. The mechanism of injury is debated but many orthopedists feel it involves inversion of the ankle with extreme turning out of the foot (supination with external rotation).",
"      <br/>",
"      <br/>",
"      Computed tomography is required to discern the degree of displacement in patients with Salter-Harris IV fractures. Open reduction with internal fixation of these injuries is usually necessary to obtain adequate reduction. Failure to reestablish articular continuity may result in premature arthritis [",
"      <a class=\"abstract\" href=\"UTD.htm?23/49/24345/abstract/1\">",
"       1",
"      </a>",
"      ]. In addition, risk of growth arrest is significant [",
"      <a class=\"abstract\" href=\"UTD.htm?23/49/24345/abstract/1\">",
"       1",
"      </a>",
"      ]. (See",
"      <a class=\"local\" href=\"#H31\">",
"       'Complications'",
"      </a>",
"      below.)",
"      <br/>",
"      <br/>",
"      These injuries warrant close ongoing orthopedic care to ensure adequate reduction and to determine the optimal timing for hardware removal and ultimately, return to normal activities.",
"     </li>",
"     <li>",
"      <strong>",
"       Salter-Harris V",
"      </strong>",
"      &mdash; These rare fractures result from axial loading of the extremity (eg, a fall on the heel from a height leading to physeal compression) (",
"      <a class=\"graphic graphic_figure graphicRef54582 \" href=\"UTD.htm?20/55/21361\">",
"       figure 6",
"      </a>",
"      ). Patients with multisystem trauma may be at particular risk for unrecognized Salter-Harris V injuries. Initial plain films may show narrowing of the physis but are frequently unremarkable. Any suspected Salter-Harris V fracture warrants urgent orthopedic assessment. These patients need ongoing orthopedic care for several years because of the high risk of growth arrest and need for corrective surgery. Unfortunately, many of these injuries are difficult to detect and may not come to attention until growth arrest has already occurred [",
"      <a class=\"abstract\" href=\"UTD.htm?23/49/24345/abstract/7\">",
"       7",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H28\">",
"    <span class=\"h1\">",
"     DISCHARGE AND FOLLOW-UP",
"    </span>",
"    &nbsp;&mdash;&nbsp;After definitive care, children with ankle fractures should follow-up with an orthopedic surgeon with pediatric expertise within one week. Children with the appropriate capability should also receive crutches.",
"   </p>",
"   <p>",
"    Children who have received a cast and their caretakers should be given detailed cast care instructions. (See",
"    <a class=\"medical medical_patient\" href=\"UTD.htm?25/21/25937?source=see_link\">",
"     \"Patient information: Cast and splint care (Beyond the Basics)\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Children who have received operative care should be admitted for 24 to 48 hour observation of neurovascular status and soft tissue compartments. Once discharged, these patients are followed closely and may require weekly orthopedic evaluation with radiographs to determine the optimal timing for subsequent hardware removal.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H29\">",
"    <span class=\"h2\">",
"     Home pain management",
"    </span>",
"    &nbsp;&mdash;&nbsp;Most children with nondisplaced Salter-Harris I or II fractures have adequate pain control with",
"    <a class=\"drug drug_pediatric\" href=\"UTD.htm?7/48/7946?source=see_link\">",
"     ibuprofen",
"    </a>",
"    (10",
"    <span class=\"nowrap\">",
"     mg/kg;",
"    </span>",
"    maximum single dose 800 mg).",
"   </p>",
"   <p>",
"    Patients with Salter-Harris III or higher fractures, especially those who require operative fixation, typically require oral opioid pain medication (eg,",
"    <a class=\"drug drug_pediatric\" href=\"UTD.htm?38/23/39287?source=see_link\">",
"     oxycodone",
"    </a>",
"    or oral prompt-release",
"    <a class=\"drug drug_pediatric\" href=\"UTD.htm?31/30/32233?source=see_link\">",
"     morphine",
"    </a>",
"    ).",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H31\">",
"    <span class=\"h1\">",
"     COMPLICATIONS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Potential complications of ankle fractures include the following:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Growth arrest &ndash; Ankle fractures in children usually involve the physis (growth plate) (",
"      <a class=\"graphic graphic_figure graphicRef79444 \" href=\"UTD.htm?26/18/26918\">",
"       figure 4",
"      </a>",
"      ). Growth arrest is most commonly seen in children with Salter-Harris III or IV fractures of the tibia, especially when initial reduction is incomplete. Thus, all tibial growth plate fractures should be monitored closely by an orthopedist for up to two years to observe for proper healing [",
"      <a class=\"abstract\" href=\"UTD.htm?23/49/24345/abstract/1\">",
"       1",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Osteoarthritis &ndash; Arthritis has been reported in up to 29 percent of patients with a Salter-Harris III or IV ankle fracture and seems to be most associated with the degree of fracture displacement and the presence of residual displacement after reduction [",
"      <a class=\"abstract\" href=\"UTD.htm?23/49/24345/abstract/26\">",
"       26",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Ankle stiffness &ndash; Posttraumatic ankle stiffness has been observed in up to 6 percent of patients after ankle fracture and is associated with osteoarthritis [",
"      <a class=\"abstract\" href=\"UTD.htm?23/49/24345/abstract/26\">",
"       26",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Complex regional pain syndrome &ndash; Complex regional pain syndrome (previously, reflex sympathetic dystrophy) may follow an ankle fracture and is identified by marked pain with light touch to the skin (allodynia), swelling, and vasomotor changes. Splinting results in worsening symptoms. Multidisciplinary pain evaluation and treatment, including physical therapy, is sometimes helpful. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?36/56/37768?source=see_link\">",
"       \"Complex regional pain syndrome in children\"",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H32\">",
"    <span class=\"h1\">",
"     OUTCOMES",
"    </span>",
"    &nbsp;&mdash;&nbsp;Most children with ankle fractures will enjoy a return to baseline activities without any long-term complications. Once a patient's immobilization device has been removed, return to activities may be facilitated with ankle range of motion exercises. Patients with significant ankle stiffness remaining at four weeks after brace or cast removal may benefit from formal physical therapy sessions.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"PATIENT_INFORMATION\">",
"    <span class=\"h1\">",
"     INFORMATION FOR PATIENTS",
"    </span>",
"    &nbsp;&mdash;&nbsp;UpToDate offers two types of patient education materials, &ldquo;The Basics&rdquo; and &ldquo;Beyond the Basics.&rdquo; The Basics patient education pieces are written in plain language, at the 5",
"    <sup>",
"     th",
"    </sup>",
"    to 6",
"    <sup>",
"     th",
"    </sup>",
"    grade reading level, and they answer the four or five key questions a patient might have about a given condition. These articles are best for patients who want a general overview and who prefer short, easy-to-read materials. Beyond the Basics patient education pieces are longer, more sophisticated, and more detailed. These articles are written at the 10",
"    <sup>",
"     th",
"    </sup>",
"    to 12",
"    <sup>",
"     th",
"    </sup>",
"    grade reading level and are best for patients who want in-depth information and are comfortable with some medical jargon.",
"   </p>",
"   <p>",
"    Here are the patient education articles that are relevant to this topic. We encourage you to print or e-mail these topics to your patients. (You can also locate patient education articles on a variety of subjects by searching on &ldquo;patient info&rdquo; and the keyword(s) of interest.)",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Basics topic (see",
"      <a class=\"medical medical_basics\" href=\"UTD.htm?39/25/40338?source=see_link\">",
"       \"Patient information: Ankle fracture (The Basics)\"",
"      </a>",
"      and",
"      <a class=\"medical medical_basics\" href=\"UTD.htm?10/51/11058?source=see_link\">",
"       \"Patient information: Cast and splint care (The Basics)\"",
"      </a>",
"      )",
"     </li>",
"     <li>",
"      Beyond the Basics topic (see",
"      <a class=\"medical medical_patient\" href=\"UTD.htm?25/21/25937?source=see_link\">",
"       \"Patient information: Cast and splint care (Beyond the Basics)\"",
"      </a>",
"      )",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H33\">",
"    <span class=\"h1\">",
"     SUMMARY AND RECOMMENDATIONS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Ankle fractures are among the most common acute injuries of the lower extremity in children, and account for up to 40 percent of all injuries to the skeletally immature athlete. Distal fibular physeal fractures are the most common types of pediatric ankle fracture and are associated with a relatively low risk for long-term complications. In contrast, distal tibial physeal fractures are associated with a higher risk for long-term complications, such as growth arrest. In young teenagers, Salter-Harris III and IV tibial fractures occur in patterns that reflect the anatomy of distal tibia growth plate closure. (See",
"    <a class=\"local\" href=\"#H2\">",
"     'Epidemiology'",
"    </a>",
"    above and",
"    <a class=\"local\" href=\"#H4\">",
"     'Distal tibial physis'",
"    </a>",
"    above.)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H34\">",
"    <span class=\"h2\">",
"     Clinical findings and imaging",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      The child with an ankle fracture typically has a history of inversion or eversion of the ankle with swelling and pain near the ankle joint (",
"      <a class=\"graphic graphic_figure graphicRef60173 \" href=\"UTD.htm?0/8/140\">",
"       figure 3",
"      </a>",
"      ). Most patients are unable to walk or have significant limitation of ambulation. (See",
"      <a class=\"local\" href=\"#H7\">",
"       'Clinical features'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      In patients with an obvious deformity (",
"      <a class=\"graphic graphic_picture graphicRef82323 \" href=\"UTD.htm?8/55/9072\">",
"       picture 1",
"      </a>",
"      ), marked swelling with moderate to severe pain, or high suspicion for a displaced fracture, analgesia (eg, intravenous",
"      <a class=\"drug drug_pediatric\" href=\"UTD.htm?31/30/32233?source=see_link\">",
"       morphine",
"      </a>",
"      0.1",
"      <span class=\"nowrap\">",
"       mg/kg;",
"      </span>",
"      maximum single dose: 10 mg) is advisable prior to physical examination and radiography. These patients should not perform active range of motion or attempt to walk. (See",
"      <a class=\"local\" href=\"#H9\">",
"       'Physical examination'",
"      </a>",
"      above and",
"      <a class=\"local\" href=\"#H23\">",
"       'Analgesia and initial care'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Patients with deformity and high clinical suspicion for fracture based on physical examination (eg, pain, swelling, deformity, inability to ambulate) should receive plain radiographs including anterior-posterior (AP), lateral, and mortise views. (See",
"      <a class=\"local\" href=\"#H15\">",
"       'Plain radiographs'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      We suggest that children under 16 years NOT routinely undergo screening with the OAR to determine the need for radiography. (See",
"      <a class=\"local\" href=\"#H12\">",
"       'Ottawa Ankle Rules'",
"      </a>",
"      above and",
"      <a class=\"local\" href=\"#H9\">",
"       'Physical examination'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Pediatric ankle fractures are most commonly described using the Salter-Harris classification system (",
"      <a class=\"graphic graphic_figure graphicRef54582 \" href=\"UTD.htm?20/55/21361\">",
"       figure 6",
"      </a>",
"      ). The juvenile Tillaux fracture represents a unique type of Salter-Harris III fracture (",
"      <a class=\"graphic graphic_diagnosticimage graphicRef76290 \" href=\"UTD.htm?29/50/30511\">",
"       image 1",
"      </a>",
"      ). Triplane ankle fractures in children are Salter-Harris IV fractures (",
"      <a class=\"graphic graphic_diagnosticimage graphicRef67327 \" href=\"UTD.htm?28/14/28901\">",
"       image 2",
"      </a>",
"      ). (See",
"      <a class=\"local\" href=\"#H16\">",
"       'Classification of fractures'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H35\">",
"    <span class=\"h2\">",
"     Management",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      The clinician should promptly identify children with vascular insufficiency and emergently involve an orthopedic surgeon with appropriate pediatric expertise. Rarely, these children will require partial closed reduction in the emergency department by the emergency clinician or orthopedist in an attempt to restore distal circulation. Patients who display a cold, cyanotic foot despite reduction attempts require emergent operative exploration and vascular repair. (See",
"      <a class=\"local\" href=\"#H22\">",
"       'Absent pulse'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      For children with an ankle fracture and no signs of neurovascular compromise, initial therapy consists of measures to reduce swelling, pain management, and restriction of ambulation. (See",
"      <a class=\"local\" href=\"#H23\">",
"       'Analgesia and initial care'",
"      </a>",
"      above.).",
"     </li>",
"     <li>",
"      The clinician should obtain prompt orthopedic consultation for children with any of the following ankle fractures (see",
"      <a class=\"local\" href=\"#H24\">",
"       'Indications for orthopedic consultation or referral'",
"      </a>",
"      above):",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"hyphen-block\">",
"     <li>",
"      Fractures with neurovascular compromise",
"     </li>",
"     <li>",
"      Open fractures",
"     </li>",
"     <li>",
"      Salter-Harris III (including juvenile Tillaux fractures), IV (including Triplane fractures), or V physeal fractures",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      We suggest that children with nondisplaced Salter-Harris I or II or avulsion fractures of the distal fibula receive immobilization with a removable ankle brace (eg, AirCast Air-Stirrup ankle brace&reg;), posterior plaster splint, or tubular bandage (",
"      <a class=\"grade\" href=\"._grade_5?title=Grade 2B\">",
"       Grade 2B",
"      </a>",
"      ). Children with appropriate capability should be given crutches and be made nonweightbearing until pain subsides. (See",
"      <a class=\"local\" href=\"#H26\">",
"       'Distal fibula fractures'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Patients with a nondisplaced Salter-Harris I or II fracture of the tibia should undergo immobilization in a below-knee posterior splint or below-knee cast and no weightbearing pending evaluation and continued care by an orthopedist with pediatric expertise. (See",
"      <a class=\"local\" href=\"#H27\">",
"       'Distal tibia fractures'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Following definitive care, children with nonoperative ankle fractures should follow-up with an orthopedic surgeon with pediatric expertise within one week. (See",
"      <a class=\"local\" href=\"#H28\">",
"       'Discharge and Follow-up'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Children who have received operative care should be admitted for 24 to 48 hour observation of neurovascular status and soft tissue compartments. Once discharged, these patients are followed closely and may require weekly orthopedic evaluation with radiographs to determine the optimal timing for subsequent hardware removal. (See",
"      <a class=\"local\" href=\"#H28\">",
"       'Discharge and Follow-up'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H36\">",
"    <span class=\"h2\">",
"     Outcomes",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Most children with ankle fractures will enjoy a return to baseline activities without any long-term complications. (See",
"      <a class=\"local\" href=\"#H32\">",
"       'Outcomes'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/49/24345/abstract/1\">",
"      Marsh JS, Daigneault JP. Ankle injuries in the pediatric population. Curr Opin Pediatr 2000; 12:52.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/49/24345/abstract/2\">",
"      Ryan LM, DePiero AD, Sadow KB, et al. Recognition and management of pediatric fractures by pediatric residents. Pediatrics 2004; 114:1530.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/49/24345/abstract/3\">",
"      Taras HL, Nader PR. Ten years of graduates evaluate a pediatric residency program. Am J Dis Child 1990; 144:1102.",
"     </a>",
"    </li>",
"    <li>",
"     Cummings RJ. Distal tibial and fibular fractures. In: Rockwood and Wilkins' Fractures in Children, 6th, Rockwood CA, Wilkins KE, Beaty JH.  (Eds), Lippincott Williams &amp; Wilkins, Philadelphia 2006. p.1122.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/49/24345/abstract/5\">",
"      Damore DT, Metzl JD, Ramundo M, et al. Patterns in childhood sports injury. Pediatr Emerg Care 2003; 19:65.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/49/24345/abstract/6\">",
"      Boutis K, Willan AR, Babyn P, et al. A randomized, controlled trial of a removable brace versus casting in children with low-risk ankle fractures. Pediatrics 2007; 119:e1256.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/49/24345/abstract/7\">",
"      Kay RM, Matthys GA. Pediatric ankle fractures: evaluation and treatment. J Am Acad Orthop Surg 2001; 9:268.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/49/24345/abstract/8\">",
"      Dowling S, Spooner CH, Liang Y, et al. Accuracy of Ottawa Ankle Rules to exclude fractures of the ankle and midfoot in children: a meta-analysis. Acad Emerg Med 2009; 16:277.",
"     </a>",
"    </li>",
"    <li>",
"     file://www.hospitalreport.ca/downloads/sector.html/ (Accessed on August 21, 2007).",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/49/24345/abstract/10\">",
"      Runyon MS. Can we safely apply the Ottawa Ankle Rules to children? Acad Emerg Med 2009; 16:352.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/49/24345/abstract/11\">",
"      Clark KD, Tanner S. Evaluation of the Ottawa ankle rules in children. Pediatr Emerg Care 2003; 19:73.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/49/24345/abstract/12\">",
"      Boutis K, Komar L, Jaramillo D, et al. Sensitivity of a clinical examination to predict need for radiography in children with ankle injuries: a prospective study. Lancet 2001; 358:2118.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/49/24345/abstract/13\">",
"      Chorley JN, Hergenroeder AC. Management of ankle sprains. Pediatr Ann 1997; 26:56.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/49/24345/abstract/14\">",
"      Dayan PS, Vitale M, Langsam DJ, et al. Derivation of clinical prediction rules to identify children with fractures after twisting injuries of the ankle. Acad Emerg Med 2004; 11:736.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/49/24345/abstract/15\">",
"      Gravel J, Hedrei P, Grimard G, Gouin S. Prospective validation and head-to-head comparison of 3 ankle rules in a pediatric population. Ann Emerg Med 2009; 54:534.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/49/24345/abstract/16\">",
"      Rogers LF. The radiography of epiphyseal injuries. Radiology 1970; 96:289.",
"     </a>",
"    </li>",
"    <li>",
"     Cummings RJ. Distal tibial and fibular fractures. In: Rockwood and Wilkins' Fractures in Children, 6th, Wilkins KE, Beaty JH.  (Eds), Lippincott-Raven, Philadelphia 2006. p.1122.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/49/24345/abstract/18\">",
"      Lemburg SP, Lilienthal E, Heyer CM. Growth plate fractures of the distal tibia: is CT imaging necessary? Arch Orthop Trauma Surg 2010; 130:1411.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/49/24345/abstract/19\">",
"      Lohman M, Kivisaari A, Kallio P, et al. Acute paediatric ankle trauma: MRI versus plain radiography. Skeletal Radiol 2001; 30:504.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/49/24345/abstract/20\">",
"      Launay F, Barrau K, Petit P, et al. [Ankle injuries without fracture in children. Prospective study with magnetic resonance in 116 patients]. Rev Chir Orthop Reparatrice Appar Mot 2008; 94:427.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/49/24345/abstract/21\">",
"      Collins NC. Is ice right? Does cryotherapy improve outcome for acute soft tissue injury? Emerg Med J 2008; 25:65.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/49/24345/abstract/22\">",
"      Zomorrodi A, Bennett JE, Attia MW, et al. Consistency between emergency department and orthopedic physicians in the diagnosis and treatment of distal fibular Salter Harris I fractures. Pediatr Emerg Care 2011; 27:301.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/49/24345/abstract/23\">",
"      Boutis K, Narayanan UG, Dong FF, et al. Magnetic resonance imaging of clinically suspected Salter-Harris I fracture of the distal fibula. Injury 2010; 41:852.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/49/24345/abstract/24\">",
"      Gleeson AP, Stuart MJ, Wilson B, Phillips B. Ultrasound assessment and conservative management of inversion injuries of the ankle in children: plaster of Paris versus Tubigrip. J Bone Joint Surg Br 1996; 78:484.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/49/24345/abstract/25\">",
"      Hawkins BJ, Bays PN. Catastrophic complication of simple cast treatment: case report. J Trauma 1993; 34:760.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/49/24345/abstract/26\">",
"      Caterini R, Farsetti P, Ippolito E. Long-term followup of physeal injury to the ankle. Foot Ankle 1991; 11:372.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 6547 Version 9.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.3 - C21.34",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     Morehouse School of Medicine",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [1104-118.195.65.244-76F9A528C7-S473950.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f23_49_24345=[""].join("\n");
var outline_f23_49_24345=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H33\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY &amp; RECOMMENDATIONS",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      EPIDEMIOLOGY",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      RELEVANT ANATOMY",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H4\">",
"      Distal tibial physis",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H5\">",
"      Distal fibular physis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H6\">",
"      MECHANISM OF INJURY",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H7\">",
"      CLINICAL FEATURES",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H8\">",
"      History",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H9\">",
"      Physical examination",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H10\">",
"      - Assessment of ankle stability",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H11\">",
"      Clinical decision rules for radiography",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H12\">",
"      - Ottawa Ankle Rules",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H13\">",
"      - Other clinical decision rules",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H14\">",
"      RADIOGRAPHIC DIAGNOSIS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H15\">",
"      Plain radiographs",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H16\">",
"      Classification of fractures",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H17\">",
"      - Juvenile Tillaux fracture",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H18\">",
"      - Triplane fracture",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H19\">",
"      Computed tomography",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H20\">",
"      Magnetic resonance imaging",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H21\">",
"      INITIAL MANAGEMENT",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H22\">",
"      Absent pulse",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H23\">",
"      Analgesia and initial care",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H24\">",
"      INDICATIONS FOR ORTHOPEDIC CONSULTATION OR REFERRAL",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H25\">",
"      DEFINITIVE CARE",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H26\">",
"      Distal fibula fractures",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H27\">",
"      Distal tibia fractures",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H28\">",
"      DISCHARGE AND FOLLOW-UP",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H29\">",
"      Home pain management",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H31\">",
"      COMPLICATIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H32\">",
"      OUTCOMES",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#PATIENT_INFORMATION\">",
"      INFORMATION FOR PATIENTS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H33\">",
"      SUMMARY AND RECOMMENDATIONS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H34\">",
"      Clinical findings and imaging",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H35\">",
"      Management",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H36\">",
"      Outcomes",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"EM/6547\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"EM/6547|DiagnosticImage\">",
"      <a href=\"#\" title=\"DIAGNOSTIC IMAGES\">",
"       DIAGNOSTIC IMAGES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_diagnosticimage\" href=\"UTD.htm?29/50/30511\" title=\"diagnostic image 1\">",
"      Juvenile Tillaux fx",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_diagnosticimage\" href=\"UTD.htm?28/14/28901\" title=\"diagnostic image 2\">",
"      Triplane fx child",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_diagnosticimage\" href=\"UTD.htm?30/46/31456\" title=\"diagnostic image 3\">",
"      Salter I distal fibula",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_diagnosticimage\" href=\"UTD.htm?21/12/21711\" title=\"diagnostic image 4\">",
"      Salter II ankle",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"EM/6547|FIG\">",
"      <a href=\"#\" title=\"FIGURES\">",
"       FIGURES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?34/57/35728\" title=\"figure 1\">",
"      Medial ankle ligaments",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?0/9/159\" title=\"figure 2\">",
"      Lateral ankle ligaments",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?0/8/140\" title=\"figure 3\">",
"      Actions of the ankle",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?26/18/26918\" title=\"figure 4\">",
"      Growth plate anatomy",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?32/53/33618\" title=\"figure 5\">",
"      Ottawa ankle rules",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?20/55/21361\" title=\"figure 6\">",
"      Salter-Harris classification system",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?10/1/10257\" title=\"figure 7\">",
"      Tillaux anatomy",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"EM/6547|PIC\">",
"      <a href=\"#\" title=\"PICTURES\">",
"       PICTURES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?8/55/9072\" title=\"picture 1\">",
"      Ankle deformity child",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?14/23/14706\" title=\"picture 2\">",
"      Air cast",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"EM/6547|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?0/42/684\" title=\"table 1\">",
"      High risk trauma mechanisms",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?33/31/34296?source=related_link\">",
"      Ankle sprain",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?39/11/40119?source=related_link\">",
"      Approach to the initially stable child with blunt or penetrating injury",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?36/56/37768?source=related_link\">",
"      Complex regional pain syndrome in children",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?19/40/20104?source=related_link\">",
"      General principles of fracture management: Fracture patterns and description in children",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?14/35/14903?source=related_link\">",
"      Metatarsal and toe fractures in children",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?35/33/36376?source=related_link\">",
"      Overview of ankle fractures in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?39/25/40338?source=related_link\">",
"      Patient information: Ankle fracture (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_patient\" href=\"UTD.htm?25/21/25937?source=related_link\">",
"      Patient information: Cast and splint care (Beyond the Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?10/51/11058?source=related_link\">",
"      Patient information: Cast and splint care (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?14/54/15208?source=related_link\">",
"      Splinting of musculoskeletal injuries",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?29/16/29962?source=related_link\">",
"      Trauma management: Approach to the unstable child",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f23_49_24346="Clinical features and diagnosis of seasonal influenza in children";
var content_f23_49_24346=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"5\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Clinical features and diagnosis of seasonal influenza in children",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?23/49/24346/contributors\">",
"     Author",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?23/49/24346/contributors\">",
"     Flor M Munoz, MD, MSc",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?23/49/24346/contributors\">",
"     Section Editors",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?23/49/24346/contributors\">",
"     George B Mallory, MD",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?23/49/24346/contributors\">",
"     Morven S Edwards, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?23/49/24346/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?23/49/24346/contributors\">",
"     Mary M Torchia, MD",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"UTD.htm?23/49/24346/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Mar 20, 2013.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Influenza is an acute respiratory illness caused by influenza A or B viruses. It occurs in outbreaks every year, mainly during the winter season (in temperate climates). Signs and symptoms of upper",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    lower respiratory tract involvement are common, but the presentation of influenza in children is variable. The manifestations vary depending upon age and previous experience with the virus.",
"   </p>",
"   <p>",
"    Among healthy children, influenza generally is an acute, self-limited, and uncomplicated disease [",
"    <a class=\"abstract\" href=\"UTD.htm?23/49/24346/abstract/1,2\">",
"     1,2",
"    </a>",
"    ]. However, it can be associated with severe morbidity and mortality. Influenza causes an appreciable disease burden (eg, school and work absence, increased frequency of outpatient medical visits), and children are important vectors for the spread of disease [",
"    <a class=\"abstract\" href=\"UTD.htm?23/49/24346/abstract/3\">",
"     3",
"    </a>",
"    ]. In addition, certain groups of children are at increased risk of severe or complicated influenza infection (",
"    <a class=\"graphic graphic_table graphicRef72029 \" href=\"UTD.htm?32/50/33579\">",
"     table 1",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"UTD.htm?23/49/24346/abstract/4\">",
"     4",
"    </a>",
"    ]. (See",
"    <a class=\"local\" href=\"#H5\">",
"     'Risk factors'",
"    </a>",
"    below.)",
"   </p>",
"   <p>",
"    The clinical features and diagnosis of influenza in children will be reviewed here. The treatment and prevention are discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?26/7/26746?source=see_link\">",
"     \"Antiviral drugs for the prevention and treatment of seasonal influenza in children\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?27/18/27946?source=see_link\">",
"     \"Seasonal influenza vaccination in children\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     EPIDEMIOLOGY",
"    </span>",
"    &nbsp;&mdash;&nbsp;Influenza occurs in distinct outbreaks of varying extent every year. This epidemiologic pattern reflects the changing nature of the antigenic properties of influenza viruses. The subsequent spread depends upon the susceptibility of the population. The epidemiology of influenza virus infections, including antigenic changes, characteristics of outbreaks, and morbidity and mortality in adults is discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?14/58/15272?source=see_link\">",
"     \"Epidemiology of influenza\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h2\">",
"     Influenza activity",
"    </span>",
"    &nbsp;&mdash;&nbsp;The Centers for Disease Control and Prevention (CDC), in collaboration with the World Health Organization (WHO) and its reporting network, tracks influenza virus isolates throughout the world to monitor disease activity and to predict the appropriate components for the annual influenza vaccine. This information, which is updated weekly during influenza season, is available from the",
"    <a class=\"external\" href=\"file://www.cdc.gov/flu/weekly/\">",
"     CDC",
"    </a>",
"    . In addition,",
"    <a class=\"external\" href=\"file://www.who.int/influenza/gisrs_laboratory/flunet/en/\">",
"     FluNet",
"    </a>",
"    , a database for global influenza virus surveillance, is available through the WHO.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4\">",
"    <span class=\"h2\">",
"     Transmission",
"    </span>",
"    &nbsp;&mdash;&nbsp;Influenza viruses are spread from person to person, primarily through contact with respiratory secretions (through sneezing, coughing, talking, touching) [",
"    <a class=\"abstract\" href=\"UTD.htm?23/49/24346/abstract/5,6\">",
"     5,6",
"    </a>",
"    ]. Large amounts of virus are present in respiratory secretions of infected persons, which also can be transmitted through fomites.",
"   </p>",
"   <p>",
"    Viral shedding peaks at 24 to 48 hours of illness and then rapidly declines; little or no viral replication is detectable in the respiratory tract after 5 to 10 days [",
"    <a class=\"abstract\" href=\"UTD.htm?23/49/24346/abstract/7-10\">",
"     7-10",
"    </a>",
"    ]. Due to the relative lack of immunity, longer periods of shedding can occur in immunocompromised hosts and young children, especially those with primary infection [",
"    <a class=\"abstract\" href=\"UTD.htm?23/49/24346/abstract/11-13\">",
"     11-13",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The incubation period is usually one to four days (mean two days), resulting in high transmissibility [",
"    <a class=\"abstract\" href=\"UTD.htm?23/49/24346/abstract/14\">",
"     14",
"    </a>",
"    ]. The incubation period for the 2009 H1N1 influenza virus was approximately 1.5 to 3 days during the pandemic, but extended to seven days in a minority of patients [",
"    <a class=\"abstract\" href=\"UTD.htm?23/49/24346/abstract/15\">",
"     15",
"    </a>",
"    ]. The serial interval (ie, the interval between the onsets of epidemiologically related cases) was estimated to be three to four days [",
"    <a class=\"abstract\" href=\"UTD.htm?23/49/24346/abstract/7,16\">",
"     7,16",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5\">",
"    <span class=\"h2\">",
"     Risk factors",
"    </span>",
"    &nbsp;&mdash;&nbsp;Young children and those with certain underlying medical conditions (",
"    <a class=\"graphic graphic_table graphicRef72029 \" href=\"UTD.htm?32/50/33579\">",
"     table 1",
"    </a>",
"    ) are at increased risk for hospitalization or severe or complicated influenza infection [",
"    <a class=\"abstract\" href=\"UTD.htm?23/49/24346/abstract/4,17-19\">",
"     4,17-19",
"    </a>",
"    ]. (See",
"    <a class=\"local\" href=\"#H9\">",
"     'Complications'",
"    </a>",
"    below.)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6\">",
"    <span class=\"h2\">",
"     Disease burden",
"    </span>",
"    &nbsp;&mdash;&nbsp;It is estimated that 15 to 42 percent of preschool and school-age children become infected with influenza each year, only a portion of whom seek medical treatment [",
"    <a class=\"abstract\" href=\"UTD.htm?23/49/24346/abstract/1,20-27\">",
"     1,20-27",
"    </a>",
"    ]. Influenza virus infections in children are associated with increased frequency of outpatient visits, hospitalization, days missed from school for the patient and his or her siblings, and missed days of work for the parent(s) [",
"    <a class=\"abstract\" href=\"UTD.htm?23/49/24346/abstract/4,22,23,28\">",
"     4,22,23,28",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The 2009 pandemic H1N1 influenza virus was associated with increased morbidity (including life-threatening illness requiring intensive care, mechanical ventilation, or extracorporeal membrane oxygen support) and mortality among hospitalized children compared with the usual seasonal influenza virus strains [",
"    <a class=\"abstract\" href=\"UTD.htm?23/49/24346/abstract/4,29-33\">",
"     4,29-33",
"    </a>",
"    ]. (See",
"    <a class=\"local\" href=\"#H336495101\">",
"     'Mortality'",
"    </a>",
"    below and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?36/27/37305?source=see_link&amp;anchor=H12#H12\">",
"     \"Clinical manifestations and diagnosis of pandemic H1N1 influenza ('swine influenza')\", section on 'Complications'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H336495087\">",
"    <span class=\"h3\">",
"     Outpatient visits",
"    </span>",
"    &nbsp;&mdash;&nbsp;The number of outpatient visits among children related to influenza virus infection each year in the United States has ranged from 6 to 29 per 100 children, and varies according to age and year [",
"    <a class=\"abstract\" href=\"UTD.htm?23/49/24346/abstract/1,21,23-25,27\">",
"     1,21,23-25,27",
"    </a>",
"    ]. In a population-based study, the ratio of outpatient visits to hospitalization for confirmed influenza was approximately 10:1 for infants 0 to &lt;6 months of age, 100:1 for those 6 through 23 months of age, and 250:1 for those 24 through 59 months [",
"    <a class=\"abstract\" href=\"UTD.htm?23/49/24346/abstract/1\">",
"     1",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H336495094\">",
"    <span class=\"h3\">",
"     Hospitalization",
"    </span>",
"    &nbsp;&mdash;&nbsp;Influenza virus infection is associated with increased rates of hospitalization in children with risk factors for severe or complicated influenza infection (",
"    <a class=\"graphic graphic_table graphicRef72029 \" href=\"UTD.htm?32/50/33579\">",
"     table 1",
"    </a>",
"    ), and in otherwise healthy children younger than five years, particularly those younger than two years (",
"    <a class=\"graphic graphic_figure graphicRef61859 \" href=\"UTD.htm?27/38/28270\">",
"     figure 1",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"UTD.htm?23/49/24346/abstract/1,4,27,34,35\">",
"     1,4,27,34,35",
"    </a>",
"    ].",
"    <br/>",
"   </p>",
"   <p>",
"    In national surveillance (2003-2008), laboratory-confirmed seasonal influenza hospitalization rates among children ranged according to age as follows [",
"    <a class=\"abstract\" href=\"UTD.htm?23/49/24346/abstract/34\">",
"     34",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      &lt;6 months: 9 to 30 per 10,000 children",
"     </li>",
"     <li>",
"      6 to 23 months: 3 to 11 per 10,000 children",
"     </li>",
"     <li>",
"      2 to 4 years: 1 to 4 per 10,000 children",
"     </li>",
"     <li>",
"      5 to 17 years: 0.3 to 0.8 per 10,000 children",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    In prospective, population based surveillance (2000-2004), high-risk conditions (eg, asthma, prematurity, chronic illness, etc) were present in 21 percent of children hospitalized with influenza [",
"    <a class=\"abstract\" href=\"UTD.htm?23/49/24346/abstract/1\">",
"     1",
"    </a>",
"    ]",
"    <br/>",
"   </p>",
"   <p>",
"    The major cause of hospitalization in infants with influenza is an undifferentiated febrile illness, which may require an evaluation for serious bacterial illness because of the acute onset of fever and absence of localizing signs [",
"    <a class=\"abstract\" href=\"UTD.htm?23/49/24346/abstract/36,37\">",
"     36,37",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?27/26/28074?source=see_link\">",
"     \"Evaluation and management of fever in the neonate and young infant (less than three months of age)\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?22/14/22762?source=see_link\">",
"     \"Fever without a source in children 3 to 36 months of age\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H336495101\">",
"    <span class=\"h3\">",
"     Mortality",
"    </span>",
"    &nbsp;&mdash;&nbsp;Influenza-associated deaths in children (&lt;18 years) should be reported to the CDC through the state health department [",
"    <a class=\"abstract\" href=\"UTD.htm?23/49/24346/abstract/4,14\">",
"     4,14",
"    </a>",
"    ]. If the death was complicated by",
"    <em>",
"     Staphylococcus aureus",
"    </em>",
"    infection, the",
"    <em>",
"     S. aureus",
"    </em>",
"    isolate should be sent to the CDC [",
"    <a class=\"abstract\" href=\"UTD.htm?23/49/24346/abstract/38\">",
"     38",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Estimates of influenza mortality vary from season to season, depending upon the particular influenza virus types and subtypes in circulation [",
"    <a class=\"abstract\" href=\"UTD.htm?23/49/24346/abstract/39-42\">",
"     39-42",
"    </a>",
"    ]. Updated information is available from the",
"    <a class=\"external\" href=\"file://www.cdc.gov/flu/weekly/\">",
"     CDC",
"    </a>",
"    . During seasonal influenza epidemics, fatal infections are less common among children than among adults (average of 0.2 deaths per 100,000 persons &lt;19 years compared with 1.5 and 66 deaths among 100,000 persons ages 19 through 64 years and &ge;65 years, respectively, between 1976 and 2007) [",
"    <a class=\"abstract\" href=\"UTD.htm?23/49/24346/abstract/41\">",
"     41",
"    </a>",
"    ]. Mortality is increased approximately threefold during seasons when influenza A H3N2 strains account for at least 20 percent of isolates [",
"    <a class=\"abstract\" href=\"UTD.htm?23/49/24346/abstract/41\">",
"     41",
"    </a>",
"    ]. Pediatric mortality was increased during the 2009 H1N1 influenza pandemic [",
"    <a class=\"abstract\" href=\"UTD.htm?23/49/24346/abstract/4\">",
"     4",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Although the risk of death is increased among children with risk factors for severe or complicated influenza, most pediatric influenza deaths occur among children with no risk factors [",
"    <a class=\"abstract\" href=\"UTD.htm?23/49/24346/abstract/4,43,44\">",
"     4,43,44",
"    </a>",
"    ]. Mortality is increased among healthy children younger than five years and especially among those younger than six months. Bacterial coinfection, particularly with",
"    <em>",
"     S. aureus",
"    </em>",
"    or",
"    <em>",
"     Streptococcus pneumoniae",
"    </em>",
"    , increases the risk of death [",
"    <a class=\"abstract\" href=\"UTD.htm?23/49/24346/abstract/45\">",
"     45",
"    </a>",
"    ]. (See",
"    <a class=\"local\" href=\"#H14\">",
"     'Bacterial coinfection'",
"    </a>",
"    below.)",
"   </p>",
"   <p>",
"    <br/>",
"    These findings highlight the importance of fully immunizing children with high-risk conditions against influenza and of immunizing household contacts of infants zero to six months of age. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?27/18/27946?source=see_link&amp;anchor=H7#H7\">",
"     \"Seasonal influenza vaccination in children\", section on 'Indications'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H79747253\">",
"    <span class=\"h2\">",
"     H3N2 variant influenza",
"    </span>",
"    &nbsp;&mdash;&nbsp;Since July 2011, the United States Centers for Diseases Control and Prevention (CDC) has reported an increasing number of cases of infection caused by H3N2 influenza A viruses caused by reassortment of swine-origin H3N2 influenza A viruses and pandemic H1N1 influenza A viruses (H3N2 variant influenza) [",
"    <a class=\"abstract\" href=\"UTD.htm?23/49/24346/abstract/46-48\">",
"     46-48",
"    </a>",
"    ]. Most cases have occurred in children and in individuals with exposure to swine. Surveillance of swine herds suggests that the same strain is circulating concurrently in swine. Based on cases that have occurred in clusters and cases that have occurred following swine exposure, it is likely that limited human-to-human and swine-to-human transmission has occurred. Additional unexpected reassortment combinations may occur; updated information is available from the",
"    <a class=\"external\" href=\"file://www.cdc.gov/flu/about/season/upcoming.htm\">",
"     CDC",
"    </a>",
"    . The seasonal influenza vaccine is not expected to provide protection against these strains among children younger than 10 years, but may provide some cross-protection for older children and adults [",
"    <a class=\"abstract\" href=\"UTD.htm?23/49/24346/abstract/49-51\">",
"     49-51",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?14/58/15272?source=see_link&amp;anchor=H104949276#H104949276\">",
"     \"Epidemiology of influenza\", section on 'H3N2 variant influenza'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7\">",
"    <span class=\"h1\">",
"     CLINICAL FEATURES",
"    </span>",
"    &nbsp;&mdash;&nbsp;The clinical manifestations of influenza virus infection depend upon the age of the child and his or her previous experience with influenza virus. The classic features of uncomplicated influenza virus infection include the abrupt onset of fever, headache, myalgia, and malaise. These symptoms are accompanied by manifestations of respiratory-tract illness, such as cough, sore throat, and rhinitis [",
"    <a class=\"abstract\" href=\"UTD.htm?23/49/24346/abstract/1,52\">",
"     1,52",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    All of the classic features may not be present in children with influenza virus infection, which makes clinical diagnosis difficult. In part, this is because young children cannot vocalize such symptoms as myalgias and headache. Young children also have less experience with influenza viruses, and therefore less immunity. They tend to have higher fevers, febrile seizures, less prominent respiratory findings, and more gastrointestinal complaints (eg, nausea, vomiting, diarrhea, poor appetite) initially [",
"    <a class=\"abstract\" href=\"UTD.htm?23/49/24346/abstract/21,52-54\">",
"     21,52-54",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    In cases of uncomplicated influenza, few localizing physical findings are evident, and in some children, fever and malaise may be the only recognized manifestations [",
"    <a class=\"abstract\" href=\"UTD.htm?23/49/24346/abstract/11,37\">",
"     11,37",
"    </a>",
"    ]. The clinical features of influenza infection in an unselected population were described in a prospective cohort of children (&le;13 years) who underwent clinical and laboratory evaluation for episodes of fever or respiratory illness (regardless of severity) during two consecutive respiratory virus seasons (2231 child-seasons) [",
"    <a class=\"abstract\" href=\"UTD.htm?23/49/24346/abstract/52\">",
"     52",
"    </a>",
"    ]. Among 353 children with laboratory-confirmed influenza and complete data, clinical features were as follows (",
"    <a class=\"graphic graphic_table graphicRef50643 \" href=\"UTD.htm?26/60/27597\">",
"     table 2",
"    </a>",
"    ):",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Fever &ndash; 95 percent (50 percent had fever &gt;39&ordm;C)",
"     </li>",
"     <li>",
"      Cough &ndash; 77 percent",
"     </li>",
"     <li>",
"      Rhinitis &ndash; 78 percent",
"     </li>",
"     <li>",
"      Headache &ndash; 26 percent (among children 3 to 13 years of age)",
"     </li>",
"     <li>",
"      Myalgia &ndash; 7 percent (among children 3 to 13 years of age)",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    In older children and adults, influenza A (H3N2) is usually associated with more severe illness. In some studies, the clinical findings of influenza types and subtypes do not differ significantly in children &le;13 years of age [",
"    <a class=\"abstract\" href=\"UTD.htm?23/49/24346/abstract/40,52\">",
"     40,52",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Findings on examination may include tachypnea; conjunctival erythema; nasal injection, edema, and discharge; and cervical adenopathy [",
"    <a class=\"abstract\" href=\"UTD.htm?23/49/24346/abstract/55\">",
"     55",
"    </a>",
"    ]. Oropharyngeal abnormalities other than slight to moderate hyperemia are uncommon, even with complaints of sore throat.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8\">",
"    <span class=\"h1\">",
"     CLINICAL COURSE",
"    </span>",
"    &nbsp;&mdash;&nbsp;Influenza in otherwise healthy children generally is an acute, self-limited, and uncomplicated disease, although even among previously healthy children, more severe illness requiring hospitalization and, rarely, fatal illness, may occur [",
"    <a class=\"abstract\" href=\"UTD.htm?23/49/24346/abstract/1,2\">",
"     1,2",
"    </a>",
"    ]. (See",
"    <a class=\"local\" href=\"#H6\">",
"     'Disease burden'",
"    </a>",
"    above.) In certain \"high-risk\" groups of children (",
"    <a class=\"graphic graphic_table graphicRef72029 \" href=\"UTD.htm?32/50/33579\">",
"     table 1",
"    </a>",
"    ), influenza infection may be complicated and severe [",
"    <a class=\"abstract\" href=\"UTD.htm?23/49/24346/abstract/4,17,18\">",
"     4,17,18",
"    </a>",
"    ]. (See",
"    <a class=\"local\" href=\"#H5\">",
"     'Risk factors'",
"    </a>",
"    above and",
"    <a class=\"local\" href=\"#H9\">",
"     'Complications'",
"    </a>",
"    below.)",
"   </p>",
"   <p>",
"    Patients with uncomplicated influenza usually improve gradually over two to five days. However, the illness may last for more than a week, particularly among young children. The continued presence of cough for longer periods is common. Persistence of symptoms of weakness and easy fatigability, sometimes referred to as postinfluenza asthenia, may last for several weeks in older children.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9\">",
"    <span class=\"h1\">",
"     COMPLICATIONS",
"    </span>",
"    &nbsp;&mdash;&nbsp;The most common complication of influenza in children is otitis media, followed by lower respiratory tract involvement [",
"    <a class=\"abstract\" href=\"UTD.htm?23/49/24346/abstract/56\">",
"     56",
"    </a>",
"    ]. Other complications, including central nervous system (CNS) involvement, are less frequent [",
"    <a class=\"abstract\" href=\"UTD.htm?23/49/24346/abstract/57-59\">",
"     57-59",
"    </a>",
"    ]. It is estimated that complications of influenza result in a 10 to 30 percent increase in prescriptions for antimicrobials during the influenza season [",
"    <a class=\"abstract\" href=\"UTD.htm?23/49/24346/abstract/23\">",
"     23",
"    </a>",
"    ]. &nbsp;",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10\">",
"    <span class=\"h2\">",
"     Otitis media",
"    </span>",
"    &nbsp;&mdash;&nbsp;Otitis media complicates the course of influenza in 10 to 50 percent of children [",
"    <a class=\"abstract\" href=\"UTD.htm?23/49/24346/abstract/22,52,60\">",
"     22,52,60",
"    </a>",
"    ]. An estimated 3 to 5 percent of children have influenza-associated acute otitis media each year [",
"    <a class=\"abstract\" href=\"UTD.htm?23/49/24346/abstract/21,61\">",
"     21,61",
"    </a>",
"    ]. The typical time of onset for otitis media is three to four days after the onset of influenza symptoms. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?28/60/29642?source=see_link&amp;anchor=H15#H15\">",
"     \"Acute otitis media in children: Epidemiology, microbiology, clinical manifestations, and complications\", section on 'Pathogenesis'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H11\">",
"    <span class=\"h2\">",
"     Lower respiratory tract",
"    </span>",
"    &nbsp;&mdash;&nbsp;The lower respiratory tract manifestations of influenza in children younger than two to three years of age often are clinically indistinguishable from those due to respiratory syncytial virus (RSV) or parainfluenza viral infections. Like these viruses, influenza may cause interstitial pneumonia, laryngotracheitis (croup), bronchitis, and occasionally bronchiolitis [",
"    <a class=\"abstract\" href=\"UTD.htm?23/49/24346/abstract/1,62\">",
"     1,62",
"    </a>",
"    ]. Influenza virus laryngotracheitis or tracheobronchitis may be particularly severe or complicated by bacterial superinfection (bacterial tracheitis) [",
"    <a class=\"abstract\" href=\"UTD.htm?23/49/24346/abstract/62,63\">",
"     62,63",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?6/56/7050?source=see_link&amp;anchor=H15#H15\">",
"     \"Respiratory syncytial virus infection: Clinical features and diagnosis\", section on 'Clinical manifestations'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?35/60/36808?source=see_link&amp;anchor=H10#H10\">",
"     \"Parainfluenza viruses in children\", section on 'Clinical presentation'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?31/49/32536?source=see_link&amp;anchor=H8#H8\">",
"     \"Bacterial tracheitis in children: Clinical features and diagnosis\", section on 'Presentation'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The 2009 pandemic H1N1 influenza virus was associated with life-threatening lower respiratory tract illness requiring intensive care, mechanical ventilation, or extracorporeal membrane oxygen support [",
"    <a class=\"abstract\" href=\"UTD.htm?23/49/24346/abstract/29,30,32,33\">",
"     29,30,32,33",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?36/27/37305?source=see_link&amp;anchor=H12#H12\">",
"     \"Clinical manifestations and diagnosis of pandemic H1N1 influenza ('swine influenza')\", section on 'Complications'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Influenza also may cause exacerbations of chronic underlying conditions, especially asthma [",
"    <a class=\"abstract\" href=\"UTD.htm?23/49/24346/abstract/64,65\">",
"     64,65",
"    </a>",
"    ]. Asthmatic exacerbations are the most common of the respiratory tract complications among influenza-related medically attended illnesses.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9687278\">",
"    <span class=\"h3\">",
"     Pneumonia",
"    </span>",
"    &nbsp;&mdash;&nbsp;Pneumonia is a major complication of influenza, particularly in high-risk patients (",
"    <a class=\"graphic graphic_table graphicRef72029 \" href=\"UTD.htm?32/50/33579\">",
"     table 1",
"    </a>",
"    ). In children without underlying high-risk conditions, influenza pneumonia occurs most frequently in children younger than two years [",
"    <a class=\"abstract\" href=\"UTD.htm?23/49/24346/abstract/1,66,67\">",
"     1,66,67",
"    </a>",
"    ]. Influenza pneumonia is usually benign and of short duration. However, among children hospitalized with influenza, those with pneumonia have a more severe clinical course than those without pneumonia [",
"    <a class=\"abstract\" href=\"UTD.htm?23/49/24346/abstract/67\">",
"     67",
"    </a>",
"    ]. Coinfection with bacteria such as",
"    <em>",
"     S. aureus",
"    </em>",
"    and",
"    <em>",
"     S. pneumoniae",
"    </em>",
"    may be particularly severe and rapidly fatal. (See",
"    <a class=\"local\" href=\"#H15\">",
"     'S. aureus'",
"    </a>",
"    below.)",
"   </p>",
"   <p>",
"    The radiographic pattern of influenza pneumonia is variable. In a review of 134 cases of radiographically confirmed influenza pneumonia in children younger than four years, the infiltrates were interstitial in one-half of cases, alveolar in one-fourth, and interstitial and alveolar in one-fourth [",
"    <a class=\"abstract\" href=\"UTD.htm?23/49/24346/abstract/66\">",
"     66",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H12\">",
"    <span class=\"h2\">",
"     Neurologic",
"    </span>",
"    &nbsp;&mdash;&nbsp;Central nervous system complications of influenza include aseptic meningitis, acute cerebellar ataxia, transverse myelitis, Guillain-Barr&eacute; syndrome, acute necrotizing and postinfectious encephalitis (also known as acute disseminated encephalomyelitis), encephalopathy, febrile seizures, and acute mental status changes [",
"    <a class=\"abstract\" href=\"UTD.htm?23/49/24346/abstract/31,68-73\">",
"     31,68-73",
"    </a>",
"    ]. Reye syndrome is rare with the diminished use of",
"    <a class=\"drug drug_pediatric\" href=\"UTD.htm?19/10/19624?source=see_link\">",
"     aspirin",
"    </a>",
"    in children. (See appropriate topic reviews).",
"   </p>",
"   <p>",
"    Among a retrospective cohort of 842 children with laboratory-confirmed influenza, the incidence of neurologic complications was 4 per 100,000 person-years [",
"    <a class=\"abstract\" href=\"UTD.htm?23/49/24346/abstract/68\">",
"     68",
"    </a>",
"    ]. Neurologic complications were more frequent among children six months to four years of age and among those with underlying neurologic or neuromuscular disease. Among the 72 patients with neurologic complications, seizures occurred 77 percent, influenza-related encephalopathy in 11 percent, and postinfectious influenza encephalopathy in 3 percent. Data from the National Inpatient Register in Sweden indicate that the incidence of influenza-associated encephalitis is 0.21 per 1 million person-years and 1.5 per 1000 patients hospitalized with influenza [",
"    <a class=\"abstract\" href=\"UTD.htm?23/49/24346/abstract/74\">",
"     74",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The clinical manifestations of influenza-associated encephalitis in children were described in a cross-sectional survey in Japan [",
"    <a class=\"abstract\" href=\"UTD.htm?23/49/24346/abstract/75\">",
"     75",
"    </a>",
"    ]. Among 472 cases of influenza-associated encephalitis in children younger than 15 years, the peak incidence was at one to two years. The clinical manifestations varied according to age (0 to 5 years versus 6 to 15 years), with older patients having a greater incidence of influenza B infection, increased frequency of loss of consciousness or altered consciousness as the initial neurologic symptom, fewer seizures, and lower incidence of sequelae. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?21/16/21769?source=see_link&amp;anchor=H2#H2\">",
"     \"Acute viral encephalitis in children and adolescents: Clinical manifestations and diagnosis\", section on 'Clinical features'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H13\">",
"    <span class=\"h2\">",
"     Myositis",
"    </span>",
"    &nbsp;&mdash;&nbsp;Acute myositis is a rare and severe complication of influenza [",
"    <a class=\"abstract\" href=\"UTD.htm?23/49/24346/abstract/76,77\">",
"     76,77",
"    </a>",
"    ]. The hallmark of acute myositis is extreme tenderness of the affected muscles, most commonly in the calves. In severe cases, swelling and bogginess of the muscles may be noted. Serum creatine phosphokinase (CPK) concentrations are markedly elevated, and myoglobinuria with associated renal failure has been reported [",
"    <a class=\"abstract\" href=\"UTD.htm?23/49/24346/abstract/61,77,78\">",
"     61,77,78",
"    </a>",
"    ]. The pathogenesis of the myositis is not well understood, but influenza virus has been detected in affected muscles [",
"    <a class=\"abstract\" href=\"UTD.htm?23/49/24346/abstract/79\">",
"     79",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?9/41/9879?source=see_link&amp;anchor=H6#H6\">",
"     \"Viral myositis\", section on 'Clinical manifestations'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?35/56/36745?source=see_link&amp;anchor=H10#H10\">",
"     \"Muscle enzymes in the evaluation of neuromuscular diseases\", section on 'Infectious myopathies'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Mild, transient myositis with mild CPK elevation is more common. It is more frequently observed with influenza B than influenza A infections [",
"    <a class=\"abstract\" href=\"UTD.htm?23/49/24346/abstract/76,78,80,81\">",
"     76,78,80,81",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H14\">",
"    <span class=\"h2\">",
"     Bacterial coinfection",
"    </span>",
"    &nbsp;&mdash;&nbsp;Secondary bacterial coinfection (pneumonia or bacteremia), most commonly due to",
"    <em>",
"     S. aureus",
"    </em>",
"    or",
"    <em>",
"     S. pneumoniae",
"    </em>",
"    , may occur in children without high-risk conditions [",
"    <a class=\"abstract\" href=\"UTD.htm?23/49/24346/abstract/45,82-86\">",
"     45,82-86",
"    </a>",
"    ]. In population-based surveillance for seasonal influenza, bacterial coinfection occurred in 2 percent of children during 2003-2008 [",
"    <a class=\"abstract\" href=\"UTD.htm?23/49/24346/abstract/34\">",
"     34",
"    </a>",
"    ]. The risk of pneumococcal pneumonia associated with influenza virus may be reduced by immunization against",
"    <em>",
"     S. pneumoniae",
"    </em>",
"    [",
"    <a class=\"abstract\" href=\"UTD.htm?23/49/24346/abstract/87-89\">",
"     87-89",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?7/14/7402?source=see_link&amp;anchor=H10#H10\">",
"     \"Pneumococcal (Streptococcus pneumoniae) conjugate vaccines in children\", section on 'Pneumonia'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H15\">",
"    <span class=\"h3\">",
"     S. aureus",
"    </span>",
"    &nbsp;&mdash;&nbsp;Influenza infection complicated by",
"    <em>",
"     S. aureus",
"    </em>",
"    pneumonia may be particularly severe and rapidly fatal [",
"    <a class=\"abstract\" href=\"UTD.htm?23/49/24346/abstract/45,82,84,85,90,91\">",
"     45,82,84,85,90,91",
"    </a>",
"    ]. Most cases of severe coinfection with influenza and",
"    <em>",
"     S. aureus",
"    </em>",
"    occur in individuals with no previous medical problems [",
"    <a class=\"abstract\" href=\"UTD.htm?23/49/24346/abstract/82,92\">",
"     82,92",
"    </a>",
"    ]. Coinfection with influenza and methicillin-resistant",
"    <em>",
"     S. aureus",
"    </em>",
"    appears to be associated with a personal history of methicillin-resistant",
"    <em>",
"     S. aureus",
"    </em>",
"    (MRSA) skin infection or contact with a person with MRSA skin infection [",
"    <a class=\"abstract\" href=\"UTD.htm?23/49/24346/abstract/84\">",
"     84",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?29/6/29802?source=see_link&amp;anchor=H17#H17\">",
"     \"Treatment of invasive methicillin-resistant Staphylococcus aureus infection in children\", section on 'Pneumonia'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?29/21/30042?source=see_link&amp;anchor=H12#H12\">",
"     \"Epidemiology and clinical spectrum of methicillin-resistant Staphylococcus aureus infections in children\", section on 'Epidemiology and risk factors'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Fatal cases of coinfection with influenza and",
"    <em>",
"     S. aureus",
"    </em>",
"    should be reported to the CDC [",
"    <a class=\"abstract\" href=\"UTD.htm?23/49/24346/abstract/14\">",
"     14",
"    </a>",
"    ]. In such cases, the",
"    <em>",
"     S. aureus",
"    </em>",
"    isolate should be sent to the CDC [",
"    <a class=\"abstract\" href=\"UTD.htm?23/49/24346/abstract/38\">",
"     38",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H16\">",
"    <span class=\"h2\">",
"     Other complications",
"    </span>",
"    &nbsp;&mdash;&nbsp;Other complications of influenza infections include myocarditis, pericarditis, and toxic shock syndrome [",
"    <a class=\"abstract\" href=\"UTD.htm?23/49/24346/abstract/93-99\">",
"     93-99",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Myocarditis and pericarditis were reported in the 1918 pandemic of influenza but have been documented infrequently in more recent reports [",
"      <a class=\"abstract\" href=\"UTD.htm?23/49/24346/abstract/94,95\">",
"       94,95",
"      </a>",
"      ]. Electrocardiographic changes may be noted in patients with underlying cardiac disease who develop influenza. In adults, these changes more often are attributable to the underlying cardiac disease than influenza infection of the heart. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?33/53/34647?source=see_link&amp;anchor=H3#H3\">",
"       \"Clinical manifestations and diagnosis of myocarditis in children\", section on 'Clinical manifestations'",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Toxic shock syndrome, associated with",
"      <em>",
"       S. aureus",
"      </em>",
"      infection and acute influenza, has been described after both influenza A and B infections [",
"      <a class=\"abstract\" href=\"UTD.htm?23/49/24346/abstract/93,96-99\">",
"       93,96-99",
"      </a>",
"      ]. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?7/52/8010?source=see_link&amp;anchor=H11#H11\">",
"       \"Staphylococcal toxic shock syndrome\", section on 'Clinical presentation'",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H17\">",
"    <span class=\"h1\">",
"     DIAGNOSIS",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H18\">",
"    <span class=\"h2\">",
"     Clinical suspicion",
"    </span>",
"    &nbsp;&mdash;&nbsp;During influenza season (",
"    <a class=\"graphic graphic_figure graphicRef60877 \" href=\"UTD.htm?12/3/12349\">",
"     figure 2",
"    </a>",
"    ), influenza virus infection should be considered in [",
"    <a class=\"abstract\" href=\"UTD.htm?23/49/24346/abstract/17\">",
"     17",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Febrile infants",
"     </li>",
"     <li>",
"      Children with fever and acute onset of respiratory illness (even if these symptoms develop during hospitalization)",
"     </li>",
"     <li>",
"      Children with fever and exacerbation of underlying chronic lung disease",
"     </li>",
"     <li>",
"      Children with community-acquired febrile pneumonia",
"     </li>",
"     <li>",
"      Children with fever (&ge;100&ordm;F (37.8&ordm;C)) and severe illness (cough, sore throat, or both in the absence of another known cause of illness)",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Influenza virus infection also should be considered at any time of year in children with febrile respiratory illness who are epidemiologically linked to an outbreak of influenza [",
"    <a class=\"abstract\" href=\"UTD.htm?23/49/24346/abstract/17\">",
"     17",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Clinical diagnosis of influenza in children is difficult, particularly infants and young children [",
"    <a class=\"abstract\" href=\"UTD.htm?23/49/24346/abstract/1,100\">",
"     1,100",
"    </a>",
"    ]. Other viruses, particularly RSV and parainfluenza viruses, may cause similar syndromes in children concurrently with outbreaks of influenza [",
"    <a class=\"abstract\" href=\"UTD.htm?23/49/24346/abstract/52,101,102\">",
"     52,101,102",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?6/56/7050?source=see_link&amp;anchor=H15#H15\">",
"     \"Respiratory syncytial virus infection: Clinical features and diagnosis\", section on 'Clinical manifestations'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?35/60/36808?source=see_link&amp;anchor=H10#H10\">",
"     \"Parainfluenza viruses in children\", section on 'Clinical presentation'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Confirmation of the diagnosis of influenza requires laboratory testing; laboratory testing should be performed if the results will influence clinical management (",
"    <a class=\"graphic graphic_algorithm graphicRef74504 \" href=\"UTD.htm?28/25/29086\">",
"     algorithm 1",
"    </a>",
"    ). (See",
"    <a class=\"local\" href=\"#H19\">",
"     'Laboratory diagnosis'",
"    </a>",
"    below.)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H19\">",
"    <span class=\"h2\">",
"     Laboratory diagnosis",
"    </span>",
"    &nbsp;&mdash;&nbsp;Confirmation of the diagnosis of influenza in children requires viral isolation or detection of viral proteins or viral RNA in respiratory-tract secretions or other samples (eg, cerebrospinal fluid, muscle or tissue biopsy, etc).",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H20\">",
"    <span class=\"h3\">",
"     Indications",
"    </span>",
"    &nbsp;&mdash;&nbsp;Laboratory testing for influenza virus should be performed if the results will influence decisions regarding treatment, prophylaxis of contacts, performance of other diagnostic tests, or infection control (",
"    <a class=\"graphic graphic_algorithm graphicRef74504 \" href=\"UTD.htm?28/25/29086\">",
"     algorithm 1",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"UTD.htm?23/49/24346/abstract/17\">",
"     17",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?26/7/26746?source=see_link&amp;anchor=H20#H20\">",
"     \"Antiviral drugs for the prevention and treatment of seasonal influenza in children\", section on 'Antiviral therapy'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    During influenza season (",
"    <a class=\"graphic graphic_figure graphicRef60877 \" href=\"UTD.htm?12/3/12349\">",
"     figure 2",
"    </a>",
"    ), laboratory testing may be indicated for:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Children with clinical suspicion of influenza who are at high risk for complications (",
"      <a class=\"graphic graphic_table graphicRef72029 \" href=\"UTD.htm?32/50/33579\">",
"       table 1",
"      </a>",
"      ), including children younger than two years of age",
"     </li>",
"     <li>",
"      Hospitalized children with acute febrile respiratory illness (even if symptoms develop during hospitalization)",
"     </li>",
"     <li>",
"      Hospitalized children with severe respiratory illness, including community-acquired pneumonia",
"     </li>",
"     <li>",
"      Hospitalized children with possible neurologic complications of influenza (eg, meningitis, encephalopathy)",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Decisions regarding testing must take into account the duration of symptoms. If possible, specimens for testing should be obtained within 72 hours of illness onset [",
"    <a class=\"abstract\" href=\"UTD.htm?23/49/24346/abstract/14,103\">",
"     14,103",
"    </a>",
"    ]. In immunocompetent older children and adults, there is little viral shedding after five days of illness, and negative tests do not reliably exclude influenza. In infants, young children, and immunocompromised hosts, the duration of viral shedding may exceed one week. (See",
"    <a class=\"local\" href=\"#H4\">",
"     'Transmission'",
"    </a>",
"    above.)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H21\">",
"    <span class=\"h3\">",
"     Specimen collection",
"    </span>",
"    &nbsp;&mdash;&nbsp;Confirmation of the diagnosis of influenza requires viral isolation or detection of viral proteins or viral RNA in respiratory-tract secretions (throat",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    nasal swabs, nasal washes, lower respiratory tract secretions, or in other specimens). Nasopharyngeal specimens or nasal specimens combined with throat specimens are usually more effective than throat swab specimens alone for viral isolation or rapid detection [",
"    <a class=\"abstract\" href=\"UTD.htm?23/49/24346/abstract/17,104\">",
"     17,104",
"    </a>",
"    ]. Specimens for influenza testing should be transported on ice and then refrigerated.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H22\">",
"    <span class=\"h3\">",
"     Approach to testing",
"    </span>",
"    &nbsp;&mdash;&nbsp;Numerous tests are available for the detection of influenza virus. Testing methods are summarized in the table (",
"    <a class=\"graphic graphic_table graphicRef69655 \" href=\"UTD.htm?31/2/31789\">",
"     table 3",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"UTD.htm?23/49/24346/abstract/17\">",
"     17",
"    </a>",
"    ]. The likelihood of a positive test is increased when specimens are obtained within 24 to 72 hours of symptoms onset, when the amount of influenza virus in the nasopharynx is at its peak [",
"    <a class=\"abstract\" href=\"UTD.htm?23/49/24346/abstract/105\">",
"     105",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The approach to testing depends upon the availability and accuracy of the test and how soon the results are necessary.",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Polymerase chain reaction &ndash; RT-PCR is the preferred diagnostic test for influenza virus. RT-PCR tests are the most sensitive and specific (",
"      <a class=\"graphic graphic_table graphicRef69655 \" href=\"UTD.htm?31/2/31789\">",
"       table 3",
"      </a>",
"      ) and can differentiate between influenza types (A or B) and subtypes [",
"      <a class=\"abstract\" href=\"UTD.htm?23/49/24346/abstract/17,61,106,107\">",
"       17,61,106,107",
"      </a>",
"      ]. However, they may not be readily available in all settings and require a minimum of two hours for results. The CDC has developed a modular test kit that can identify influenza types and subtypes, including avian influenza A (H5N1) on upper and lower respiratory tract specimens [",
"      <a class=\"abstract\" href=\"UTD.htm?23/49/24346/abstract/108\">",
"       108",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Immunofluorescence &ndash; Direct and indirect fluorescent antibody assays have moderate sensitivity and high specificity and generally perform better than the rapid-detection tests (",
"      <a class=\"graphic graphic_table graphicRef69655 \" href=\"UTD.htm?31/2/31789\">",
"       table 3",
"      </a>",
"      ) [",
"      <a class=\"abstract\" href=\"UTD.htm?23/49/24346/abstract/17,106,109\">",
"       17,106,109",
"      </a>",
"      ]. They distinguish between influenza types (A or B) and between influenza and other respiratory viruses. However, the performance of fluorescent antibody tests depends upon laboratory expertise and the quality of the respiratory specimen. During periods of peak influenza activity, confirmation of negative fluorescent antibody tests with PCR or viral culture may be warranted [",
"      <a class=\"abstract\" href=\"UTD.htm?23/49/24346/abstract/17\">",
"       17",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Rapid diagnostic tests &ndash; Rapid influenza diagnostic tests provide results within 10 to 30 minutes [",
"      <a class=\"abstract\" href=\"UTD.htm?23/49/24346/abstract/17\">",
"       17",
"      </a>",
"      ]. Rapid diagnostic tests include antigen detection (enzyme immunoassay, EIA) and neuraminidase detection assays. Rapid tests can be used to confirm influenza, but not to exclude it [",
"      <a class=\"abstract\" href=\"UTD.htm?23/49/24346/abstract/105,110\">",
"       105,110",
"      </a>",
"      ].",
"      <br/>",
"      <br/>",
"      Rapid influenza diagnostic tests are less sensitive and specific than RT-PCR and fluorescent antibody tests [",
"      <a class=\"abstract\" href=\"UTD.htm?23/49/24346/abstract/106,111,112\">",
"       106,111,112",
"      </a>",
"      ]. In a meta-analysis of 60 studies that evaluated rapid influenza antigen tests in children, the pooled sensitivity was 66.6 percent (95% CI 61.6-71.7 percent) and the pooled specificity was 98.2 percent (95% CI 97.5-99 percent); the pooled sensitivity was higher in children than in adults (53.9 percent, 95% CI 47.9-59.8 percent) [",
"      <a class=\"abstract\" href=\"UTD.htm?23/49/24346/abstract/110\">",
"       110",
"      </a>",
"      ]. In individual studies, the reported sensitivity (44 to 97 percent for seasonal influenza; 18 to 70 percent for 2009 H1N1 influenza A) and specificity (76 to 100 percent for seasonal influenza; 86 to 94 percent for 2009 H1N1 influenza A) differ by test and specimen [",
"      <a class=\"abstract\" href=\"UTD.htm?23/49/24346/abstract/14,105,106,111,113,114\">",
"       14,105,106,111,113,114",
"      </a>",
"      ].",
"      <br/>",
"      <br/>",
"      The performance of rapid tests varies depending upon patient age, duration of illness, sample type, the prevalence of influenza in the community, virus type, and concentration of influenza virus in the sample [",
"      <a class=\"abstract\" href=\"UTD.htm?23/49/24346/abstract/105,110-112\">",
"       105,110-112",
"      </a>",
"      ]. In a meta-analysis of studies of rapid diagnostic tests in children and adults, the pooled sensitivity was higher for influenza A than influenza B (64.6 versus 52.2 percent) [",
"      <a class=\"abstract\" href=\"UTD.htm?23/49/24346/abstract/110\">",
"       110",
"      </a>",
"      ]. A summary of commercially available rapid influenza diagnostic tests is provided by the",
"      <a class=\"external\" href=\"file://www.cdc.gov/flu/professionals/diagnosis/rapidclin.htm\">",
"       CDC",
"      </a>",
"      .",
"      <br/>",
"      <br/>",
"      Given the variability in sensitivity, clinicians may find it helpful to know the sensitivity and specificity of their clinical laboratory&rsquo;s rapid diagnostic test(s) against the currently circulating strains of influenza.&nbsp;This information may be obtained from local, state, and public health laboratories, or the",
"      <a class=\"external\" href=\"file://www.cdc.gov/flu/professionals/diagnosis/index.htm\">",
"       CDC",
"      </a>",
"      .",
"      <br/>",
"      <br/>",
"      When influenza activity in the community is low, false positive results are most likely to occur and the predictive value is poor. Therefore, rapid diagnostic tests are recommended for use only during periods when influenza is prevalent in the community [",
"      <a class=\"abstract\" href=\"UTD.htm?23/49/24346/abstract/115,116\">",
"       115,116",
"      </a>",
"      ]. However, because the chance that a rapid test may be falsely negative increases during periods of peak influenza activity, confirmation of negative tests with viral culture or RT-PCR may be warranted when the prevalence of influenza in the community is high (",
"      <a class=\"graphic graphic_algorithm graphicRef59181 \" href=\"UTD.htm?26/5/26704\">",
"       algorithm 2",
"      </a>",
"      ) [",
"      <a class=\"abstract\" href=\"UTD.htm?23/49/24346/abstract/17,103,117\">",
"       17,103,117",
"      </a>",
"      ].",
"      <br/>",
"      <br/>",
"      The availability of rapid diagnostic test results may alter decision-making in children with signs and symptoms of influenza and febrile infants without a focus of infection [",
"      <a class=\"abstract\" href=\"UTD.htm?23/49/24346/abstract/118-123\">",
"       118-123",
"      </a>",
"      ]. In such cases, a positive rapid influenza test is associated with decreased laboratory tests, radiographs, prescriptions for antibiotics, and time to discharge from the emergency department, as well as increased prescriptions for antiviral therapy. The approach to febrile young infants (zero to three months) with a positive rapid diagnostic test for influenza is discussed separately. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?27/26/28074?source=see_link&amp;anchor=H29#H29\">",
"       \"Evaluation and management of fever in the neonate and young infant (less than three months of age)\", section on 'Influenza'",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Viral culture &ndash; Viral culture usually is not helpful in clinical decision-making because results are not available for 48 to 72 hours (",
"      <a class=\"graphic graphic_table graphicRef69655 \" href=\"UTD.htm?31/2/31789\">",
"       table 3",
"      </a>",
"      ) [",
"      <a class=\"abstract\" href=\"UTD.htm?23/49/24346/abstract/17\">",
"       17",
"      </a>",
"      ]. However, viral culture is helpful for influenza surveillance and in confirming screening test results. Viral culture is preferred to rapid diagnostic testing during periods of low influenza activity, particularly for individuals who are epidemiologically linked to an influenza outbreak.",
"     </li>",
"     <li>",
"      Serologic testing &ndash; Serologic testing is not helpful in clinical decision-making because diagnosis requires paired acute and convalescent sera (",
"      <a class=\"graphic graphic_table graphicRef69655 \" href=\"UTD.htm?31/2/31789\">",
"       table 3",
"      </a>",
"      ) [",
"      <a class=\"abstract\" href=\"UTD.htm?23/49/24346/abstract/17\">",
"       17",
"      </a>",
"      ]. However, serologic testing, such as hemagglutination-inhibition, enzyme-linked immunosorbent assay (ELISA), and complement fixation assays, can be used to establish the diagnosis of influenza retrospectively. A fourfold or greater rise in antibody titers demonstrated between serum specimens obtained during acute illness and convalescent specimens obtained 10 to 14 days later is considered diagnostic [",
"      <a class=\"abstract\" href=\"UTD.htm?23/49/24346/abstract/14\">",
"       14",
"      </a>",
"      ]. Serologic testing is useful primarily for research purposes.",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H79747012\">",
"    <span class=\"h4\">",
"     H3N2 variant viruses",
"    </span>",
"    &nbsp;&mdash;&nbsp;H3N2 variant influenza (H3N2v) virus infection should be suspected in individuals with a febrile respiratory illness who have been exposed to swine and in individuals with a febrile respiratory illness who have contacts with close exposure to swine [",
"    <a class=\"abstract\" href=\"UTD.htm?23/49/24346/abstract/46,48\">",
"     46,48",
"    </a>",
"    ]. Updated information about areas where H3N2v has been reported is available from the",
"    <a class=\"external\" href=\"file://www.cdc.gov/flu/swineflu/index.htm\">",
"     CDC Web site",
"    </a>",
"    .",
"   </p>",
"   <p>",
"    Genome sequencing at the CDC can confirm isolates as H3N2v influenza viruses [",
"    <a class=\"abstract\" href=\"UTD.htm?23/49/24346/abstract/46,124\">",
"     46,124",
"    </a>",
"    ]. Clinicians who suspect H3N2v influenza infection should obtain a nasopharyngeal swab, place it in viral transport media, and contact their state or local health department to have the sample sent for testing using real-time reverse-transcription polymerase chain reaction [",
"    <a class=\"abstract\" href=\"UTD.htm?23/49/24346/abstract/124\">",
"     124",
"    </a>",
"    ]. The ability of rapid antigen tests to detect H3N2v influenza appears to vary substantially among the available tests. Thus, a negative rapid antigen test should not be considered conclusive evidence of lack of H3N2v influenza infection. Additional information about H3N2v is available from the",
"    <a class=\"external\" href=\"file://www.cdc.gov/flu/swineflu/index.htm\">",
"     CDC",
"    </a>",
"    .",
"   </p>",
"   <p>",
"    (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?14/58/15272?source=see_link&amp;anchor=H104949276#H104949276\">",
"     \"Epidemiology of influenza\", section on 'H3N2 variant influenza'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H23\">",
"    <span class=\"h2\">",
"     Additional evaluation",
"    </span>",
"    &nbsp;&mdash;&nbsp;Assessment for influenza-bacterial coinfection should be undertaken among children with more severe community-acquired pneumonia and respiratory illnesses and among children with a history of having had an influenza-like illness within the previous one to two weeks and abrupt recrudescence of fever [",
"    <a class=\"abstract\" href=\"UTD.htm?23/49/24346/abstract/17,38\">",
"     17,38",
"    </a>",
"    ]. (See",
"    <a class=\"local\" href=\"#H14\">",
"     'Bacterial coinfection'",
"    </a>",
"    above.)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"PATIENT_INFORMATION\">",
"    <span class=\"h1\">",
"     INFORMATION FOR PATIENTS",
"    </span>",
"    &nbsp;&mdash;&nbsp;UpToDate offers two types of patient education materials, &ldquo;The Basics&rdquo; and &ldquo;Beyond the Basics.&rdquo; The Basics patient education pieces are written in plain language, at the 5",
"    <sup>",
"     th",
"    </sup>",
"    to 6",
"    <sup>",
"     th",
"    </sup>",
"    grade reading level, and they answer the four or five key questions a patient might have about a given condition. These articles are best for patients who want a general overview and who prefer short, easy-to-read materials. Beyond the Basics patient education pieces are longer, more sophisticated, and more detailed. These articles are written at the 10",
"    <sup>",
"     th",
"    </sup>",
"    to 12",
"    <sup>",
"     th",
"    </sup>",
"    grade reading level and are best for patients who want in-depth information and are comfortable with some medical jargon.",
"   </p>",
"   <p>",
"    Here are the patient education articles that are relevant to this topic. We encourage you to print or e-mail these topics to your patients. (You can also locate patient education articles on a variety of subjects by searching on &ldquo;patient info&rdquo; and the keyword(s) of interest.)",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Beyond the Basics topics (see",
"      <a class=\"medical medical_patient\" href=\"UTD.htm?38/12/39105?source=see_link\">",
"       \"Patient information: Influenza prevention (Beyond the Basics)\"",
"      </a>",
"      and",
"      <a class=\"medical medical_patient\" href=\"UTD.htm?34/12/35013?source=see_link\">",
"       \"Patient information: Influenza symptoms and treatment (Beyond the Basics)\"",
"      </a>",
"      )",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H25\">",
"    <span class=\"h1\">",
"     SUMMARY AND RECOMMENDATIONS",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Influenza occurs in distinct outbreaks of varying extent every year. (See",
"      <a class=\"local\" href=\"#H2\">",
"       'Epidemiology'",
"      </a>",
"      above and",
"      <a class=\"medical medical_review\" href=\"UTD.htm?14/58/15272?source=see_link\">",
"       \"Epidemiology of influenza\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Young children and children with certain underlying medical conditions are at increased risk for hospitalization or severe or complicated influenza infection (",
"      <a class=\"graphic graphic_table graphicRef72029 \" href=\"UTD.htm?32/50/33579\">",
"       table 1",
"      </a>",
"      ). (See",
"      <a class=\"local\" href=\"#H5\">",
"       'Risk factors'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      The classic features of uncomplicated influenza virus infection include abrupt onset of fever, headache, myalgia, and malaise, accompanied by manifestations of respiratory-tract illness, such as cough, sore throat, and rhinitis. However, all of these features may not be present in children (",
"      <a class=\"graphic graphic_table graphicRef50643 \" href=\"UTD.htm?26/60/27597\">",
"       table 2",
"      </a>",
"      ). (See",
"      <a class=\"local\" href=\"#H7\">",
"       'Clinical features'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Influenza symptoms may last for more than a week, particularly among young children. (See",
"      <a class=\"local\" href=\"#H8\">",
"       'Clinical course'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Otitis media, asthma exacerbations, and pneumonia are the most common complications of influenza infection among children. (See",
"      <a class=\"local\" href=\"#H9\">",
"       'Complications'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Secondary bacterial coinfection (pneumonia or bacteremia), most commonly due to",
"      <em>",
"       Staphylococcus aureus",
"      </em>",
"      or",
"      <em>",
"       Streptococcus pneumoniae",
"      </em>",
"      , may occur in children with or without high-risk conditions. Complicating",
"      <em>",
"       S. aureus",
"      </em>",
"      pneumonia may be particularly severe and rapidly fatal. (See",
"      <a class=\"local\" href=\"#H14\">",
"       'Bacterial coinfection'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      During influenza season (",
"      <a class=\"graphic graphic_figure graphicRef60877 \" href=\"UTD.htm?12/3/12349\">",
"       figure 2",
"      </a>",
"      ), influenza virus infection should be considered in (see",
"      <a class=\"local\" href=\"#H18\">",
"       'Clinical suspicion'",
"      </a>",
"      above):",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"hyphen-block\">",
"     <li>",
"      Febrile infants",
"     </li>",
"     <li>",
"      Children with fever and acute onset of respiratory illness (even if these symptoms develop during hospitalization)",
"     </li>",
"     <li>",
"      Children with fever and exacerbation of underlying chronic lung disease",
"     </li>",
"     <li>",
"      Children with community-acquired pneumonia",
"     </li>",
"     <li>",
"      Children with fever (&ge;100&ordm;F (37.8&ordm;C)) and severe illness (cough, sore throat, or both in the absence of another known cause of illness)",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Confirmation of the diagnosis of influenza virus infection requires viral isolation or detection of viral proteins or viral RNA in respiratory tract secretions. Laboratory testing for influenza virus should be performed if the results will influence decisions regarding treatment, prophylaxis of contacts, performance of other diagnostic tests, or infection control (",
"      <a class=\"graphic graphic_algorithm graphicRef74504 \" href=\"UTD.htm?28/25/29086\">",
"       algorithm 1",
"      </a>",
"      ). (See",
"      <a class=\"local\" href=\"#H19\">",
"       'Laboratory diagnosis'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      The approach to testing for influenza depends upon the availability of the test and how soon the results are necessary (",
"      <a class=\"graphic graphic_table graphicRef69655 \" href=\"UTD.htm?31/2/31789\">",
"       table 3",
"      </a>",
"      ). Reverse transcriptase polymerase chain reaction tests (RT-PCR) are preferred. Fluorescent antibody tests and rapid influenza tests may be used if RT-PCR is not available. During periods of increased influenza activity, confirmation of negative fluorescent antibody and rapid influenza tests with viral culture or RT-PCR may be warranted (",
"      <a class=\"graphic graphic_algorithm graphicRef59181 \" href=\"UTD.htm?26/5/26704\">",
"       algorithm 2",
"      </a>",
"      ). (See",
"      <a class=\"local\" href=\"#H22\">",
"       'Approach to testing'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H24965605\">",
"    <span class=\"h1\">",
"     ACKNOWLEDGMENT",
"    </span>",
"    &nbsp;&mdash;&nbsp;We are saddened by the death of Caroline Breese Hall, MD, who passed away in December 2012. We wish to acknowledge Dr. Hall&rsquo;s many contributions to UpToDate, in particular her work as an author of this topic.",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/49/24346/abstract/1\">",
"      Poehling KA, Edwards KM, Weinberg GA, et al. The underrecognized burden of influenza in young children. N Engl J Med 2006; 355:31.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/49/24346/abstract/2\">",
"      Kumar S, Havens PL, Chusid MJ, et al. Clinical and epidemiologic characteristics of children hospitalized with 2009 pandemic H1N1 influenza A infection. Pediatr Infect Dis J 2010; 29:591.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/49/24346/abstract/3\">",
"      Glezen WP. Clinical practice. Prevention and treatment of seasonal influenza. N Engl J Med 2008; 359:2579.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/49/24346/abstract/4\">",
"      Fiore AE, Uyeki TM, Broder K, et al. Prevention and control of influenza with vaccines: recommendations of the Advisory Committee on Immunization Practices (ACIP), 2010. MMWR Recomm Rep 2010; 59:1.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/49/24346/abstract/5\">",
"      Bischoff WE, Reid T, Russell GB, Peters TR. Transocular entry of seasonal influenza-attenuated virus aerosols and the efficacy of n95 respirators, surgical masks, and eye protection in humans. J Infect Dis 2011; 204:193.",
"     </a>",
"    </li>",
"    <li>",
"     IOM (Institute of Medicine). Preventing Transmission of Pandemic Influenza and Other Viral Respiratory Diseases: Personal Protective Equipment for Healthcare Personnel Update 2010, National Academies Press, Washington, DC 2011.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/49/24346/abstract/7\">",
"      Cowling BJ, Chan KH, Fang VJ, et al. Comparative epidemiology of pandemic and seasonal influenza A in households. N Engl J Med 2010; 362:2175.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/49/24346/abstract/8\">",
"      De Serres G, Rouleau I, Hamelin ME, et al. Contagious period for pandemic (H1N1) 2009. Emerg Infect Dis 2010; 16:783.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/49/24346/abstract/9\">",
"      Lau LL, Cowling BJ, Fang VJ, et al. Viral shedding and clinical illness in naturally acquired influenza virus infections. J Infect Dis 2010; 201:1509.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/49/24346/abstract/10\">",
"      Suess T, Buchholz U, Dupke S, et al. Shedding and transmission of novel influenza virus A/H1N1 infection in households--Germany, 2009. Am J Epidemiol 2010; 171:1157.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/49/24346/abstract/11\">",
"      Hall CB, Douglas RG Jr. Nosocomial influenza infection as a cause of intercurrent fevers in infants. Pediatrics 1975; 55:673.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/49/24346/abstract/12\">",
"      Klimov AI, Rocha E, Hayden FG, et al. Prolonged shedding of amantadine-resistant influenzae A viruses by immunodeficient patients: detection by polymerase chain reaction-restriction analysis. J Infect Dis 1995; 172:1352.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/49/24346/abstract/13\">",
"      Frank AL, Taber LH, Wells CR, et al. Patterns of shedding of myxoviruses and paramyxoviruses in children. J Infect Dis 1981; 144:433.",
"     </a>",
"    </li>",
"    <li>",
"     American Academy of Pediatrics. Influenza. In: Red Book: 2012 Report of the Committee on Infectious Diseases, 29th, Pickering LK.  (Ed), American Academy of Pediatrics, Elk Grove Village, IL 2012. p.439.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/49/24346/abstract/15\">",
"      Writing Committee of the WHO Consultation on Clinical Aspects of Pandemic (H1N1) 2009 Influenza, Bautista E, Chotpitayasunondh T, et al. Clinical aspects of pandemic 2009 influenza A (H1N1) virus infection. N Engl J Med 2010; 362:1708.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/49/24346/abstract/16\">",
"      Cowling BJ, Fang VJ, Riley S, et al. Estimation of the serial interval of influenza. Epidemiology 2009; 20:344.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/49/24346/abstract/17\">",
"      Harper SA, Bradley JS, Englund JA, et al. Seasonal influenza in adults and children--diagnosis, treatment, chemoprophylaxis, and institutional outbreak management: clinical practice guidelines of the Infectious Diseases Society of America. Clin Infect Dis 2009; 48:1003.",
"     </a>",
"    </li>",
"    <li>",
"     Centers for Disease Control and Prevention. 2011-2012 Influenza antiviral medications: Summary for clinicians. file://www.cdc.gov/flu/professionals/antivirals/summary-clinicians.htm (Accessed on September 05, 2011).",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/49/24346/abstract/19\">",
"      Blanton L, Peacock G, Cox C, et al. Neurologic disorders among pediatric deaths associated with the 2009 pandemic influenza. Pediatrics 2012; 130:390.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/49/24346/abstract/20\">",
"      Brownstein JS, Kleinman KP, Mandl KD. Identifying pediatric age groups for influenza vaccination using a real-time regional surveillance system. Am J Epidemiol 2005; 162:686.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/49/24346/abstract/21\">",
"      Neuzil KM, Zhu Y, Griffin MR, et al. Burden of interpandemic influenza in children younger than 5 years: a 25-year prospective study. J Infect Dis 2002; 185:147.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/49/24346/abstract/22\">",
"      Heikkinen T, Silvennoinen H, Peltola V, et al. Burden of influenza in children in the community. J Infect Dis 2004; 190:1369.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/49/24346/abstract/23\">",
"      Neuzil KM, Mellen BG, Wright PF, et al. The effect of influenza on hospitalizations, outpatient visits, and courses of antibiotics in children. N Engl J Med 2000; 342:225.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/49/24346/abstract/24\">",
"      Bourgeois FT, Valim C, Wei JC, et al. Influenza and other respiratory virus-related emergency department visits among young children. Pediatrics 2006; 118:e1.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/49/24346/abstract/25\">",
"      O'Brien MA, Uyeki TM, Shay DK, et al. Incidence of outpatient visits and hospitalizations related to influenza in infants and young children. Pediatrics 2004; 113:585.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/49/24346/abstract/26\">",
"      Nair H, Brooks WA, Katz M, et al. Global burden of respiratory infections due to seasonal influenza in young children: a systematic review and meta-analysis. Lancet 2011; 378:1917.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/49/24346/abstract/27\">",
"      Poehling KA, Edwards KM, Griffin MR, et al. The burden of influenza in young children, 2004-2009. Pediatrics 2013; 131:207.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/49/24346/abstract/28\">",
"      Committee on Infectious Diseases, American Academy of Pediatrics. Recommendations for prevention and control of influenza in children, 2012-2013. Pediatrics 2012; 130:780.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/49/24346/abstract/29\">",
"      Louie JK, Gavali S, Acosta M, et al. Children hospitalized with 2009 novel influenza A(H1N1) in California. Arch Pediatr Adolesc Med 2010; 164:1023.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/49/24346/abstract/30\">",
"      Yung M, Slater A, Festa M, et al. Pandemic H1N1 in children requiring intensive care in Australia and New Zealand during winter 2009. Pediatrics 2011; 127:e156.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/49/24346/abstract/31\">",
"      Ekstrand JJ, Herbener A, Rawlings J, et al. Heightened neurologic complications in children with pandemic H1N1 influenza. Ann Neurol 2010; 68:762.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/49/24346/abstract/32\">",
"      Noah MA, Peek GJ, Finney SJ, et al. Referral to an extracorporeal membrane oxygenation center and mortality among patients with severe 2009 influenza A(H1N1). JAMA 2011; 306:1659.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/49/24346/abstract/33\">",
"      Bagdure D, Curtis DJ, Dobyns E, et al. Hospitalized children with 2009 pandemic influenza A (H1N1): comparison to seasonal influenza and risk factors for admission to the ICU. PLoS One 2010; 5:e15173.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/49/24346/abstract/34\">",
"      Dawood FS, Fiore A, Kamimoto L, et al. Burden of seasonal influenza hospitalization in children, United States, 2003 to 2008. J Pediatr 2010; 157:808.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/49/24346/abstract/35\">",
"      Zhou H, Thompson WW, Viboud CG, et al. Hospitalizations associated with influenza and respiratory syncytial virus in the United States, 1993-2008. Clin Infect Dis 2012; 54:1427.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/49/24346/abstract/36\">",
"      Bender JM, Ampofo K, Gesteland P, et al. Influenza virus infection in infants less than three months of age. Pediatr Infect Dis J 2010; 29:6.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/49/24346/abstract/37\">",
"      Dagan R, Hall CB. Influenza A virus infection imitating bacterial sepsis in early infancy. Pediatr Infect Dis 1984; 3:218.",
"     </a>",
"    </li>",
"    <li>",
"     CDC Health Advisory. Influenza-associated pediatric mortality and Staphylococcus aureus co-infection file://emergency.cdc.gov/HAN/han00268.asp (Accessed on September 06, 2011).",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/49/24346/abstract/39\">",
"      Fleming DM, Pannell RS, Cross KW. Mortality in children from influenza and respiratory syncytial virus. J Epidemiol Community Health 2005; 59:586.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/49/24346/abstract/40\">",
"      Monto AS. Epidemiology of influenza. Vaccine 2008; 26 Suppl 4:D45.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/49/24346/abstract/41\">",
"      Centers for Disease Control and Prevention (CDC). Estimates of deaths associated with seasonal influenza --- United States, 1976-2007. MMWR Morb Mortal Wkly Rep 2010; 59:1057.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/49/24346/abstract/42\">",
"      Centers for Disease Control and Prevention (CDC). Influenza-associated pediatric deaths--United States, September 2010-August 2011. MMWR Morb Mortal Wkly Rep 2011; 60:1233.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/49/24346/abstract/43\">",
"      Bhat N, Wright JG, Broder KR, et al. Influenza-associated deaths among children in the United States, 2003-2004. N Engl J Med 2005; 353:2559.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/49/24346/abstract/44\">",
"      Louie JK, Schechter R, Honarmand S, et al. Severe pediatric influenza in California, 2003-2005: implications for immunization recommendations. Pediatrics 2006; 117:e610.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/49/24346/abstract/45\">",
"      Finelli L, Fiore A, Dhara R, et al. Influenza-associated pediatric mortality in the United States: increase of Staphylococcus aureus coinfection. Pediatrics 2008; 122:805.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/49/24346/abstract/46\">",
"      Centers for Disease Control and Prevention (CDC). Update: Influenza A (H3N2)v transmission and guidelines - five states, 2011. MMWR Morb Mortal Wkly Rep 2012; 60:1741.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/49/24346/abstract/47\">",
"      Centers for Disease Control and Prevention (CDC). Notes from the field: Outbreak of influenza A (H3N2) virus among persons and swine at a county fair--Indiana, July 2012. MMWR Morb Mortal Wkly Rep 2012; 61:561.",
"     </a>",
"    </li>",
"    <li>",
"     Centers for Disease Control and Prevention. CDC reports cases 18-29 of H3N2v virus infection; continues to recommend interim precautions when interacting with pigs. file://www.cdc.gov/flu/spotlights/h3n2v_us_cases.htm (Accessed on August 03, 2012).",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/49/24346/abstract/49\">",
"      Centers for Disease Control and Prevention (CDC). Antibodies cross-reactive to influenza A (H3N2) variant virus and impact of 2010-11 seasonal influenza vaccine on cross-reactive antibodies - United States. MMWR Morb Mortal Wkly Rep 2012; 61:237.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/49/24346/abstract/50\">",
"      Waalen K, Kilander A, Dudman SG, et al. Age-dependent prevalence of antibodies cross-reactive to the influenza A(H3N2) variant virus in sera collected in Norway in 2011. Euro Surveill 2012; 17.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/49/24346/abstract/51\">",
"      Skowronski DM, De Serres G, Janjua NZ, et al. Cross-reactive antibody to swine influenza A(H3N2) subtype virus in children and adults before and after immunisation with 2010/11 trivalent inactivated influenza vaccine in Canada, August to November 2010. Euro Surveill 2012; 17.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/49/24346/abstract/52\">",
"      Silvennoinen H, Peltola V, Lehtinen P, et al. Clinical presentation of influenza in unselected children treated as outpatients. Pediatr Infect Dis J 2009; 28:372.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/49/24346/abstract/53\">",
"      Peltola V, Ziegler T, Ruuskanen O. Influenza A and B virus infections in children. Clin Infect Dis 2003; 36:299.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/49/24346/abstract/54\">",
"      Chiu SS, Tse CY, Lau YL, Peiris M. Influenza A infection is an important cause of febrile seizures. Pediatrics 2001; 108:E63.",
"     </a>",
"    </li>",
"    <li>",
"     Glezen WP. Influenza viruses. In: Feigin and Cherry's Textbook of Pediatric Infectious Diseases, Feigin RD, Cherry JD, Demmler-Harrison GJ, Kaplan SL (Eds), Saunders, Philadelphia 2009. p.2395.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/49/24346/abstract/56\">",
"      Glezen WP. Prevention of acute otitis media by prophylaxis and treatment of influenza virus infections. Vaccine 2000; 19 Suppl 1:S56.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/49/24346/abstract/57\">",
"      Grose C. The puzzling picture of acute necrotizing encephalopathy after influenza A and B virus infection in young children. Pediatr Infect Dis J 2004; 23:253.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/49/24346/abstract/58\">",
"      Togashi T, Matsuzono Y, Narita M, Morishima T. Influenza-associated acute encephalopathy in Japanese children in 1994-2002. Virus Res 2004; 103:75.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/49/24346/abstract/59\">",
"      Weitkamp JH, Spring MD, Brogan T, et al. Influenza A virus-associated acute necrotizing encephalopathy in the United States. Pediatr Infect Dis J 2004; 23:259.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/49/24346/abstract/60\">",
"      Henderson FW, Collier AM, Sanyal MA, et al. A longitudinal study of respiratory viruses and bacteria in the etiology of acute otitis media with effusion. N Engl J Med 1982; 306:1377.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/49/24346/abstract/61\">",
"      Rennels MB, Meissner HC, Committee on Infectious Diseases. Technical report: Reduction of the influenza burden in children. Pediatrics 2002; 110:e80.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/49/24346/abstract/62\">",
"      Rihkanen H, R&ouml;nkk&ouml; E, Nieminen T, et al. Respiratory viruses in laryngeal croup of young children. J Pediatr 2008; 152:661.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/49/24346/abstract/63\">",
"      Peltola V, Heikkinen T, Ruuskanen O. Clinical courses of croup caused by influenza and parainfluenza viruses. Pediatr Infect Dis J 2002; 21:76.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/49/24346/abstract/64\">",
"      Neuzil KM, Wright PF, Mitchel EF Jr, Griffin MR. The burden of influenza illness in children with asthma and other chronic medical conditions. J Pediatr 2000; 137:856.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/49/24346/abstract/65\">",
"      Miller EK, Griffin MR, Edwards KM, et al. Influenza burden for children with asthma. Pediatrics 2008; 121:1.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/49/24346/abstract/66\">",
"      Lahti E, Peltola V, Virkki R, Ruuskanen O. Influenza pneumonia. Pediatr Infect Dis J 2006; 25:160.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/49/24346/abstract/67\">",
"      Dawood FS, Fiore A, Kamimoto L, et al. Influenza-associated pneumonia in children hospitalized with laboratory-confirmed influenza, 2003-2008. Pediatr Infect Dis J 2010; 29:585.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/49/24346/abstract/68\">",
"      Newland JG, Laurich VM, Rosenquist AW, et al. Neurologic complications in children hospitalized with influenza: characteristics, incidence, and risk factors. J Pediatr 2007; 150:306.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/49/24346/abstract/69\">",
"      Maricich SM, Neul JL, Lotze TE, et al. Neurologic complications associated with influenza A in children during the 2003-2004 influenza season in Houston, Texas. Pediatrics 2004; 114:e626.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/49/24346/abstract/70\">",
"      Lin CH, Huang YC, Chiu CH, et al. Neurologic manifestations in children with influenza B virus infection. Pediatr Infect Dis J 2006; 25:1081.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/49/24346/abstract/71\">",
"      Amin R, Ford-Jones E, Richardson SE, et al. Acute childhood encephalitis and encephalopathy associated with influenza: a prospective 11-year review. Pediatr Infect Dis J 2008; 27:390.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/49/24346/abstract/72\">",
"      Haber P, DeStefano F, Angulo FJ, et al. Guillain-Barr&eacute; syndrome following influenza vaccination. JAMA 2004; 292:2478.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/49/24346/abstract/73\">",
"      Huang YC, Li WC, Tsao KC, et al. Influenza-associated central nervous system dysfunction in Taiwanese children: clinical characteristics and outcomes with and without administration of oseltamivir. Pediatr Infect Dis J 2009; 28:647.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/49/24346/abstract/74\">",
"      Hjalmarsson A, Blomqvist P, Brytting M, et al. Encephalitis after influenza in Sweden 1987-1998: a rare complication of a common infection. Eur Neurol 2009; 61:289.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/49/24346/abstract/75\">",
"      Wada T, Morishima T, Okumura A, et al. Differences in clinical manifestations of influenza-associated encephalopathy by age. Microbiol Immunol 2009; 53:83.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/49/24346/abstract/76\">",
"      Hu JJ, Kao CL, Lee PI, et al. Clinical features of influenza A and B in children and association with myositis. J Microbiol Immunol Infect 2004; 37:95.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/49/24346/abstract/77\">",
"      Agyeman P, Duppenthaler A, Heininger U, Aebi C. Influenza-associated myositis in children. Infection 2004; 32:199.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/49/24346/abstract/78\">",
"      Hall CB, Douglas RG Jr, Geiman JM, Meagher MP. Viral shedding patterns of children with influenza B infection. J Infect Dis 1979; 140:610.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/49/24346/abstract/79\">",
"      Gamboa ET, Eastwood AB, Hays AP, et al. Isolation of influenza virus from muscle in myoglobinuric polymyositis. Neurology 1979; 29:1323.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/49/24346/abstract/80\">",
"      Chi CY, Wang SM, Lin CC, et al. Clinical features of children infected with different strains of influenza B in southern Taiwan. Pediatr Infect Dis J 2008; 27:640.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/49/24346/abstract/81\">",
"      Mall S, Buchholz U, Tibussek D, et al. A large outbreak of influenza B-associated benign acute childhood myositis in Germany, 2007/2008. Pediatr Infect Dis J 2011; 30:e142.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/49/24346/abstract/82\">",
"      Hageman JC, Uyeki TM, Francis JS, et al. Severe community-acquired pneumonia due to Staphylococcus aureus, 2003-04 influenza season. Emerg Infect Dis 2006; 12:894.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/49/24346/abstract/83\">",
"      Ampofo K, Bender J, Sheng X, et al. Seasonal invasive pneumococcal disease in children: role of preceding respiratory viral infection. Pediatrics 2008; 122:229.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/49/24346/abstract/84\">",
"      Centers for Disease Control and Prevention (CDC). Severe methicillin-resistant Staphylococcus aureus community-acquired pneumonia associated with influenza--Louisiana and Georgia, December 2006-January 2007. MMWR Morb Mortal Wkly Rep 2007; 56:325.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/49/24346/abstract/85\">",
"      Reed C, Kallen AJ, Patton M, et al. Infection with community-onset Staphylococcus aureus and influenza virus in hospitalized children. Pediatr Infect Dis J 2009; 28:572.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/49/24346/abstract/86\">",
"      Centers for Disease Control and Prevention (CDC). Bacterial coinfections in lung tissue specimens from fatal cases of 2009 pandemic influenza A (H1N1) - United States, May-August 2009. MMWR Morb Mortal Wkly Rep 2009; 58:1071.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/49/24346/abstract/87\">",
"      Madhi SA, Klugman KP, Vaccine Trialist Group. A role for Streptococcus pneumoniae in virus-associated pneumonia. Nat Med 2004; 10:811.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/49/24346/abstract/88\">",
"      Simonsen L, Taylor RJ, Young-Xu Y, et al. Impact of pneumococcal conjugate vaccination of infants on pneumonia and influenza hospitalization and mortality in all age groups in the United States. MBio 2011; 2:e00309.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/49/24346/abstract/89\">",
"      Klugman KP, Chien YW, Madhi SA. Pneumococcal pneumonia and influenza: a deadly combination. Vaccine 2009; 27 Suppl 3:C9.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/49/24346/abstract/90\">",
"      Ampofo K, Herbener A, Blaschke AJ, et al. Association of 2009 pandemic influenza A (H1N1) infection and increased hospitalization with parapneumonic empyema in children in Utah. Pediatr Infect Dis J 2010; 29:905.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/49/24346/abstract/91\">",
"      Nguyen T, Kyle UG, Jaimon N, et al. Coinfection with Staphylococcus aureus increases risk of severe coagulopathy in critically ill children with influenza A (H1N1) virus infection. Crit Care Med 2012; 40:3246.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/49/24346/abstract/92\">",
"      Cheng VC, Lau YK, Lee KL, et al. Fatal co-infection with swine origin influenza virus A/H1N1 and community-acquired methicillin-resistant Staphylococcus aureus. J Infect 2009; 59:366.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/49/24346/abstract/93\">",
"      Tolan RW Jr. Toxic shock syndrome complicating influenza A in a child: case report and review. Clin Infect Dis 1993; 17:43.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/49/24346/abstract/94\">",
"      Rothberg MB, Haessler SD. Complications of seasonal and pandemic influenza. Crit Care Med 2010; 38:e91.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/49/24346/abstract/95\">",
"      Kumar K, Guirgis M, Zieroth S, et al. Influenza myocarditis and myositis: case presentation and review of the literature. Can J Cardiol 2011; 27:514.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/49/24346/abstract/96\">",
"      Sion ML, Hatzitolios AI, Toulis EN, et al. Toxic shock syndrome complicating influenza A infection: a two-case report with one case of bacteremia and endocarditis. Intensive Care Med 2001; 27:443.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/49/24346/abstract/97\">",
"      Sharkey R, Mulloy E, O'Neill G, et al. Toxic shock syndrome following influenza A infection. Intensive Care Med 1999; 25:335.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/49/24346/abstract/98\">",
"      Conway EE Jr, Haber RS, Gumprecht J, Singer LP. Toxic shock syndrome following influenza A in a child. Crit Care Med 1991; 19:123.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/49/24346/abstract/99\">",
"      Prechter GC, Gerhard AK. Postinfluenza toxic shock syndrome. Chest 1989; 95:1153.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/49/24346/abstract/100\">",
"      Peltola V, Reunanen T, Ziegler T, et al. Accuracy of clinical diagnosis of influenza in outpatient children. Clin Infect Dis 2005; 41:1198.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/49/24346/abstract/101\">",
"      Babcock HM, Merz LR, Dubberke ER, Fraser VJ. Case-control study of clinical features of influenza in hospitalized patients. Infect Control Hosp Epidemiol 2008; 29:921.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/49/24346/abstract/102\">",
"      van den Dool C, Hak E, Wallinga J, et al. Symptoms of influenza virus infection in hospitalized patients. Infect Control Hosp Epidemiol 2008; 29:314.",
"     </a>",
"    </li>",
"    <li>",
"     Centers for Disease Control and Prevention. Interim guidance on the use of influenza antiviral agents during the 2010-2011 influenza season file://www.cdc.gov/flu/professionals/antivirals/guidance/ (Accessed on January 10, 2011).",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/49/24346/abstract/104\">",
"      Robinson JL, Lee BE, Kothapalli S, et al. Use of throat swab or saliva specimens for detection of respiratory viruses in children. Clin Infect Dis 2008; 46:e61.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/49/24346/abstract/105\">",
"      Centers for Disease Control and Prevention. Evaluation of 11 commercially available rapid influenza diagnostic tests--United States, 2011-2012. MMWR Morb Mortal Wkly Rep 2012; 61:873.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/49/24346/abstract/106\">",
"      Ginocchio CC, Zhang F, Manji R, et al. Evaluation of multiple test methods for the detection of the novel 2009 influenza A (H1N1) during the New York City outbreak. J Clin Virol 2009; 45:191.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/49/24346/abstract/107\">",
"      Daum LT, Canas LC, Schadler CA, et al. A rapid, single-step multiplex reverse transcription-PCR assay for the detection of human H1N1, H3N2, and B influenza viruses. J Clin Virol 2002; 25:345.",
"     </a>",
"    </li>",
"    <li>",
"     New CDC-developed diagnostic lab test for flu approved. file://www.cdc.gov/media/releases/2011/p0902_diag_lab.html?s_cid=2011_p0902_diag_lab.htm (Accessed on September 21, 2011).",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/49/24346/abstract/109\">",
"      Uyeki TM. Influenza diagnosis and treatment in children: a review of studies on clinically useful tests and antiviral treatment for influenza. Pediatr Infect Dis J 2003; 22:164.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/49/24346/abstract/110\">",
"      Chartrand C, Leeflang MM, Minion J, et al. Accuracy of rapid influenza diagnostic tests: a meta-analysis. Ann Intern Med 2012; 156:500.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/49/24346/abstract/111\">",
"      Centers for Disease Control and Prevention (CDC). Performance of rapid influenza diagnostic tests during two school outbreaks of 2009 pandemic influenza A (H1N1) virus infection - Connecticut, 2009. MMWR Morb Mortal Wkly Rep 2009; 58:1029.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/49/24346/abstract/112\">",
"      Cruz AT, Cazacu AC, Greer JM, Demmler GJ. Rapid assays for the diagnosis of influenza A and B viruses in patients evaluated at a large tertiary care children's hospital during two consecutive winter seasons. J Clin Virol 2008; 41:143.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/49/24346/abstract/113\">",
"      Centers for Disease Control and Prevention (CDC). Evaluation of rapid influenza diagnostic tests for influenza A (H3N2)v virus and updated case count--United States, 2012. MMWR Morb Mortal Wkly Rep 2012; 61:619.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/49/24346/abstract/114\">",
"      Faix DJ, Sherman SS, Waterman SH. Rapid-test sensitivity for novel swine-origin influenza A (H1N1) virus in humans. N Engl J Med 2009; 361:728.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/49/24346/abstract/115\">",
"      Glezen WP. Modifying clinical practices to manage influenza in children effectively. Pediatr Infect Dis J 2008; 27:738.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/49/24346/abstract/116\">",
"      Grijalva CG, Poehling KA, Edwards KM, et al. Accuracy and interpretation of rapid influenza tests in children. Pediatrics 2007; 119:e6.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/49/24346/abstract/117\">",
"      Chan KH, Lam SY, Puthavathana P, et al. Comparative analytical sensitivities of six rapid influenza A antigen detection test kits for detection of influenza A subtypes H1N1, H3N2 and H5N1. J Clin Virol 2007; 38:169.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/49/24346/abstract/118\">",
"      Poehling KA, Zhu Y, Tang YW, Edwards K. Accuracy and impact of a point-of-care rapid influenza test in young children with respiratory illnesses. Arch Pediatr Adolesc Med 2006; 160:713.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/49/24346/abstract/119\">",
"      Bonner AB, Monroe KW, Talley LI, et al. Impact of the rapid diagnosis of influenza on physician decision-making and patient management in the pediatric emergency department: results of a randomized, prospective, controlled trial. Pediatrics 2003; 112:363.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/49/24346/abstract/120\">",
"      Benito-Fern&aacute;ndez J, V&aacute;zquez-Ronco MA, Morteruel-Aizkuren E, et al. Impact of rapid viral testing for influenza A and B viruses on management of febrile infants without signs of focal infection. Pediatr Infect Dis J 2006; 25:1153.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/49/24346/abstract/121\">",
"      Doan QH, Kissoon N, Dobson S, et al. A randomized, controlled trial of the impact of early and rapid diagnosis of viral infections in children brought to an emergency department with febrile respiratory tract illnesses. J Pediatr 2009; 154:91.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/49/24346/abstract/122\">",
"      Abanses JC, Dowd MD, Simon SD, Sharma V. Impact of rapid influenza testing at triage on management of febrile infants and young children. Pediatr Emerg Care 2006; 22:145.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/49/24346/abstract/123\">",
"      Mintegi S, Garcia-Garcia JJ, Benito J, et al. Rapid influenza test in young febrile infants for the identification of low-risk patients. Pediatr Infect Dis J 2009; 28:1026.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/49/24346/abstract/124\">",
"      Centers for Disease Control and Prevention. Evaluation of rapid influenza diagnostic tests for influenza A (H3N2)v virus and updated case count &mdash; United States, 2012. MMWR Morb Mortal Wkly Rep 2012; 61 (Early Release):1.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 5973 Version 25.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [1105-213.131.41.98-71122602D8-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f23_49_24346=[""].join("\n");
var outline_f23_49_24346=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H25\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY &amp; RECOMMENDATIONS",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      EPIDEMIOLOGY",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      Influenza activity",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H4\">",
"      Transmission",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H5\">",
"      Risk factors",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H6\">",
"      Disease burden",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H336495087\">",
"      - Outpatient visits",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H336495094\">",
"      - Hospitalization",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H336495101\">",
"      - Mortality",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H79747253\">",
"      H3N2 variant influenza",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H7\">",
"      CLINICAL FEATURES",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H8\">",
"      CLINICAL COURSE",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H9\">",
"      COMPLICATIONS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H10\">",
"      Otitis media",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H11\">",
"      Lower respiratory tract",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H9687278\">",
"      - Pneumonia",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H12\">",
"      Neurologic",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H13\">",
"      Myositis",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H14\">",
"      Bacterial coinfection",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H15\">",
"      - S. aureus",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H16\">",
"      Other complications",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H17\">",
"      DIAGNOSIS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H18\">",
"      Clinical suspicion",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H19\">",
"      Laboratory diagnosis",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H20\">",
"      - Indications",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H21\">",
"      - Specimen collection",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H22\">",
"      - Approach to testing",
"     </a>",
"    </li>",
"    <li class=\"bulletItem2\">",
"     <a class=\"outlineLink\" href=\"#H79747012\">",
"      H3N2 variant viruses",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H23\">",
"      Additional evaluation",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#PATIENT_INFORMATION\">",
"      INFORMATION FOR PATIENTS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H25\">",
"      SUMMARY AND RECOMMENDATIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H24965605\">",
"      ACKNOWLEDGMENT",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"PEDS/5973\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"PEDS/5973|ALG\">",
"      <a href=\"#\" title=\"ALGORITHMS\">",
"       ALGORITHMS",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_algorithm\" href=\"UTD.htm?28/25/29086\" title=\"algorithm 1\">",
"      Influenza testing when virus is circulating in the community",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_algorithm\" href=\"UTD.htm?26/5/26704\" title=\"algorithm 2\">",
"      RIDTs during periods of high influenza activity",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"PEDS/5973|FIG\">",
"      <a href=\"#\" title=\"FIGURES\">",
"       FIGURES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?27/38/28270\" title=\"figure 1\">",
"      Influenza hospitalization by age",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?12/3/12349\" title=\"figure 2\">",
"      Peak influenza activity",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"PEDS/5973|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?32/50/33579\" title=\"table 1\">",
"      Groups at high risk for influenza complications",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?26/60/27597\" title=\"table 2\">",
"      Flu signs symptoms children",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?31/2/31789\" title=\"table 3\">",
"      Influenza testing methods",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?28/60/29642?source=related_link\">",
"      Acute otitis media in children: Epidemiology, microbiology, clinical manifestations, and complications",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?21/16/21769?source=related_link\">",
"      Acute viral encephalitis in children and adolescents: Clinical manifestations and diagnosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?26/7/26746?source=related_link\">",
"      Antiviral drugs for the prevention and treatment of seasonal influenza in children",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?31/49/32536?source=related_link\">",
"      Bacterial tracheitis in children: Clinical features and diagnosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?33/53/34647?source=related_link\">",
"      Clinical manifestations and diagnosis of myocarditis in children",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?36/27/37305?source=related_link\">",
"      Clinical manifestations and diagnosis of pandemic H1N1 influenza ('swine influenza')",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?29/21/30042?source=related_link\">",
"      Epidemiology and clinical spectrum of methicillin-resistant Staphylococcus aureus infections in children",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?14/58/15272?source=related_link\">",
"      Epidemiology of influenza",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?27/26/28074?source=related_link\">",
"      Evaluation and management of fever in the neonate and young infant (less than three months of age)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?22/14/22762?source=related_link\">",
"      Fever without a source in children 3 to 36 months of age",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?35/56/36745?source=related_link\">",
"      Muscle enzymes in the evaluation of neuromuscular diseases",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?35/60/36808?source=related_link\">",
"      Parainfluenza viruses in children",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_patient\" href=\"UTD.htm?38/12/39105?source=related_link\">",
"      Patient information: Influenza prevention (Beyond the Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_patient\" href=\"UTD.htm?34/12/35013?source=related_link\">",
"      Patient information: Influenza symptoms and treatment (Beyond the Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?7/14/7402?source=related_link\">",
"      Pneumococcal (Streptococcus pneumoniae) conjugate vaccines in children",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?6/56/7050?source=related_link\">",
"      Respiratory syncytial virus infection: Clinical features and diagnosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?27/18/27946?source=related_link\">",
"      Seasonal influenza vaccination in children",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?7/52/8010?source=related_link\">",
"      Staphylococcal toxic shock syndrome",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?29/6/29802?source=related_link\">",
"      Treatment of invasive methicillin-resistant Staphylococcus aureus infection in children",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?9/41/9879?source=related_link\">",
"      Viral myositis",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f23_49_24347="Chemical elimination of poisons";
var content_f23_49_24347=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PULM%2F57040&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PULM%2F57040&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Methods for enhanced elimination of poisons",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tbody>",
"      <tr>",
"       <td>",
"        Multiple-dose activated charcoal",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Saline diuresis",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1_start\">",
"        Urinary ion trapping",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1\">",
"        Alkalinization",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1\">",
"        Acidification",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1_start\">",
"        Extracorporeal methods&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1\">",
"        Hemodialysis",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1\">",
"        Hemoperfusion",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1\">",
"        Hemofiltration",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1\">",
"        Peritoneal dialysis",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1\">",
"        Plasmapheresis",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1\">",
"        Exchange transfusion",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Hyperbaric oxygen",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Chelation therapy",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Cerebrospinal fluid removal",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Specific antibody-toxin binding",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f23_49_24347=[""].join("\n");
var outline_f23_49_24347=null;
var title_f23_49_24348="Diagnostic value of findings in suspected FBA";
var content_f23_49_24348=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PULM%2F64415&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=8\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PULM%2F64415&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=8\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Diagnostic value of specific findings in children with suspected foreign body aspiration",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tbody>",
"      <tr>",
"       <td class=\"subtitle1\">",
"        &nbsp;",
"       </td>",
"       <td class=\"subtitle1\">",
"        Positive Predictive Value",
"       </td>",
"       <td class=\"subtitle1\">",
"        Sensitivity",
"       </td>",
"       <td class=\"subtitle1\">",
"        Specificity",
"       </td>",
"       <td class=\"subtitle1\">",
"        Negative Predictive Value",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        History of choking",
"       </td>",
"       <td>",
"        50/63/78",
"       </td>",
"       <td>",
"        85/79/81",
"       </td>",
"       <td>",
"        21/46/33",
"       </td>",
"       <td>",
"        60/64/38",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Unilateral decrease in breath sounds",
"       </td>",
"       <td>",
"        84/84/-",
"       </td>",
"       <td>",
"        65/67/-",
"       </td>",
"       <td>",
"        88/85/-",
"       </td>",
"       <td>",
"        73/68/-",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Wheezing",
"       </td>",
"       <td>",
"        65/47/74",
"       </td>",
"       <td>",
"        33/10/60",
"       </td>",
"       <td>",
"        84/87/40",
"       </td>",
"       <td>",
"        57/45/26",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Radiopaque foreign body",
"       </td>",
"       <td>",
"        100/100/-",
"       </td>",
"       <td>",
"        20/7/-",
"       </td>",
"       <td>",
"        100/100/-",
"       </td>",
"       <td>",
"        57/47/-",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Unilateral obstructive emphysema",
"       </td>",
"       <td>",
"        81/86/-",
"       </td>",
"       <td>",
"        53/55/-",
"       </td>",
"       <td>",
"        88/89/-",
"       </td>",
"       <td>",
"        67/63/-",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Abnormal inspiratory radiograph",
"       </td>",
"       <td>",
"        72/-/83",
"       </td>",
"       <td>",
"        70/-/82",
"       </td>",
"       <td>",
"        74/-/44",
"       </td>",
"       <td>",
"        73/-/41",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    Diagnostic value of specific findings in children with foreign body aspiration, as estimated in three different case series in which the diagnosis was confirmed or excluded by bronchoscopy. Each value is given as Ref 1/Ref 2/Ref 3. A hyphen (-) is used where no data was provided by the reference.",
"    <div class=\"footnotes\">",
"     <p>",
"      &nbsp;",
"     </p>",
"    </div>",
"    <div class=\"reference\">",
"     Data from:",
"     <ol>",
"      <li>",
"       Martinot A, Closset M, Marquette CH, et al. Indications for flexible versus rigid bronchoscopy in children with suspected foreign-body aspiration. Am J Respir Crit Care Med 1997; 155:1676.",
"      </li>",
"      <li>",
"       Francois M, Thach-Toan, Maisani D, et al. [Endoscopy for exploration for foreign bodies of the lower respiratory tract of the child. Apropos of 668 cases.] Ann Otolaryngol Chir Cervicofac 1985; 102:433.",
"      </li>",
"      <li>",
"       Hoeve LJ, Rombout J, Pot DJ. Foreign body aspiration in children. The diagnostic value of signs, symptoms, and pre-operative examination. Clin Otolaryngol 1993; 18:55.",
"      </li>",
"     </ol>",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f23_49_24348=[""].join("\n");
var outline_f23_49_24348=null;
var title_f23_49_24349="Disorders causing visual hallucinations";
var content_f23_49_24349=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=NEURO%2F73106&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=NEURO%2F73106&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Disorders causing visual hallucinations",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tr>",
"      <td class=\"subtitle1\">",
"       Etiology",
"      </td>",
"      <td class=\"subtitle1\">",
"       Classification and characteristic features",
"      </td>",
"      <td class=\"subtitle1\">",
"       Location",
"      </td>",
"      <td class=\"subtitle1\">",
"       Triggers",
"      </td>",
"      <td class=\"subtitle1\">",
"       Duration",
"      </td>",
"      <td class=\"subtitle1\">",
"       Frequency",
"      </td>",
"      <td class=\"subtitle1\">",
"       Insight",
"      </td>",
"      <td class=\"subtitle1\">",
"       Associated symptoms",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"subtitle2_left\">",
"       Retinal pathology",
"      </td>",
"      <td>",
"       <p>",
"        Simple",
"       </p>",
"       <p>",
"        Intrinsic motion is common; eg, flashing lights",
"       </p>",
"      </td>",
"      <td>",
"       Monocular or binocular, depending on underlying pathology",
"      </td>",
"      <td>",
"       Valsalva if due to posterior vitreous detachment",
"      </td>",
"      <td>",
"       Seconds",
"      </td>",
"      <td>",
"       Variable",
"      </td>",
"      <td>",
"       Intact",
"      </td>",
"      <td>",
"       Possible vision loss per abnormal funduscopic examination",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"subtitle2_left\">",
"       Vision loss, release hallucinations",
"      </td>",
"      <td>",
"       <p>",
"        Simple or complex",
"       </p>",
"       <p>",
"        Can be stationary, have intrinsic motion, or move en bloc",
"       </p>",
"      </td>",
"      <td>",
"       Monocular or binocular, full field or hemifield depending on underlying pathology",
"      </td>",
"      <td>",
"       Sensory deprivation, decreased arousal",
"      </td>",
"      <td>",
"       Variable",
"      </td>",
"      <td>",
"       Frequent, at least weekly, up to multiple times in one day",
"      </td>",
"      <td>",
"       Often intact",
"      </td>",
"      <td>",
"       Related to underlying condition",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"subtitle2_left\">",
"       Migraine",
"      </td>",
"      <td>",
"       <p>",
"        Usually simple and geometric in form; eg, fortification spectra, scintillating scotoma",
"       </p>",
"       <p>",
"        Spread or movement across the visual field over minutes is characteristic",
"       </p>",
"      </td>",
"      <td>",
"       <p>",
"        Binocular, usually hemifield",
"       </p>",
"       <p>",
"        Often start centrally and move to periphery",
"       </p>",
"      </td>",
"      <td>",
"       Migraine triggers (eg, lack of sleep, red wine, menses)",
"      </td>",
"      <td>",
"       Several minutes to an hour",
"      </td>",
"      <td>",
"       Variable, usually less often than weekly",
"      </td>",
"      <td>",
"       Intact",
"      </td>",
"      <td>",
"       Migraine headache, often with nausea, vomiting, photophobia",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"subtitle2_left\">",
"       Seizures",
"      </td>",
"      <td>",
"       <p>",
"        Simple more common than complex",
"       </p>",
"       <p>",
"        Typically circular and colored",
"       </p>",
"       <p>",
"        Movement across the field is rapid (seconds)",
"       </p>",
"      </td>",
"      <td>",
"       Binocular, hemifield",
"      </td>",
"      <td>",
"       Usually occur without trigger",
"      </td>",
"      <td>",
"       Seconds to 1-2 minutes",
"      </td>",
"      <td>",
"       Variable",
"      </td>",
"      <td>",
"       Usually intact",
"      </td>",
"      <td>",
"       Other ictal phenomena (eg, automatisms, deja vu, convulsions), postictal headache common",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"subtitle2_left\">",
"       Dementia with Lewy bodies, Parkinson disease",
"      </td>",
"      <td>",
"       Simple or complex",
"      </td>",
"      <td>",
"       Binocular, full field",
"      </td>",
"      <td>",
"       Usually no trigger",
"      </td>",
"      <td>",
"       Variable, usually minutes",
"      </td>",
"      <td>",
"       Variable, can be daily",
"      </td>",
"      <td>",
"       Variable, perhaps related to cognitive status",
"      </td>",
"      <td>",
"       Dementia, Parkinsonism",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"subtitle2_left\">",
"       Alcohol withdrawal",
"      </td>",
"      <td>",
"       Complex, often associated with auditory and tactile hallucinations",
"      </td>",
"      <td>",
"       Binocular, full field",
"      </td>",
"      <td>",
"       Abstinence",
"      </td>",
"      <td>",
"       Persistent",
"      </td>",
"      <td>",
"       Persist during withdrawal",
"      </td>",
"      <td>",
"       Often impaired",
"      </td>",
"      <td>",
"       Autonomic disturbances, confusion, agitation",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"subtitle2_left\">",
"       Peduncular hallucinosis",
"      </td>",
"      <td>",
"       Complex, often associated with auditory and tactile hallucinations",
"      </td>",
"      <td>",
"       Binocular, full field",
"      </td>",
"      <td>",
"       More common in evening hours",
"      </td>",
"      <td>",
"       Variable may persist",
"      </td>",
"      <td>",
"       Variable",
"      </td>",
"      <td>",
"       Maybe impaired",
"      </td>",
"      <td>",
"       Sleep disturbances, other brainstem or diencephalic signs",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"subtitle2_left\">",
"       Narcolepsy",
"      </td>",
"      <td>",
"       Complex, often associated with auditory and tactile hallucinations",
"      </td>",
"      <td>",
"       Binocular, full field",
"      </td>",
"      <td>",
"       Usually on falling to or on awakening from sleep",
"      </td>",
"      <td>",
"       Variable, seconds to minutes",
"      </td>",
"      <td>",
"       Often nightly",
"      </td>",
"      <td>",
"       Usually intact",
"      </td>",
"      <td>",
"       Cataplexy, excessive daytime sleepiness, sleep paralysis",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"subtitle2_left\">",
"       Psychiatric illness",
"      </td>",
"      <td>",
"       Complex, often associated with auditory and tactile hallucinations",
"      </td>",
"      <td>",
"       Binocular, full field",
"      </td>",
"      <td>",
"       No trigger",
"      </td>",
"      <td>",
"       Variable",
"      </td>",
"      <td>",
"       Frequent",
"      </td>",
"      <td>",
"       Usually absent",
"      </td>",
"      <td>",
"       Disordered thoughts, delusions",
"      </td>",
"     </tr>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f23_49_24349=[""].join("\n");
var outline_f23_49_24349=null;
var title_f23_49_24350="Stimulants and antidepressants - palliative care";
var content_f23_49_24350=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PALC%2F85673&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=10\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PALC%2F85673&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=10\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Management of depression in adult palliative care patients: Pharmacologic therapy with stimulants and antidepressants*",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <colgroup span=\"5\" width=\"20%\">",
"     </colgroup>",
"     <tbody>",
"      <tr>",
"       <td class=\"subtitle1\">",
"        Drug",
"       </td>",
"       <td class=\"subtitle1\">",
"        Starting dose",
"       </td>",
"       <td class=\"subtitle1\">",
"        Suggested dose range",
"       </td>",
"       <td class=\"subtitle1\">",
"        Role",
"       </td>",
"       <td class=\"subtitle1\">",
"        Precautions",
"        <sup>",
"         &bull;",
"        </sup>",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle2_left\" colspan=\"5\">",
"        Psychostimulants",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Methylphenidate (immediate release)",
"       </td>",
"       <td>",
"        2.5 mg orally each morning and noon",
"       </td>",
"       <td>",
"        5 to 10 mg orally each morning and noon",
"       </td>",
"       <td rowspan=\"3\">",
"        Applies to methylphenidate, dextroamphetamine and modafinil: Useful for treatment of depression in patients with life-expectancy of weeks to months, or requiring prompt relief of symptoms, including apathy, cognitive impairment, low energy, anorexia",
"        <sup>",
"         &Delta;",
"        </sup>",
"        , hypersomnia. Counteracts opioid associated sedation. Onset of action 24 to 48 hours. Titrate dose upward as needed after one to two days.",
"       </td>",
"       <td rowspan=\"3\">",
"        Applies to methylphenidate, dextroamphetamine and modafinil: Insomnia, restlessness, agitation, palpitations, increased blood pressure, anorexia",
"        <sup>",
"         &Delta;",
"        </sup>",
"        , tremor, dry mouth. Risk of cardiac decompensation in patients with heart disease. Give doses early in the day; some patients may need an additional half dose of methylphenidate in late afternoon.",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Dextroamphetamine",
"       </td>",
"       <td>",
"        5 mg each morning",
"       </td>",
"       <td>",
"        5 to 15 mg orally each morning and noon",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Modafinil",
"       </td>",
"       <td>",
"        100 mg each morning",
"       </td>",
"       <td>",
"        200 mg orally each morning",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle2_left\" colspan=\"5\">",
"        Selective serotonin reuptake inhibitors (SSRIs)",
"        <sup>",
"         &loz;",
"        </sup>",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Citalopram",
"       </td>",
"       <td>",
"        10 mg per day",
"       </td>",
"       <td>",
"        20 to 40 mg per day",
"        <sup>",
"         &sect;",
"        </sup>",
"       </td>",
"       <td rowspan=\"2\">",
"        Applies to citalopram and escitalopram: Effective for anxiety, generally well-tolerated, non-sedating, low risk of sleep disturbance or sexual side effects. Comparatively few significant drug interactions.",
"       </td>",
"       <td>",
"        Applies to citalopram: Dose related risk of QT prolongation. Mild discontinuation symptoms may occur absent tapering.",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Escitalopram",
"       </td>",
"       <td>",
"        5 mg per day",
"       </td>",
"       <td>",
"        10 to 20 mg per day",
"       </td>",
"       <td>",
"        Applies to escitalopram: Mild discontinuation symptoms may occur absent tapering.",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Sertraline",
"       </td>",
"       <td>",
"        25 mg per day",
"       </td>",
"       <td>",
"        50 to 100 mg per day",
"       </td>",
"       <td>",
"        Non-sedating, low risk of insomnia, lacks significant cardiovascular effects.",
"       </td>",
"       <td>",
"        More frequent gastrointestinal symptoms including diarrhea. Variable oral bioavailability. Oral solution contains alcohol. Discontinuation symptoms may occur absent tapering.",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Fluoxetine",
"       </td>",
"       <td>",
"        10 mg per day",
"       </td>",
"       <td>",
"        20 to 40 mg per day",
"       </td>",
"       <td>",
"        Activating effect may be useful for treatment of depressed patients with low energy or hypersomnia. Tapering upon discontinuation is not needed due to long half-life.",
"       </td>",
"       <td>",
"        Prolonged half-life and active metabolites require weeks to reach steady-state, prolonging time needed to evaluate effect of dose adjustment and complicating wash-out and withdrawal. Less well tolerated than sertraline.",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Paroxetine",
"       </td>",
"       <td>",
"        10 mg per day in evening",
"       </td>",
"       <td>",
"        20 to 40 mg per day",
"       </td>",
"       <td>",
"        Sedating; possibly useful for depressed or anxious patients with insomnia.",
"       </td>",
"       <td>",
"        Weakly anticholinergic. May cause constipation, dry mouth or drowsiness. Associated with more severe discontinuation symptoms in absence of tapering.",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle2_left\" colspan=\"5\">",
"        Serotonin norepinephrine reuptake inhibitors (SNRIs)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Venlafaxine (extended release)",
"       </td>",
"       <td>",
"        37.5 mg per day",
"       </td>",
"       <td>",
"        75 to&nbsp;225 mg&nbsp;per day",
"       </td>",
"       <td>",
"        Activating effect may be useful for treatment of melancholic depressed patients with low energy or hypersomnia. Useful for patients with comorbid painful conditions such as diabetic neuropathy.",
"       </td>",
"       <td>",
"        Insomnia. May cause dose-dependent increases in blood pressure (primarily diastolic) and heart rate. Associated with more severe discontinuation symptoms in absence of tapering.",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Duloxetine",
"       </td>",
"       <td>",
"        10 to 20 mg per day",
"       </td>",
"       <td>",
"        20 to 60 mg per day",
"       </td>",
"       <td>",
"        Useful for patients with comorbid painful conditions such as diabetic neuropathy, chemotherapy-induced neuropathy, or chronic pain. Mildly sedating. Low risk of insomnia.",
"       </td>",
"       <td>",
"        Significant drug interactions.",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle2_left\" colspan=\"5\">",
"        Atypical antidepressants",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Bupropion (sustained release)",
"       </td>",
"       <td>",
"        75 mg in morning initially then twice daily",
"       </td>",
"       <td>",
"        150 mg in morning and mid-afternoon (twice daily)",
"       </td>",
"       <td>",
"        Activating effect may be useful for treatment of depressed patients with low energy and apathy. Low risk of cognitive toxicity. Dopaminergic action may be advantageous for depressed patients with Parkinson disease.",
"       </td>",
"       <td>",
"        Avoid in seizure disorders and depressed patients with agitation. Dose-dependent increase in diastolic blood pressure. Insomnia, constipation, dry mouth, dizziness.",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Mirtazapine",
"       </td>",
"       <td>",
"        7.5 mg every evening",
"       </td>",
"       <td>",
"        15 to 60 mg every evening",
"       </td>",
"       <td>",
"        Sedating; useful for patients with insomnia or who may benefit from weight gain. Appetite stimulant and anti-nausea effects can be noted within days.",
"       </td>",
"       <td>",
"        Drowsiness, weight gain. Prolonged half-life and active metabolites. Risk of accumulation with renal and/or hepatic insufficiency.",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Trazodone",
"       </td>",
"       <td>",
"        12.5 to 25 mg taken 30 to 60 minutes before bedtime for hypnotic effect",
"       </td>",
"       <td>",
"        25 to 100 mg taken 30 to 60 minutes before bedtime for hypnotic effect",
"       </td>",
"       <td>",
"        Used in low doses as an adjunct to SSRI for treatment of insomnia.",
"       </td>",
"       <td>",
"        Sedation, orthostatic hypotension, nausea. Residual daytime sedation and cognitive impairment.",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle2_left\" colspan=\"5\">",
"        Tricyclic antidepressants (TCAs)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Desipramine",
"       </td>",
"       <td>",
"        10 mg every morning",
"       </td>",
"       <td>",
"        25 to 150 mg every&nbsp;morning or in two divided doses",
"       </td>",
"       <td>",
"        Mild stimulant effects may be useful for depressed patients with low energy and hypersomnia who have not responded to first line antidepressants. Useful for patients with comorbid painful conditions such as diabetic neuropathy. Established therapeutic serum concentration 125 to 300 ng/mL.",
"       </td>",
"       <td rowspan=\"2\">",
"        Applies to desipramine and nortriptyline: Not well tolerated in palliative care patients due to anticholinergic effects including dry mouth, delirium, constipation, urinary retention or altered vision. May be fatal in overdose. Can cause arrhythmia or orthostatic hypotension. Significant drug interactions.",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Nortriptyline",
"       </td>",
"       <td>",
"        10 mg every evening",
"       </td>",
"       <td>",
"        10 to 100 mg every evening or in two divided doses",
"       </td>",
"       <td>",
"        Mildly sedating. Taken at bedtime for depressed patients with insomnia. May be useful for melancholic, anxious, depressed patients who have not responded to first line antidepressants. Useful for patients with comorbid painful conditions such as diabetic neuropathy. Established therapeutic serum concentration 50 to 150 ng/mL.",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"     * The onset of action for psychostimulants is generally faster than that for conventional antidepressants (&lt;24 hours versus 4 to 8 weeks).",
"     <br/>",
"     <span class=\"bullet\">",
"      &bull;",
"     </span>",
"     For additional information on specific side effects, refer to table on Side effects of antidepressant medications.",
"     <br/>",
"     &Delta; Apathetic patients without appetite, who respond to stimulant medications, generally have an improvement in appetite.",
"     <br/>",
"     <span class=\"lozenge\">",
"      &loz;",
"     </span>",
"     In general, SSRIs associated with few drug interactions; easy to titrate, minimal cardiac side effects.",
"     <br/>",
"     &sect; Maximum recommended daily dose of citalopram is 20 mg for patients &gt;60 years of age, with significant hepatic insufficiency, or taking interacting medications that can increase citalopram levels.",
"    </div>",
"    <div class=\"reference\">",
"     References:",
"     <br>",
"      <ol>",
"       <li>",
"        Kennedy G, Marcus P. Use of antidepressants in older patients with co-morbid medical conditions: guidance from studies of depression in somatic illness. Drugs Aging 2005; 22:273.",
"       </li>",
"       <li>",
"        Irwin S, Block, S. Depression. In: Evidence-Based Practice of Palliative Medicine, Goldstein NE, Morrison RS (Eds), Saunders, Philadelphia. In press.",
"       </li>",
"      </ol>",
"     </br>",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f23_49_24350=[""].join("\n");
var outline_f23_49_24350=null;
var title_f23_49_24351="Urine osmolality vs gravity";
var content_f23_49_24351=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=NEPH%2F75070&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=NEPH%2F75070&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Urine osmolality versus specific gravity",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 369px; height: 230px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Relationship between the specific gravity and osmolality of the urine from normal subjects who have neither glucose nor protein in the urine. For comparison, the relationship between the specific gravity and osmolality for glucose solutions is included. Glucose is larger than the main solutes in normal urine such as sodium, potassium, ammonium, and urea; as a result, a glucose solution has a higher specific gravity at a given osmolality than normal urine.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Data from Miles B, Paton A, deWardener H, Br Med J 1954; 2:904.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f23_49_24351=[""].join("\n");
var outline_f23_49_24351=null;
